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Abstract 
Enantiomerically pure a-hydroxy acids and their derivatives are an important class of organic 
compounds due to their utility as building blocks for the asymmetric synthesis of natural products 
and biologically active molecules. As a result, several synthetic strategies towards these targets 
have been reported in recent years. This thesis describes the applications of an ephedrine-based 
morpholine-dione as a chiral controller for the asymmetric synthesis of a-hydroxy acid 
derivatives. The methodology has been applied in enantioselective synthetic approaches to 
functionalized oxacycles as well as selected natural products such as (-)-quinic acid, (R)-
homocitric acid lactone and (+)-laurencin. 
A formal , enantioselective synthesis of (-)-quinic acid was achieved from a (1S,2R)-
ephedrine-derived morpholine-dione which was converted to a dialkyl morpholinone via a highly 
diastereoselective allylation reaction. Using a similar strategy and by employing the 
enantiomeric (1R,2S)-ephedrine-derived dione, a concise and highly enantioselective synthesis of 
(R)-homocitric acid lactone was achieved. 
Enantioselective routes to functionalized, seven-, eight-, and nine-membered oxacycles 
that are amenable to further elaboration have been developed. Salient features of the 
methodology include highly diastereoselective and regioselective transformations of an 
ephedrine-derived epoxy-morpholinone to functionalized precursors of the oxacycles. The 
ephedrine scaffold exerts remote stereocontrol in the functionalization of the appended oxacycle. 
An application of the strategy for the enantioselective synthesis of medium-sized 
oxacycles has been demonstrated in a convergent, enantioselective route to an advanced 
intermediate for the synthesis of the marine natural product (+)-laurencin. The methodology 
employs ring-opening of an ephedrine-based spiro-epoxide with a chiral secondary alcohol, 
Ill 
hemiacetal allylation and ring closing metathesis as the key steps for elaboration of the 
functionalized medium-ring ether moiety in laurencin. 
Studies on applications of the epoxy-morpholinone in the synthesis of funtionalized 
pyrrolidines were also conducted. The methodology, which is currently under development, 
employs ring-opening of an ephedrine-based spiroepoxide with a primary amine. Ring-closing of 
the amine side-chain on the resulting hemiacetal should provide functionalized pyrrolidines. 
In the investigations described above, removal of the ephedrine portion has been 
achieved by reductive cleavage (dissolving metal reduction), which results in destruction of the 
ephedrine portion. Hence, potentially recoverable chiral amino alcohols were examined as 
alternatives to ephedrine. This study has identified diphenyl alaninol as a potential substitute for 
ephedrine and has also provided some insights into the morpholinone structural elements that are 
necessary for good diastereoselection. 
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Chapter 1 
Stereoselective Approaches for the Synthesis of 
a,a-Disubstituted a-Hydroxy Acids :An Overview 
2 
Introduction 
The stereoselective synthesis of a-hydroxy carboxylic acids is one of the most 
actively investigated areas in organic synthesis. 1 The a-hydroxycarboxyl group is found 
in several biologically important natural products such as the anti-cancer agent 
camptothecin/ the antifungal agent cryptoporiopsin3 and also in pharmaceutical agents 
such as the anti-diabetes drug (-)-ragaglitazar.4 In addition, the biological activities of 
several other complex natural products such as the cytotoxic leiodolide,53 anti-cancer 
agents in the harringtonine series5b and drugs from the taxane category, are dependent on 
their a-hydroxyester side chains.5c Moreover, a-hydroxy carboxylic acid derivatives are 
important building blocks in the asymmetric synthesis of biologically relevant 
molecules.6 (Figure 1). 
camptothecin 
(anti-cancer agent) 
cryptoporiopsin 
(anti-fungal) 
~ 0 0~ ~OH ~N~OAJ bEt 
v (-)-ragaglitazar 
(anti-diabetes) 
Figure 1. Examples of biologically active a-hydroxy carboxylic acid derivatives. 
A survey of the literature reveals that though several methods for the synthesis of 
a-hydroxy caroboxylic acids have been reported7 relatively few methods are suitable for 
3 
the synthesis of a,a-dialkyl a-hydroxy acids. This chapter aims at providing a brief 
overview of the developments in this field. 
Stereoselective synthesis of a,a-disubstituted-a-hydroxy acids 
From a retrosynthetic perspective, a,a-dialkyl-a-hydroxy acids can be envisioned to be 
accessed by four major routes, which are 
);> nucleophilic alkylation of a-keto acid derivatives (A) 
);> electrophilic alkylation of glycolic acid derivatives (B) 
);> hydrocyanation of ketones followed by hydrolysis (C) 
);> a-hydroxylation of enolates derived from esters and amides (D) 
D 
0 1) cyanohydrin formation 
R)lR
1
¢=:======= 
2) hydrolysis 
0 
R~0'R* 
0 
A Tinucleophilic attack of R1 8 
8 
R R1 )(._ · .OH 1) enolateformation 
HO' II 
0 2) reaction with 
RXand R1X 
C II 1) enolateformation 
ij 2) a-hydroxylation 
*R' and R * are chiral groups 
Figure 2. Retrosynthetic routes to a,a-dialkylated-a-hydroxy acids. 
The first two routes mentioned above, namely the nucleophilic alkylation of a-
keto acid derivatives (route A) and the electrophilic alkylation of glycolic acid derivatives 
(route B) employ chiral auxiliaries to modify the substrate. From a historical perspective, 
these routes have been at a preeminent position for the synthesis of a ,a-dialkylated-a-
c----:-- --- --- - --------------------- ~----- -
4 
hydroxy acids. The work reported in this thesis is also based on a similar concept. The 
asymmetric synthesis of a,a-dialkylated-a-hydroxy acids via the a-hydroxylation of 
enolates (route C) has been largely explored by a chiral reagent-based approach and the 
topic was last reviewed in 1992.8 Also, cyanohydrin formation from ketones (route D) for 
the asymmetric synthesis a ,a-dialkylated-a-hydroxy acids remains an active area of 
research.9 
A brief review of the major developments in the field of auxiliary-mediated 
reactions of glycolates and a-ketoacid derivatives follows. 
Route A: 
Diastereoselective nucleophilic addition to chiral a-ketoacid derivatives 
More than a century ago, McKenzie and co-workers discovered that the addition 
of Grignard reagents to a-ketoesters of chiral alcohols was a stereoselective process.10 In 
1971, Morrison and Mosher examined the addition of Grignard reagents to a-keto esters 
of (-)-mentho1. 11 Following this report, an asymmetric allylation of menthyl pyruvate and 
phenyl glyoxylate using allyltrimethylsilane as the nucleophile was disclosed by Ojima 
(16-55% ee). 12 In a notable development, Whitesell and Bhattacharya examined (-)-8-
phenylmenthol13 as a chiral auxiliary. 14 They reported that addition of Grignard reagents 
to a-ketoesters of (-)-8-phenylmenthol yielded the corresponding tertiary alcohols in high 
diastereomeric excess (>90%). The sense of asymmetric induction was rationalized by 
assuming a syn conformation for the a-ketoester in which the Re face of the ketone is 
shielded by the phenyl ring in the auxiliary (Scheme 1). 
Scheme 1. 
Si face attack 
favoured 
R =Ph, Me 
R1= Me, Ph 
5 
98-99% ee 
After the initial reports on the use of menthol and (-)-8-phenylmenthol, several 
other cyclohexane-based chiral auxiliaries such as chiro-inositol derivatives (96-98% 
ee ), 15 trans-2-pheny lcyclohexanol (82-91% ee ), 16•17 (1 R,2R)-2-nitrooxycyclohexan-1-ol 
(82- 86% ee), 18 and 2-aryloxycyclohexan-1-ols (83-97% ee) 19 were reported. Also, other 
chiral auxiliaries that are described in the literature include 2' -substituted-! , 1 '-
binapthalen-2-ols ( 4-52% de), 20 2,5-bis(methoxymethoxymethyl)pyrrolidine (1 0-90% 
de),21 chiral hydrobenzoin mono-tert-butyl ethers (45->98% de),22 and (-)-quinine.23 In 
1981 , Myers reported the alkylation of ketooxazolines (9-87% ee) by using chiral amino 
alcohols as chiral auxiliaries to prepare enantiomerically enriched a ,a-dialkyl a-hydroxy 
acids.24 Allylation of a-keto amides derived from proline esters has also been explored. 
However, the diastereoselectivities observed in these studies were not uniformly high (2-
92% ee).25 
In a recent development, Loupy and Monteux used selectively protected 
isomannide and isosorbide as chiral auxiliaries (Scheme 2)? 6 The chiral auxiliary was 
prepared by protecting one of the two hydroxyl groups in isosorbide as a benzyl ether and 
the second alcohol was esterified with benzoylformic acid. The ketone in the resulting 
substrate was shown to react with various organozinc reagents in a stereoselective 
fashion. Hydrolysis yielded the corresponding a-hydroxy acids. The stereochemical 
-----------
6 
outcome was found to vary for different nuclophiles (e.g. R = Et, 94% ee, R = iBu, 60% 
ee). 
Scheme 2. 
Hw 
H OH 
isosorbide 
i) BnBr, KOH 
H20 , reflux 
ii) PhCOCOOH, 
PTSA, toluene 
KOH 
MeOH 
RMgBr/ZnCI2 ! 
0 
R )\_O H 
Ph'bH )-¥._o, 
~-±-) 
10-90% ee H OBn 
Notably, this was the first report in which the introduction of groups other than 
methyl and phenyl as nucleophiles was demonstrated with good stereocontrol. On the 
other hand, metal-complex promoted asymmetric pyruvate Mukaiyama aldol reactions27 
have been reported with a variety of silyl enol ethers which have been used as 
nucleophiles. In these reports, (-)-8-phenylmenthot27b and (-)-menthot27c have been 
examined as auxiliaries. The stereoselectivities observed were low to moderate (24-76% 
de for (-)-8-phenylmenthol and 18-68% de for (-)-menthol). In 1994, Akiyama and co-
workers273 reported a synthesis of functionalized tertiary alcohols by diastereoselective 
aldol reactions of silyl enol ethers and ketene silyl acetals with a-keto esters bearing 
chiro-inositol as the chiral auxiliary. These reactions provide good yields and excellent 
stereoselectivities (70-98%, 94-96% de, Scheme 3). 
7 
Scheme 3. 
oQ os;Me, 
0 /S~e2tBu j 
o_ .Jl ~R1 
olr R 
~ O SnCI4, CH2CI2 
l_) R=PhorMe 
R1 = tBu, Ph, OEt 
Despite these successes, it should be pointed out that all of the studies mentioned 
above suffer from a common drawback, that is, they all employ either pyruvates or 
benzoylformates as starting materials. Not surprisingly, this has resulted in limited the use 
of this approach for the synthesis of a ,a-dialkylated a-hydroxy acids and there is a need 
for new protocols with broader substrate scope and good stereocontrol. 
In a conceptually different synthesis of a-hydroxy acids, Tamm and co-workers28 
examined an organometallic chiral auxiliary (Scheme 4). The Michael addition of n-BuLi 
to an enantiomerically pure a-benzyloxyacryliron(II) complex followed by stereospecific 
protonation (with water) or alkylation (with alkyl halides) of the intermediate enolate 
provides a-hydroxy carbonyl derivatives with 80-95% diastereoselectivity (Scheme 4). 
Oxidative cleavage of the iron-carbon bond followed by hydrogenolysis of the benzyl 
ether provides the a-hydroxy acids. 
Scheme 4. 
BnO 
(115-C5H5)(CO)(Ph3P)*Fe-r 
0 
. . BnO R . 
1) nBuL1 (11 5-C5H5)(CO)(Ph3P)*Fe~ 1) Cl2 /MeOH 
ii) Rl 0 ii) H2 I Pd-C 
R = H, Me, Et 
HO~~ /'--.._/'-.... lf .- - . 
0 
80-95% ee 
8 
Route B: 
Diastereoselective alkylation of chiral glycolates. 
In 1981, Frater demonstrated the diastereoselective alkylations of 2-substitituted-1 ,3-
dioxalan-4-ones (65-85% de).29 It was shown that the a-anions of 2-substitituted-1 ,3-
dioxalan-4-ones derived from mandelic and lactic acid (Scheme 5) could be alkylated 
with high stereoselectivity. The resulting products were then hydrolysed to the 
corresponding a,a-disubstituted a-hydroxy acids. This protocol was later termed as the 
"self regeneration of stereocenters" (SRS) by Seebach. 6r, ?b 
Scheme 5 
R2 
OH R2CHO 0 ............... 0 1) LOA, R3X OH 
R''..J'cooH p-TsOH R~40 2)hydrolysis R'''.~COOH 1 H benzene 1 R3 
80 oc 65-85% ee 
On similar lines, Seebach reported his protocol for the asymmetric synthesis of 
a,a-dialkyl a-hydroxy acids.6f,?b In this procedure, enantiomerically pure chiral a-hydroxy 
acids could be reacted with unsymmetrical ketones or aldehydes to obtain chiral cyclic 
acetals with embedded memory of chirality (Scheme 6). On enolisation, of the a-hydroxy 
stereocenter (the original chirality of the hydroxy acid) would be lost, but owing to the 
embedded chirality in the acetal, subsequent alkylation ofthe enolate is facially selective. 
The a,a-disubstituted-a-hydroxy acid can then be revealed by hydrolysis of the acetal 
(Scheme 6). The approach is commonly known as 'self regeneration of stereocenters' . 6f,?b 
However, the use of a enantiomerically pure starting material greatly limits the flexibility 
9 
of this approach, especially when the starting enantiopure a-hydroxy acids are not easily 
available. 
Scheme 6 
0 0 
HOOClR1 tBuCHO, TsOH, >f}R, Base, R2X 0~R2 H20/H+ 0 R1 H"R2 
OH H2S04, pentane ~0 R1 HO OH 
82-95% ee 
A conceptually similar protocol was disclosed by Ley and co-workers wherein 
they demonstrated the utility of a lactic acid-derived dispiroketal ("DISPOKE") for the 
synthesis of a ,a-disubstituted-a-hydroxy acids (Scheme 7).7c The procedure was based on 
an observation that the reaction of 1,2-diols with a bis-enol ether gave a single 
diastereomer of the dispiroketal product, presumably due to the influence of anomeric 
effects. Alkylation of the spiroketal followed by hydrolysis provided a ,a-dialkyl-a-
hydroxy acids with >97% ee. 7c,30 
Scheme 7 
MexOH 0-o 
0 OH 1 0 mol% HCI, Ph Me 
Me PH 
RACOOH 
>97% ee 
Later, in an important development of their DISPOKE based protocol, Ley and 
co-workers reported the synthesis of a ,a-dialkyl-a-hydroxy acids by using glycolic acid 
as a starting material (Scheme 8). 30'31 This approach requires enantiomerically enriched 
bis( enol ethers) as starting materials. 
10 
Scheme 8 
OH RJJuR 
OJ:OH----P-PT_S_,_T_H_F __ ~ 
R 
R 
R 
LDA,THF, 
then Mel 
-78 oc 
R 
R 
1\ 
HO OH , 
MeOH, CSA 
LDA,THF, 1 
then BnBr 
-78 oc 
R 
R 
The enolate of the dispiroketal obtained from glycolic acid (Scheme 8) could be 
sequentially alkylated to give the dialkylated dispiroketal as a single diastereomer. This 
could be hydrolysed to yield the a ,a-dialkyl a-hydroxy acid product. This improvement 
circumvented the need to use the enantiomerically pure hydroxy acids as starting 
materials and hence carries special significance in the synthesis of a ,a-dialkyl-a-hydroxy 
acids. 
In another study of approaches toward the targets under discussion, Uang and co-
workers employed (lS)-(+)-.N,N-diisopropyl-10-camphorsulfonamide as a chiral 
auxiliary.32 In this investigation, they observed that condensation of the dimethoxy acetal 
of the chiral auxiliary with racemic lactic or mandelic acid proceeded under 
thermodynamic control to provide the product spiroacetal as a single diastereomer with 
'S' stereochemistry at the a-carbon (Scheme 9). 
Scheme 9. 
11 
R1 ,R2 
HOXCOOH 
>98% de 
Subsequent enolate formation and alkylation with a variety of alkyl halides 
proceeded with excellent diastereoselectivity (> 98%). Hydrolysis of the dialkylation 
products provided the a,a-disubstituted-a-hydroxy acids. 
In a recent study, Tanabe and co-workers successfully in synthesized a-hydroxy-
~-ketoesters in good yields (~90%) by an asymmetric TiCl4-mediated cross-Claisen 
condensation of a chiral dioxane dione derived from atrolactic acid33 (Scheme 1 0). 
Scheme 10 
Other routes 
oo R,--1 Jl MeONa, 
TiCI4 -Bu3N R '"i' ·o MeOH 
R1COCI ___ ___. 2 o!(\"'' 
O Ph 
33-78% de 
In 1979, Terashima and Koga demonstrated a halolactonisation-based strategy for 
the synthesis of a,a-dialkyl-a-hydroxy acids. This method uses a,~-unsaturated acids and 
proline as the starting materials. 34 The procedure involves N-acylation of proline with the 
a,~-unsaturated acid chloride and a diastereoselective halolactonisation of the resulting 
amide. A mixture of halolactones (~95:5) was obtained. The diastereomers were 
~~---------------------------------------------------------------------------------------
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separated and subjected to reductive debromination (nBu3SnH) followed by acidic 
hydrolysis to provide the target a,a-dialkyl-a-hydroxy acids (Scheme 11). 
Scheme 11 
98% ee 
Qyo 
~~~' 
2 I H 
In 1996, Jacobson and Reddy35 described the asymmetric reactions of chiral imide 
enolates (obtained from Evans' N-acyl oxazolidones36) on a-ketoesters to generate 2-
hydroxy-2,3-trisubstituted succinates, albeit with poor to moderate diastereoselectivities 
(4-66% de, Scheme 12). 
Scheme 12 
1) LOA, -78 °C, THF 
2) R1COCOOR 
4-66% de 
More recently, it was shown that the Bayer-Villiger rearrangement can be 
employed for regioselective and stereoselective oxidation of a,a-disubstituted-~-
ketoesters to provide a ,a-dialkylated-a-hydroxy acid acetates.37 Thus, utilizing the fact 
that the Bayer-Villiger rearrangement proceeds with retention of configuration at the 
13 
migrating carbon, it was demonstrated that enantiomerically enriched substrates38 provide 
enantiomerically enriched a,a-disubstituted-a-hydroxy acids (Scheme 13). 
Scheme 13 
mCPBA, TfOH 
CH2CI2 
LiOH, THF 
0 
HO~OH 
Me' R1 
95% ee 
In 2007, Woerpel unveiled a unique diastereoselective strategy where a-keto-
esters were converted into a-hydroxy acids (2:97% de). The methodology involves metal-
catalyzed silylene transfer, 6n--electrocyclization, Ireland-Claisen rearrangement, and 
hydrolysis (Scheme 14).39 
Scheme 14 
0 
R,Yyo~R2 
0 
ii) HF. Pyr, rt 
t-Bu 
>v\ /t-Bu s· 1 , AgOTs (10 mol%) 
-25 •c, toluene 
HOXO~ 
R,- T ~ 
R2 
>97% de 
HF .Pyr, rt 
--
61t electro- J 
cyclization 
Importantly, this reaction sequence is stereoselective and tolerates alkyl and aryl 
substituted a-keto ester substrates. The a-hydroxy acids are obtained in moderate to good 
yields, and with excellent diastereoselectivites (47-84%, 2:97% de). 
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Examples of diastereoselective and chiral metal-complex-promoted asymmetric 
pyruvate Mukaiyama aldol reactions are also documented.40 However, only one example 
of catalytic enantioselective addition of enolsilanes to pyruvate esters is reported.41 •42 In 
this report, Evans revealed a bidentate bis( oxazolinyl)Cu(II) complex that served as an 
effective chiral Lewis acid catalyst for the enantioselecitive aldol reaction between 
enolsilanes and methyl pyruvate (Scheme 15). The aldol adducts were obtained in good to 
excellent yields (77-97%) and with excellent stereoselectivities (93-99% ee). 
Scheme 15 
-78 °C, THF 
R1 = H or Me or iBu 
R2 =EtS or iBuS or Ph or Me 
-M~HJ 
/
0 1( A R 2 
0 R1 
93-99% ee 
Nitroaldol reactions of a-ketoesters offer another route to the synthesis of a,a-
disubstituted-a-hydroxy acids and a few catalytic versions of this approach are reported.43 
Deng and co-workers43c have described the use of cinchona alkaloids as organocatalysts 
for nitroaldol reactions of a-ketoesters to synthesize the a,a-disubstituted-a-hydroxy acids 
in excellent yields and enantioselectivity (87-98%, 93-97% ee, Scheme 16). 
Scheme 16 
HO\(N02 
R" *YOEt 
0 
93-97% ee 
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The Pansare group demonstrated the use of (S)-prolinol as a chiral auxiliary for 
the synthesis of a,a-disubstituted a-hydroxy acids.44 Bis-acylation of (S)-prolinol with 
benzoylformyl chloride followed by selective ester hydrolysis in the amido ester 
intermediate gave the corresponding hemiacetal. This hemiacetal could be reacted with a 
variety of Grignard reagents (ca. 10 molar equivalents) to yield the corresponding a-
hydroxy arnides. Hydrolysis of the arnides afforded a-hydroxy acids in good yields and 
enantioselectivity (62-68%, 82-87% ee, Scheme 17). 
Scheme 17 
i) PhCOCOCI, Et3N, ~OH DMAP, CH2CI2 
~ ii) NaOH, THF 
RMgX l 
benzene o~ THF 
The Pansare group also reported a synthesis of a-hydroxy acids based on 
asymmetric carbon-carbon bond formation on an ephedrine-derived template.45 Using a 
commercially available and cheap starting material like (1R,2S)-ephedrine and acylating 
it with aliphatic a-keto acid chlorides afforded the corresponding hemiacetals (Scheme 
18) in good yields (65-71 %). The configuration of the hemiacetal stereocenter was 
established as 'S', based on X-ray crystallographic analysis. In the pivotal step of this 
sequence, the hemiacetals were allylated with allyltrimethylsilane/TiCl4 to give the 
16 
allylated morpholinones m good to excellent yields (67-97%), and as single 
diastereomers. 
Scheme 18 
Me 
Me,+ JyPh RCOCOCI, Et3N, DMAP 
H.N - I 
Cl H OH CH2CI2 
single diastereomer 
Removal of the ephedrine portion followed by reduction of the double bond and 
hydrolysis of the amide provided a,a-disubstituted chiral a-hydroxy acids (Scheme 19). 
These products were assigned the 'R ' configuration, by comparison of their optical 
rotation with reported values. 
Scheme 19 
Na, liq. NH3 
-78 oc 
Later, the group reported a modified one-pot synthesis of the hydroxy acids 
starting with an ephedrine-derived morpholine-dione.46 The chiral dione was obtained 
from (1R,2S)-ephedrine and oxalyl chloride (65%) and could be reacted with several 
Grignard reagents (Scheme 20) to generate the corresponding hemiacetal salts. These 
could then be allylated in situ to yield the corresponding dialkylated morpholinones 
which, in turn, had served as the intermediates in the synthesis of a,a-disubstituted-a-
,----,------------------------------------------ --
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hydroxy acids?1 This strategy is significantly different from those reported m the 
literature and provides excellent stereocontrol. 
Scheme 20. 
1/ 
~Si, ,TiCI4 
-78 octo -20 oc 
The utility of the ephedrine-based protocol would be highlighted if the 
methodology can be applied to interesting synthetic targets. Also, an investigation of the 
origin of stereoselectivity in the ephedrine derived oxazinone would be an important 
endeavour. Information from such studies could eventually lead to better chiral starting 
materials. These aspects were identified as goals of the doctoral studies described in this 
thesis. 
,----,--------------------------------------- -- --
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Chapter 2 
Formal Total Synthesis of (-)-Quinic Acid and Total Synthesis of 
(R)-Homocitric Acid Lactone 
Part of the work described in this chapter has been published in 
Organic Letters 2006, 8, 2035 
& 
Tetrahedron Letters 2007, 48, 7099 
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General introduction 
The art of organic synthesis is perhaps best illustrated by the applications of newer 
and better synthetic protocols towards definite targets. Indeed, development of a synthetic 
technique can be thought to be complete only when it is explained and applied towards a 
specific target. 
Over the past few years, the Pansare group has devised and reported a unique 
protocol for the synthesis of a-hydroxy acids1 by using an ephedrine-derived morpholine-
dione as a chiral starting material. This highly enantioselective strategy can serve as a 
useful alternative to the existing methods reported in the literature. To complete this 
study and also to elaborate the significance of this protocol, it was decided to apply it 
towards the synthesis of natural products falling in the class of a -hydroxy acids. Towards 
this end, (-)-quinic acid and (R)- homocitric acid were chosen as the targets. 
Chapter 2 is divided into two sections to describe the synthesis of each of the 
natural products separately along with a literature overview of the known approaches 
towards these targets. 
25 
Part 1: A concise and enantioselective formal total synthesis of 
(-)-quinic acid. 
Introduction 
HXOOH 
HO''~OH 
OH 
1 
(-)-Quinic acid 
COOH 
H0''.00H 
OH 
2 
(-)-Shikimic acid 
Figure 1. Quinic acid and Shikimic acid. 
Over the past few decades (-)-quinic acid (1 , Figure 1) has proven to be a useful 
chiral building block in asymmetric synthesis and has been employed as the starting 
material in numerous syntheses? Recently, the synthetic utility of (-)-quinic acid (1) has 
been highlighted because of its use as a starting material for the synthesis of viral 
neuraminidase inhibitors for the treatment of influenza.3 In fact, the current industrial 
procedure for the synthesis of Oseltamivir (3, Figure 2), an antiviral drug manufactured 
by Hoffmann-La Roche (Roche) under the trade name Tamiflu® uses both (-)-quinic acid 
(1) and (-)-shikimic acid (2) as starting materials. 3 
~ 
O,,,('YCOOEt 
AcHNA/ 
NH2 . H3P04 
3 
Figure 2. Oseltamivir (Tamiflu®) 
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Incidentally, in 2005, Roche announced a production shortage for Tamiflu®.4 
According to Roche, the major bottleneck in Oseltamivir production was the availability 
of (-)-quinic acid which cannot be synthesized economically and is isolated from Chinese 
star anise, an ancient cooking spice. Thus, influenced by its synthetic applicability, we 
decided to undertake an enantioselective synthesis of (-)-quinic acid. 
(-)-Quinic acid is found in plants and organisms and has a regulating role in the 
biosynthesis of aromatic compounds in the shikimate pathway.5 The biosynthesis of(-)-
quinic acid is also being actively investigated as a target in the search of new herbicidal, 
antifungal, antibacterial and antiparasitic agents that do not affect mammals.6 Owing to 
the high level of interest in this natural product, several enantioselective routes toward its 
synthesis have been described in the literature 7 and a summary depicting key 
transformations in these reports follows. 
Known synthetic routes to (-)-guinic acid 
This summary is focused primarily on the enantioselective syntheses of (-)-quinic 
acid. However, the discussion will start with Wolinsky's synthesis8 of racemic quinic 
acid, since some of the formal enantioselective syntheses are aimed at making a key 
intermediate in Wolinsky's synthesis. 
Wolinsky's synthesis starts with a Diels-Alder reaction of methyl-a-acetoxy 
acrylate (4) and 1,3-butadiene (5) to provide cyclohexene 6 (Scheme 1). 
,----,--------------------------------~---------
Scheme 1 
0 
AcOI{oMe•) 
4 5 
HXOOH 
HO''~OH 
OH 
1 
(±) quinic acid 
OH 
HO~OH 
0 
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ll) (cat.) 
160 °C, 24 h 
70% 
Ac00.. COOMe H00.. COOH H0, 1 N NaOH 1) NaHC03 (aq) . 0 0 7 d 0 2) Br2, H20 
72% 34% B-r (±)-8 {±)-6 (±)-7 
Et3N, C6H6 , 
76 % 130-180 oc 
7d 
. Ho-0 Ho~--· 00 1) Ca(0Hh,H20 , 48 h . '· O -~-~--·-· __ _ s 4 , pynd1ne, 
ii) Dowex AGSOW-X HO'' . THF, -78 ac, Sh 
92% OH 
(±)-10 
76% 
(±)-9 
Hydrolysis of 6 followed by bromolactonization afforded bromolactone 8 which 
was dehydrohalogenated to the bicyclic lactone 9. Stereoselective dihydroxylation of 9 
with osmium tetroxide provided 10. Finally, hydrolysis of the lactone in 10 provided 
quinic acid (1) in racemic form. 
In 1971, Bestmann and Heid reported the first enantioselective synthesis of(-)-
quinic acid from D-arabinose (11) (Scheme 2).7a Using the chemistry previously 
developed by their group,9 the authors demonstrate the formation of the functionalized 
cyclohexene in quinic acid from an arabinose-derived starting material 12. Treatment of 
the intermediate 12 with three molar equivalents of methylenetriphenyl phosphorane 
yielded the ylide 13. Cyclic ylide 13 was then transformed into ketone 14 over four steps. 
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The ketone in 14 was stereoselectively converted into the triacetylquinic acid nitrile by 
treatment with HCN and the resulting tertiary alcohol was acetylated to generate 
tetracetyl derivative 15. (-)-Quinic acid was then obtained from 15 (Scheme 2) following 
the previously reported procedure by Grewe. 10 
Scheme 2 
CHO 10Ts PPh3 HOE BnO CH2=PPh3 Bn0''.00Bn OH OBn (3 equiv.) ------OH OBn 
OH OTs OBn 
D-arabinose (11) 12 13 
~ t 4 steps 
AcO, CN 0 Ho:OH AcO'..c:s~OAc (i) HCN Ac0''.60Ac ~---HO'' . OH 4 steps (ii) Ac20 
OH OAc OAc 
1 15 14 
Nearly two decades after this report, Tamm and Meier reported their synthesis of 
(-)-quinic acid 1 from (-)-shikimic acid 2 (Scheme 3).7b The synthesis was devised around 
a stereoselective epoxidation11 of the intermediate 16 (obtained from shikimic acid) by 
using the cis-directing effect of the C-5 hydroxyl group in 16. Thus, epoxidation of 16 
with t-butyl hydroperoxide in the presence of vanadium diacetate as a catalyst yielded the 
epoxide 17, which, in turn, was subjected to a regioselective ring-opening by sodium 
thiophenolate to afford tertiary alcohol 18. Reductive removal of the phenylthio group in 
,...,...-,,....,--- -------------------------------- ·------~··--
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18 gave 19, which was then deprotected to provide (-)-quinic acid (1) in an overall yield 
of21-25% from (-)-shikimic acid (2). 
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A biocatalytic approach for the synthesis of (-)-quinic acid 1 from D-glucose (20) 
by using an E. coli strain (AB2848/pKD136/pTW8090A) was described by Frost in 
1992. 7e Later, the Frost group documented a refined procedure (Scheme 4) to make (-)-
quinic acid from glucose by using a different strain of E. coli (QPl.llpKD12.138).7g 
Notably, in this report, the authors admitted that significant optimization of the process is 
necessary before this route could be used on an industrial scale. 
Scheme 4 
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In another example of a biocatalysis-based approach, Sakai and co-workers 
reported a porcine liver esterase (PLE) catalyzed asymmetric hydrolysis of the meso 
diester 21 to obtain alcohol 22 (62%, 87% ee, Scheme 5).7c Compound 22 was then 
subjected to Swern oxidation to yield an enone which was stereoselectively reduced by 
employing Luche reduction conditions (NaBf4, CeCl)) to afford the alcohol 23. Inversion 
of the alcohol in 23 under Mitsunobu conditions and hydrolysis of the resulting acetate 
afforded compound 24 which could then be converted into compound 25, which is a 
known intermediate in Bestmann's synthesis of quinic acid7a (Scheme 2). 
Scheme 5 
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Renaud and co-workers reported a formal synthesis of (-)-quinic acid (1) based on 
their protocol for double alkylation of the chiral glycolate derivative 26 (Scheme 6).7r 
Double alkylation of 26 (obtained from 0-mannitol, 80% ee) provided a 2:1 mixture of 
diastereomers favoring 27 (51%). A ring closing metathesis reaction of 27 provided 
cyclohexene 28. Methanolysis of 28 yielded ester 29 which could then be converted into 
8 (82% ee) via hydrolysis and bromolactonization. Since Wolinsky8 had already reported 
--·-- -·---------
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the conversion of the bromolactone 8 into racemic quinic acid (Scheme 1), the above 
sequence accounts for a formal synthesis of the natural product. 
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Very recently, and after we reported our approach to (-)-quinic acid (1), 12 Stoltz 
and co-workers reported a catalytic enantioselective formal synthesis of (-)-quinic acid 1 
(Scheme 7). 13 This synthesis utilized a palladium-catalyzed asymmetric alkylation of the 
silyl enol ether derivative 32 to obtain dioxanones 33. An appropriate intermediate (33, R 
=allyl) was converted into the cyclohexene intermediate 7 (Scheme 1) in the Wolinsky 
synthesis8 (Scheme 1 ). 
Scheme 7 
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Objectives: 
A study of the syntheses of (-)-quinic acid reported so far clearly warrants the 
development of a concise enantioselective route to (-)-quinic acid. The objective of this 
investigation was the development of an enantioselective formal synthesis of (-)-quinic 
acid employing the ephedrine-derived morpholine-dione based synthesis of a-hydroxy 
acids developed in Pansare group. 
Results and Discussion: 
It was decided to focus on the asymmetric construction of the a-hydroxy acid 
moiety in (-)-quinic acid, which was envisioned to be obtained from the ephedrine-
derived morpholine-dione 36, as shown in Figure 3. 
H.OQ'· COOH 
HO'' . OH 
OH 
(-)-quinic acid 
ref. 8 
'N~_,,Ph 
0~0 dialkylation 
0 
36 
Br 
8 
,··:·~:tlon 
~0:. 
......._ ~,,Ph ~CM and r~ductivf! cleavage of 
N 
1
• the ephedrme port1on 
0~~ l 35 
Figure 3. Retrosynthetic analysis for (-)-quinic acid. 
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It was decided to target the lactone 8 which was an intermediate in the Wolinsky 
synthesis of quinic acid (Scheme 1). It was reasoned that the lactone could be obtained 
via a bromolactonisation reaction of the hydroxy amide 34, which should be accessible 
from the diene 35. In the forward sense, this can be achieved by subjecting the diene to a 
ring closing metathesis reaction followed by removal of the ephedrine portion. The diene 
35 should be readily obtained from the dione 36, by following the dialkylation protocol 
previously reported by our group. 1 
The previously reported synthesis1b of the enantiomer of 36 employed (1R,2S) -
ephedrine and oxalyl chloride to provide the morpho line dione in 55% yield after 
purification by column chromatography (Scheme 8). In order to eliminate this low 
yielding step at the beginning of the synthesis it was decided to optimize the reaction 
conditions. After a brief study, ethyl oxalyl chloride was determined to be a better 
alternative to oxalyl chloride. This reagent is presumably less electrophilic than oxalyl 
chloride and this is reflected in an increased reaction time ( 48 h, as compared to 5 h for 
oxalyl chloride). However, a significantly improved yield (85%) of 36 was obtained. 
Moreover, the purification was reduced to a simple trituration of the crude product with 
9:1 hexanes:dichloromethane, thus eliminating the need for chromatographic purification. 
Using this modified procedure, dione 36 could be prepared on a 10 g scale. 
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The dione 36 was then reacted with the Grignard reagent derived from 4-bromo-1-
butene (Scheme 9) to yield the hemiacetal 37 (74%). The stereochemistry of the 
hemiacetal was found to be influenced by the reaction temperature during the addition of 
the Grignard reagent. Thus, if the Grignard addition was carried out at 0 °C, 37 was 
obtained as a 5:1 mixture ofdiastereomers eH NMR) as compared to a 1:1 mixture when 
the reaction was carried out at room temperature. The stereochemistry of the major 
diastereomer was not determined since it was inconsequential in further steps. 
In the context of the proposed retrosynthesis (Figure 3), it was now possible to try 
the crucial allylation reaction. An initial attempt using allyltrimethylsilane and BF3•Et20 
at -78 oc provided no product. However, warming the reaction mixture to 0 °C gave the 
desired product 35 (Scheme 9), albeit in a low yield (20%). The use of allyltributyltin as 
the nucleophile under identical conditions also provided 35 in a low yield (14%). 
----~---------------------
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Fortunately, it was determined that usmg TiC14 as the Lewis acid and 
allyltrimethylsilane as the nucleophile at -40 °C, provided the required dialkylated 
glycolamide derivative 35 in good yield (68%) and excellent diastereoselectivity (single 
diastereomer by 1H NMR). 
At this stage, the stereochemistry of the newly generated stereocenter in 35 was 
assigned the 'S' configuration on the basis of a NOE experiment, which indicated a syn 
orientation ofthe allyl group and the benzylic hydrogen in the morpholinone ring. 
Figure 4. NOE measurement on 35. 
This result was probably the outcome of a stereoelectronically controlled axial allylation 
of the oxocarbenium ion in a boat-like transition state assembly (Scheme 10). 
Scheme 10 
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Having obtained the diene 35, the stage was set for a ring-closing metathesis 
reaction to generate the cyclohexene derivative from the diene. Gratifyingly, use of the 
Grubbs (generation I) catalyst (7 mol%, CH2Ch, room temperature) resulted in a swift 
and efficient (1 h, 96%) ring-closing metathesis reaction to yield the spirocyclohexene 
derivative 38 (Scheme 11 ). Cyclohexene 38 was then subjected to dissolving metal 
reduction (Na!NH3, -78 °C) to remove the ephedrine portion and provide hydroxy amide 
34 in good yield (82%) and high enantiomeric excess (96%). 
Scheme 11 
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Details of this homobenzylic C-N bond cleavage are not known at present. It is 
plausible that, at some stage in the reduction, a benzylic carbanion is generated (Figure 5) 
and it undergoes facile .8-elimination of the N-acyl moiety. 14 
38 
-
. 
'NH 'N~.,,Ph . 
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Figure 5. Possible mechanism for the reductive cleavage of the ephedrine portion 
The key intermediate to (-)-quinic acid was obtained by bromolactonisation of 34 
(Scheme 12). Treatment of 34 with N-bromosuccinimide in moist THF at ambient 
temperature generated the bromolactone 8 (54% (unoptimized), 96% ee). 
Scheme 12 
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Spectroscopic data for lactone 8 were in agreement with those reported earlier/f, IS 
and the optical rotation confirmed the 'S' configuration at the a-hydroxy carboxylic acid 
stereocenter in the lactone ([a ]0 -11.1, ( c 2, CH2Ch); lit. 7f[ a ]0 -9.1 , ( c 1.36, CH2Ch) for 
material with 82% ee). This observation also confirmed the stereochemistry of the 
allylation reaction that provided 35 from hemiacetal 37. 
It is noteworthy that the above-mentioned highly stereoselective synthesis of 
dialkylglycoamide (35) from a chiral oxalic acid derivative (36) is an alternative to 
conventional approaches to crural a ,a-dialkylated glycolic acid derivatives that are based 
on sequential dialkylation of glycolate anions. 16 Importantly, the approach may be 
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advantageous when the SN2 reactivity of the electrophile is a limitation in the aruon 
alkylation protocol. 
To the best of our knowledge, this is the shortest and most efficient synthesis of 
enantiomerically enriched (-)-8. 12 The only other asymmetric synthesis7r of (-)-8 reported 
at the time when this work was published, employed an enantiomerically enriched 
dioxolanone (a chiral glycolate derivative with 80% ee) as the starting material, which 
was obtained by a multistep synthesis from D-mannitol, and the key dialkylation of the 
dioxolanone proceeded with low diastereoselectivity (211, Scheme 6). The present method 
represents a significant improvement since it requires fewer steps, and the 
dialkylglycolamide derivative 35 was easily prepared with high diastereoselectivity. It 
should be noted that even after the recent report 13 by Stoltz, the method reported in this 
thesis remains unsurpassed in terms of length and enantioselectivity. 
Racemic bromolactone 88 and its iodo-analogue 39 15 (Figure 6) are easily 
converted to the oxabicyclooctene derivative 98· 15 by dehydrohalogenation and 
subsequently to racemic quinic acid8 (two steps) and a racemic, protected 3-phospho-
shikimate derivative 40 15 (four steps). Hence, the present synthetic route to 
enantiomerically enriched 8 establishes a route to enantiomerically enriched quinic acid 
and shikimic acid derivatives. 
ref. 8,15 (10 
X (±) 9 
X= Br (±) 8 
X= I(±) 39 
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Figure 6. Halolactones 8 and 42 as precursors to quinic acid and shikimates. 
Conclusions: 
In conclusion, a short, enantioselective route to (-)-quinic acid that is extendable 
to shikimic acid derivatives has been developed. It is noteworthy that this method can 
provide access to either enantiomer of these biologically important metabolites since both 
enantiomers of ephedrine are commercially available. The oxalate dialkylation is an 
alternative to the conventional dialkylation of glycolate enolates and has potential for 
applications in the synthesis of polyhydroxylated cyclopentanes and cyclohexanes, as 
well as functionalized medium-sized carbocycles by variation of the alkenyl groups in 
morpholinone 38 (Scheme 9). 
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Experimental: 
General 
All reactions requiring anhydrous conditions were performed under a positive 
pressure of nitrogen using oven-dried glassware (120 °C) that was cooled under nitrogen. 
THF was distilled from sodium benzophenone ketyl and dichloromethane was distilled 
from calcium hydride. Commercial precoated silica gel (Merck 60F-254) plates were used 
for TLC. Silica gel for column chromatography was 230-400 mesh. All melting points 
were uncorrected. IR spectra were recorded on a Bruker TENSOR 27 spectrometer. 1H 
NMR and 13C NMR spectra were recorded on a Bruker A V ANCE-500 instrument. 
Coupling constants (J) are given in Hz. Mass spectra were obtained on an Agilent 1100 
series LC/MSD chromatographic system. High-resolution mass spectra were obtained on 
a Waters GCT Premier Micromass mass spectrometer. Optical rotations were measured at 
the sodium D line on a JASCO-DIP 370 digital polarimeter at ambient temperature. 
(SR,6S)-4,5-Dimethyl-6-phenylmorpholine-2,3-dione (36): 
To a stirred solution of (1S,2R)-ephedrine hydrochloride (2.0 g, 9.9 mmol) and 
DMAP (60 mg, 0.49 mmol) in dichloromethane (200 mL) at 0 oc was added 
triethylamine (5.5 mL, 40 mmol). The mixture was stirred for 10 min and a solution of 
oxalyl chloride (1.3 mL, 15 mmol) in dichloromethane (100 mL) was added dropwise 
over a period of 3.5 hat 0 °C. The mixture was stirred at 0 oc for an hour and water (50 
-------- ----------- ------------~ 
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mL) was added. The mixture was warmed to ambient temperature and the biphase was 
separated. The dichloromethane layer was washed with water (100 mL), dried (Na2S04) 
and concentrated. The residue was purified by flash column chromatography on silica gel 
(1/2 hexane/ethyl acetate) to furnish 1.20 g (55%) of36 as a white solid. 
Mp: 181-182 °C. 
1H NMR (500 MHz, CDCh): 
8 7.46-7.39 (m, 5H), 5.89 (d, 1H, J= 2.9), 3.71-3.68 (dq, 1H, J = 2.9, 6.8), 3.20 (s, 
3H), 1.13 (d, 3H, J = 6.8) 
13C NMR (125.8 MHz, CDC~)): 
8 156.6, 153.5, 134.1 , 129.2, 129.1 , 125.7, 79.8, 58.9, 33.8, 12.3. 
IR (solid): 
2933, 1752, 1698, 1409, 1290, 1215, 1142, 1001 cm-1 
[a]230 = +185.0 (c 2, CH2Ch ). 
MS (APCI): 
220.1 (M+1, 100). 
HRMS (CI): 
m/z 220.0965 (220.0974 calc. for. C12HI4N03, M+H). 
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(SR, 68)-2-But-3-enyl-2-hydroxy-4, 5-dimethyl-6-phenylmorpholin-3-one (37): 
To a suspension of36 (219 mg, 1 mmol) in anhydrous ether at oac was added 3-
butenylmagnesiumbromide (prepared from 720 mg of Mg and 0.35 mL of 4-bromobutene 
in ether (10 mL) and the mixture was warmed up to ambient temperature. The reaction 
mixture was stirred 3 h at ambient temperature and the precipitated solids were dissolved 
with saturated aqueous NH4Cl solution. The resulting mixture was extracted with ethyl 
acetate (3 x 10 mL), the combined organic layers was dried (Na2S04) and concentrated. 
Purification of the crude product by flash chromatography on silica gel (2/1 ethyl 
acetate/hexanes) gave 204 mg (74%) of37 as a white solid. 
1H NMR (500 MHz, CDCh): 
8 7.41-7.30 (m, 5H), 5.87-5.81 (m, 1H), 5.19 (d, 1H, J = 3.4), 5.0 (br m, 1H), 4.9 
(d, 1H, J = 10.3), 4.3 (s, 1H), 3.51 (dq, 1H, J = 3.4, 7.3), 3.0 (s, 3H), 2.42-2.37 (m, 
1H), 2.25-2.2.1 (m, 3H), 1.05 (d, J = 7.3, 3H). 
13C NMR (125 .8 MHz, CDCh): 
8 169.8, 138.4, 137.4, 128.6, 127.9, 125.7, 114.8, 98.2, 73.6, 59.4, 35.1 , 34.0, 
26.3, 12.7. 
Visible peaks of the minor diastereomer: 
1H NMR (500 MHz, CDCh): 
8 5.5 (d, lH, J= 3.0), 3.04 (s, 3H), 0.99 (d, J = 6.6, 3H). 
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13C NMR (125.8 MHz, CDCi]): 
8 168.5, 138.2, 137.7, 128.5, 127.8, 125.9, 115.0, 97.8, 71.5, 59.5, 38.7, 33.8, 
28.0, 12.8. 
IR (solid): 
3306, 1645, 902, 735, 695, 668 cm-1• 
MS (APCI, positive): 
m/z 148.1 (25), 164.1 (10), 258.1 (10), 276.1 (M+1 , 75). 
HRMS (CI): 
rn/z 276.1587 (276.1599 calc. for. C16H22N03, M+H)_ 
(2S,SR,6S)-2-Allyl-2-but-3-enyl-4,5-dimethyl-6-phenylmorpholin-3-one (35): 
To a solution of 37 (275 mg, 1 mmol) in dichloromethane at -78 °C was added 
TiC14 (0.66 mL, 6 mmol) and allyltrimethylsilane (0.95 mL, 6 mmol). The mixture was 
gradually warmed to - 40 °C and allowed to stir at this temperature for 4.5 h. Saturated 
NH4Cl solution was added and the mixture was warmed to ambient temperature. Water 
was added and the mixture was extracted with CH2Ch, dried (Na2S04) and concentrated 
under reduced pressure. The residue was purified by flash chromatography on silica (211 
ethyl acetate/hexane) to give 203 mg (68%) of35 as a colorless gum. 
---~----------- ----
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1H NMR (CDCh): 
8 7.39-7.29 (m, 5H), 5.89-5.80 (m, 2H), 5.26 (d, 1H, J= 2.4), 5.10-5.00 (m, 3H), 
4.97 (d, 1H, J = 10.5), 3.51 (dq, 1H, J= 6.5, 2.4), 3.03 (s, 3H), 2.85 (dd, 1H), 2.55 
(dd, 1H), 2.42-2.38 (m, 1H), 2.05-2.00 (m, 2H), 1.92-1.85 (m, 1H), 0.98 (d, 3H, 
1=6.5). 
13C NMR (125.8 MHz, CDC13): 
8 171.4, 138.7, 138.3, 133 .1, 128.6, 127.8, 125.8, 118.5, 114.8, 82.0, 71.8, 59.5, 
40.4, 37.5, 34.0, 28.8, 13.4. 
IR (neat): 
2978, 1640, 1146, 913, 759, 700 cm-1. 
[a)23o = + 44 (c 1, CH2Ch ). 
MS (APCI, positive): 
m/z 258.1 (7), 300.1 (M+1, 100). 
HRMS (CI): 
m/z 300.1953 (300.1964 calc. for. C19H26N02, M+H). 
(2S,3R,6S)-3,4-Dimethy 1-2-phenyl-1-oxa-4-azas piro [ 5.5] undec-8-en-5-one (38): 
'N~.,,Ph 
otJ,o ,, 
~ 
To a solution of 35 (960 mg, 3.2 mmol) in dichloromethane (350 mL) at room 
temperature was added Grubbs I catalyst (175 mg, 0.21 mmol, 6.6 mol%). The reaction 
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mixture was stirred for an hour at room temperature and the solvent was removed under 
reduced pressure. The residue was purified by flash chromatography on silica gel ( 111 
ethyl acetate/hexane) to give 830 mg (96%) of38 as a white solid. 
Mp: 78-79 oc. 
1H NMR (CDCh): 
o 7.37-7.28 (m, 5H), 5.79-5.77 (m, 1H), 5.57-5 .54 (m, 1H), 5.13 (d, 1H, J = 2.5), 
3.51 (dq, 1H, J = 6.4, 2.5), 3.04 (s, 3H), 2.67-2.62 (m, 1H), 2.50-2.42 (m, 1H), 
2.42-2.38 (m, 1H), 2.22-2.05 (m, 2H), 1.95-1.91 (m, 1H), 0.98 (d, 3H, J = 6.4); 
13C NMR (125.8 MHz, CDCh): 
0 172.4, 138.4, 128.3, 127.4, 126.1, 125.5, 123.2, 77.4, 71.7, 59.1 , 33.9, 31.8, 
30.8, 21.3, 12.7; 
IR (solid): 
2934, 2362, 1635, 1092, 700, 668, 656 cm-1• 
[a]230 = -15.6 (c 1, CHzCh ). 
MS (APCI, positive): 
m/z 270.1 (7), 372.1 (M+ 1, 100). 
HRMS (CI): 
m/z 272.1647 (272.1651 calc. for. C 17H22N02, M+H). 
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(1S)-1-Hydroxy-N-methylcyclohex-3-ene-1-carboxamide (34): 
To anhydrous liquid ammonia (distilled over sodium) was added Na (40 mg, 1.74 
mmol) at - 78 °C and the mixture was stirred for 15 min. To the resulting blue solution 
was added a solution of 38 (60 mg, 0.22 mmol) in anhydrous THF (2.5 mL) and the 
mixture was stirred for 3 min. A mixture of 2/1 methanol/water (3 mL) was added and the 
reaction mixture was brought to ambient temperature and stirred for 30 min to remove 
ammonia. The resulting solution was concentrated under reduced pressure and the residue 
was purified by flash column chromatography on silica gel (8/2 ethyl acetate/hexane) to 
yield 28 mg (82%) of34 as a white solid. 
Mp: 115-116 °C. 
1H NMR (CDCl]): 
8 6.83 (br s, 1H), 5.82-5.79 (m, 1H), 5.69-5.66 (m, 1H), 2.85 (d, 3H, J = 5.3), 
2.77-2.71 (m, 2H), 2.57 (s, 1H), 2.22-2.18 (m, 2H), 2.11-2.04 (m, 2H), 1.75-1.70 
(m, 1H). 
13C NMR (125 .8 MHz, CDCl3): 
8 176.4, 126.9, 123.9, 73.5, 35.6, 30.7, 26.2, 21.6. 
IR: 
3000, 3023, 1645, 1549, 1090, 932, 655 em· ' ; 
[u]230 = + 44.3 (c 1, CH2Ch); 
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MS (APCI, positive): 
m/z 138.1 (40), 156.1 (M+l, 100). 
HRMS (CI): 
m/z 156.1022 (156.1025 calc. for CsH14N0 2, M+H). 
HPLC: 
Enantiomeric excess: 95%, Chiralpak AD-H column, hexane/isopropyl alcohol 
9/1, flow rate 1 mL/min, tR (major): 6.6 min. tR (minor): 6.3 min. 
(1S,4R,5R)-4-Bromo-1-hydroxy-6-oxabicyclo(3.2.1 ]octan-7-one (8): 
Br 
To a solution of 34 (40 mg, 0.26 mmol) in THF (1 mL) was added N-
bromosuccinimide (70 mg, 0.39 mmol). The reaction mixture was stirred for an hour at 
room temperature, saturated aqueous NaHS0 3 solution (1.5 mL) was added and the 
mixture was then extracted with ethyl acetate (3 x 3 mL). The combined organic layers 
were dried (Na2S04) and concentrated under reduced pressure and the residue was 
purified by flash chromatography on silica gel to give 31 mg (54%) of 8 as a white solid. 
Mp: 119-120 oc. 
1H NMR (CDCh): 
o 4.83 (t, 1H, J = 5), 4.34 (t, 1H, J = 4.5), 2.90 (s, 1H), 2.84 (d, lH, J = 12), 2.51-
2.47 (m, 1H) 2.42-2.33 (m, 1H) 2.29-2.15 (m, 2H), 1.83-1.80 (m, lH). 
13C NMR (125.8 MHz, CDCh): 
8177.8, 77.7, 74.4, 43.4, 38.9, 31.1 , 28.6. 
IR: 
3485, 2925, 1763, 1128, 856, 668 cm-1• 
[a]23n = -11.1 (c 2, CH2Cb). 
MS (APCI, positive): 
m/z 111.2 (20), 149.1 (46), 177.1 (100), 199 (20), 221 (M+ l , 5). 
HRMS (CI): 
mlz 220.9810 (220.9814 calc. for C7H 10Br03, M+H); GC: fR = 51 min, 
Rt-~DEXsm column, 40-280 °C, 2 °C/min. 
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Part II: Enantioselective synthesis of (R)-homocitric acid 
lactone. 
Introduction 
50 
(R)-Homocitric acid (41, Figure 7) is a key intermediate in the biosynthesis of L-
lysine, an essential amino acid in some yeast and fungi, 17 and it is also a component of the 
Fe- Mo cofactor in nitrogenase enzymes. 18 The unique biological profile of homocitric 
acid is of interest in the development of antifungal therapies 19 and in the elucidation of 
the intricacies of nitrogen fixation?0 Studies toward these objectives require access to 
enantiomerically enriched (R)-homocitric acid and its analogues,21 neither of which are 
commercially available in significant amounts. Consequently, the enantioselective 
synthesis of homocitric acid, invariably isolated as its y-lactone 42 (Figure 7), has been 
actively investigated in recent years.22 Syntheses of the racemate have also been reported 
recently? 3 In addition, it has been observed that the alkyl citrate, isocitrate, or a-alkyl 
malate motifs, which are close congeners of homocitrates, are key pharmacophoric units 
in several bioactive alkaloids, glycosides and antifungal agents.24 This has added to the 
interest in substituted a-hydroxy di- and tri-carboxylic acid derivatives in recent years. 
HOyO 
I. OH HO~OH 
0 0 
41 
HO )=o 
-:. 0 
HOKY'O 
0 
42 
Figure 7. (R)-Homocitric acid (41) and (R)-homocitric acid lactone (42). 
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Structurally, (R)-homocitric acid is a deceptively simple target having only a 
single stereocenter. The favourably positioned alcohol and carboxylic acid functional 
groups are prone to lactonization, and hence homocitric acid has consistently been 
isolated as a y-lactone. Notably, interest in the enantioselective synthesis of (R)-
homocitric acid has increased over the last few years.22a-f The following section will give 
an overview of the known stereoselective methods for the synthesis of (R)-homocitric 
acid. 
Previous syntheses of (R)-homocitric acid. 
The first enantioselective synthesis of homocitric acid lactone, albeit the antipode 
of the natural isomer, was reported by Thomas, Kalyanpur and Stevens in 1966 (Scheme 
13).22g Incidentally, the synthesis was carried out primarily to establish the absolute 
configuration of (R)-homocitric acid by synthesis of its optical isomer, which could be 
obtained by degradation of (-)-quinic acid. In the first step of this endeavour, quinic acid 
was oxidised to the ketone 43 using a catalytic oxidation protocol reported by Haslam,25 
followed by complete reduction of the ketone moiety in 43 to generate the diol 44.26 
Periodate cleavage of the diol followed by in situ oxidation of the dialdehyde provided 
(S)-homocitric acid lactone (ent-42). 
Scheme 13 
Ho:OH 
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52 
It was not until three decades later that Biellmann and co-workers published 
the first enantioselective synthesis (Scheme 14) of the natural isomer of homocitric acid 
lactone 42 starting from (-)-L-lactic acid.22f In a sequence centered around a 
stereoselective Diels-Alder reaction, the authors used reported methods27 to make the key 
starting material 45 from lactic acid. 
Scheme 14 
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46 
Dioxolanone 45 was subjected to a Diels-Aider reaction with 1 ,3-butadiene to 
obtain the cyclohexene derivative 46. Ozonolysis of 46 followed by oxidative workup 
provided the diacid 47. Hydrolysis of the dioxolanone 47 provided (R)-homocitric acid 
lactone 42 in low yield (16%, 96% ee). In the same report, the authors also describe the 
synthesis of (S)-homocitric acid 41 from ent-45 which was prepared from (S)-serine. 
~ -- ----~---------------------------------
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In 1997, Russell and co-workers used (S)-a-methylbenzylamine for the 
resolution of the racemic citric acid derivative 48 (50 g scale). The (S,R) salt 49 (20%) 
provided the required enantiomer 50 (Scheme 15).22e 
Scheme 15 
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1) Oxalyl chloride 
2) CH2N2, Et20 
THF:H20 (2:1) 
88% 
51 (R = CH2N2, 80 %) 
52 (R = CH2CI, 15 %) 
With a dual purpose of confirming the absolute stereochemistry of 50 and 
demonstrating the usefulness of their protocol, the authors undertook the synthesis of (R)-
homocitric acid lactone. Homologation of (R)-50 was achieved by using the Arndt-Eistert 
protocol. Accordingly, the required diazo ketone 51 (80%) was obtained along with a 
significant amount of chlorinated ketone 52. The mixture was then converted into the 
desired homologue by treatment with silver nitrate to afford 53. The synthesis concluded 
with the hydrolysis of 53 to give the (R)-homocitric acid lactone 42. A comparison of the 
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specific rotation value of 42 with the reported vah.ie for (R)-homocitric acid lactone 
confirmed the absolute stereochemistry of 50 and also established a route to (R)-
homocitric acid lactone from citric acid. 
Palmer and Ma explored the SRS strategy?7 developed by Seebach for the 
synthesis of (R)-homocitric acid lactone (Scheme 16).22d Dioxolanone 54 was synthesized 
from D-malic acid and stereoselectively alkylated with allyl bromide to yield 55. 
Esterification of 55 followed hydroboration of the alkene and oxidative workup gave the 
diacid 56. Hydrolysis of dioxolanone 56 followed by basic hydrolysis of the methyl ester 
yielded the trisodium salt of R-homocitric acid (57) in an overall yield of 12% from D-
malic acid. 
Scheme 16 
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(12% overall yield) 
Paju and co-workers reported an interesting enantioselective synthesis of 42 
(Scheme 17).22c In an earlier report,28 the authors had demonstrated the synthesis of 
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spirodilactone 60 from the lactone 59 (57%, >95% ee), which, in turn, was obtained by 
asymmetric hydroxylation at the C-3 position of 3-(hydroxyethyl)cyclopentane-1 ,2-dione 
(58). Using this protocol for the synthesis of 60, the authors then showcased the utility of 
their method by demonstrating the oxidation of this spirodilactone to (R)-homocitric acid 
lactone. 22c 
Scheme 17 
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Tatsumi and co-workers described a slight modification22b of Palmer' s 
synthesis22d (Scheme 16) of (R)-homocitric acid lactone (Scheme 18). In their synthesis, 
they employed a 3-iodopropionate as an electrophile (Palmer used allyl bromide) to 
obtain compound 61 from the acid 54, thus decreasing the number of steps and achieving 
a higher overall yield. 
Scheme 18 
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(32% overall yield) 
The third example of a SRS strategl7 for the synthesis of (S)-homocitric acid 
lactone was described by Huang and Li, who reported a synthesis of ent-42 from (S)-
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phenylalanine (Scheme 19).223 This strategy relied on using the phenyl group as a latent 
carboxyl group.29 
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Thus, compound 62 was prepared from (S)-phenylalanine usmg a known 
procedure27 and then stereoselectively alkylated with allyl iodide27 to give dioxolanone 
63. Compound 63 could be converted into the antipode of the naturally occurring 
homocitric acid lactone (overall yield of 12%) by conversion of the benzyl group in 63 to 
an acetate side chain and by oxidation of the allyl group to a propionate side chain. 
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Objectives: 
The objective of this study was the enantioselective synthesis of (R)-homocitric 
acid lactone by employing an ephedrine-derived morpholinone as the starting material for 
the construction of the chiral a-hydroxy carboxylic acid functionality in homocitric acid. 
Results and Discussion: 
Homocitric acid is invariably isolated as a lactone ( 42). However, from the 
retrosynthetic perspective, the focus was on the synthesis of the homocitric acid ( 41) and 
the retrosynthetic analysis is shown below (Figure 8). 
HOyO 
I. OH 
HO~OH 
0 0 
41 
HO 0 
hydrolysis H~l OH 
N ''· OH / 
0 0 
64 
ozonolysis ll 
Figure 8: Retrosynthetic analysis ofhomocitric acid (41). 
Thus, (R)-homocitric acid (41) could be obtained by hydrolysis ofthe amide in 64. 
The carboxylic acid funtionalities in 64 can be generated by the oxidative cleavage of the 
alkene moieties in 65. The hydroxyl amide 65 should be readily available from the dione 
66, by following the dialkylation protocol previously reported by the Pansare group. 1 
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The morpholine-derived ephedrine dione1b 66 was chosen as the starting material 
in this study and was obtained (85%) from commercially available (1R, 2S) ephedrine and 
ethyl oxalyl chloride by following the procedure described in Part I (Scheme 8). 
Scheme 20 
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Treatment of 66 with freshly prepared butenylmagnesiurn bromide generated the 
hemiacetal 67 (82%, Scheme 21). The diasteroselectivity of the process was moderate 
(111- 5/1, depending on the reaction temperature) and the stereochemistry of the major 
diastereomer was not determined. 
Scheme 21 
~MgBr 
ether 0 oc to rt, 4 h 
82% 
The hemiacetal in 67 was readily allylated (TiC14, allyltrimethylsilane, -40 °C) to 
furnish the dialkylmorpholinone 68 (68%) as a single diastereomer (Scheme 22). The 
newly generated stereocenter in 68 was assigned the 'R' configuration on the basis of an 
NOE experiment, which indicated a syn orientation of the allyl group and the benzylic 
hydrogen in the morpholinone ring. 
Scheme 22 
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The a-hydroxy amide in 65 was obtained by subjecting 68 to dissolving metal 
reduction (N a, NH3, -78 °C, 81%, Scheme 22). The next objective was conversion of 65 
to the lactone 42. This would require a hydrolysis of the amide in 65 and oxidative 
cleavage of the alkenes to provide carboxylic acid functional groups. 
All attempts to hydrolyze the amide in 65 were unfruitful (Table 1 ). Heating 65 in 
aqueous acids led to multiple products, some of which were presumably derived from 
intramolecular alcohol-alkene etherification reactions of 65, whereas basic hydrolysis 
conditions resulted in decomposition. Attempts to activate the amide by N-nitrosation30 
were unsuccessful as were efforts to convert the amide into an iminiurn species or an 
imidate ester. 
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Table 1: Attempted hydrolysis ofthe amide 65 
~?H reagent &?H l;~ ---- 0 l;~ 
65 69 
Entry Reagents Conditions Result 
1 1NHC1 rtf reflux Decomposition 
2 2N LiOH rtf reflux No reaction 
3 KOH, ethanediol 150 oc Decomposition 
4 2NH2S04 rtf reflux Decomposition 
5 Me30+BF4-, CH3CN rt No reaction 
6 Me30+BF4-, CH2Ch rt No reaction 
7 N204, CH3CN then LiOOH 0 octo rt No reaction 
8 Tri2hosgene 0 octo rt Decom2osition 
An oxidative cleavage of the terminal alkenes in 65 by ozonolysis (Scheme 23) 
was also attempted. However, ozonation of 65 followed by an oxidative workup yielded a 
complex mixture of products. 
Scheme 23 
i) 03 
MeOH or CH2CI2 Complex mixture 
ii) H202 (30%) 
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The failure of the amide hydrolysis and complications with the alkene oxidation in 
65 prompted the exploration of an indirect hydrolytic strategy for conversion of the amide 
to a carboxylic acid. This involved a two step sequence that is shown in Scheme 24. 
Treatment of 65 with iodine (2.5 molar equiv.) yielded a mixture of products, which was 
probably obtained by iodolactonization involving the amide and the allyl group, and 
.-------------------------------------------------------------------
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iodoetherification of some of the iodolactone by reaction of the tertiary alcohol with the 
butenyl group to generate a spiro ring system. The exact sequence of these events is not 
known. In principle, the lactonization as well as the iodoetherification products should 
readily generate the required acid 69 after metallation with zinc. 
Scheme 24 
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Fortunately, when the mixture of products (70, 71) obtained by 
iodolactonization/iodoetherification was subjected to dehalogenative elimination with 
zinc, the hydroxy acid 69 was obtained in excellent yield (91 %). Tlus observation 
provided some credence to the proposed reactions of 65 (Scheme 24) with iodine. 
The final step of the synthesis required the oxidative cleavage of the two terminal 
alkenes in 69 (Scheme 25). Tills was readily achieved by treating 69 with K.Mn04 and 
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Nal04 in aqueous acetone. Acidification of a sodium bicarbonate extract of the crude 
reaction product furnished (R)-homocitric acid y-lactone 42 (64%, 98% ee). 
Scheme 25 
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The specific rotation of the isolated lactone was in agreement with that of the 
natural product ([a]230 -57.0 (c 1, H20); (lit.6c [a]230 -48.9 (c 0.38, H20)). This new 
synthesis of (R)-homocitric acid y-lactone proceeds with an overall yield of 20% starting 
from commercially available (1R,2S) -ephedrine. 
Conclusions: 
In conclusion, an enantioselective synthesis of (R)-homocitric acid y-lactone by 
using the ephedrine dione-based protocol for a-hydroxy acid synthesis was demostrated. 
The approach is flexible and several variations can conceivably be incorporated if 
desired. For example, the antipode of (R)-homocitric acid y-lactone can be easily made by 
using the enantiomer of ephedrine. Also, it may be noted that the use of labelled butenyl 
Grignard reagents31 prepared from 4-bromobutene deuterated at C-4 should allow the 
introduction of deuterium into the lactone ring of 42. Similarly, the use of deuterated 
allyltrimethylsilanes32 should provide access to homocitrate that is deuterated in the 
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acetate side chain. The synthesis is therefore well suited for the preparation of labelled 
homocitrates20a that may be of interest in biological studies. 
Lastly, it should be mentioned that this route m conjunction with the 
stereo selective synthesis of (-)-quinic acid, clearly illustrates the utility of the protocol for 
the synthesis of a-hydroxy acids. 
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Experimental: 
(SS, 6R)-2-(But-3-enyl)-2-hydroxy-4,5-dimethyl-6-phenylmorpholin-3-one (67): 
To a suspension of 32 (1.75 g, 8.0 mmol) in anhydrous ether (25 mL) at 0 °C was 
added 3-butenylmagnesiumbromide (prepared from 600 mg of Mg and 2.6 mL of 4-
bromo-1-butene in ether (25 mL)) and the mixture was warmed up to ambient 
temperature. The reaction mixture was stirred 3 h at ambient temperature and the 
precipitated solids were dissolved with saturated aqueous NH4Cl solution. The resulting 
mixture was extracted with ethyl acetate (3 x 30 mL), the combined organic layers were 
dried (Na2S04) and concentrated. Purification of the crude product by flash 
chromatography on silica gel (211 ethyl acetate/hexane) gave 1.8 g (82%) of 67 as a white 
solid (1.8/1 mixture of diastereomers). 
o (500 MHz, CDCh): 7.4-7.3 (m, 5H), 5.92-5 .81 (m, lH), 5.21 (d, 1H, J = 3.4), 
5.1-5.0 (m, 1H), 4.95-4.92 (m, 1H), 3.51 (dq, 1H, J = 3.4, 7.3), 3.4 (bs, 1H), 3.0 
(s, 3H), 2.42-2.37 (m, 1H), 2.25-2.21 (m, 3H), 1.05 (d, J = 7.3, 3H). 
13C NMR (125 .8 MHz, CDCh): 
0 169.6, 138.2, 137.2, 128.4, 127.7, 125.5, 114.6, 98.0, 73.4, 59.2, 34.9, 33.8, 
26.1 , 12.5. 
Visible peaks of the minor diastereomer: 
1H NMR (500 MHz, CDCh): 
8 5.53 (d, 1H, J = 3.0), 3.04 (s, 3H), 0.99 (d, J= 6.6, 3H). 
13C NMR (125.8 MHz, CDCh): 
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8 168.5, 138.2, 137.7, 128.5, 127.8, 125.9, 115.0, 97.8, 71.5, 59.5, 38.7, 33.8, 
28.0, 12.8. 
IR (solid): 
3306, 1645, 902, 735, 695, 668 cm·1. 
MS (APCI, positive): 
m/z 148.1 (25), 164.1 (10), 258.1 (10), 276.1 (M+1 , 75). 
HRMS (CI, methane): 
m/z 276.1603 (276.1600 calc. for. C16H22N03, M+H). 
(2R,5S,6R)-2-AIIyl-2-but-3-enyl-4,5-dimethyl-6-phenylmorpholin-3-one (68): 
To a solution of 67 (1.8 g, 6.6 mmol) in dichloromethane (65 mL) at -78 oc was 
added TiC14 (4.3 rnL, 39.3 mmol) and allyltrimethylsilane (6.3 mL, 39.3 mmol). The 
mixture was gradually warmed to - 40 oc and allowed to stir at this temperature for 4.5 h. 
Saturated NH4Cl was added and the mixture was warmed to ambient temperature. Water 
was added, the biphase was separated and the aqueous layer was extracted with CH2Ch (3 
x 10 rnL). The combined extracts were dried (Na2S04) and concentrated. The residue was 
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purified by flash chromatography on silica (2/1 ethyl acetate/hexane) to give 1.34 g (68%) 
of 68 as a colorless gum. 
1H NMR (CDCb): 
8 7.38-7.28 (m, 5H), 5.89-5.80 (m, 2H), 5.26 (d, 1H, J = 2.4), 5.10-5.00 (br m, 
3H), 4.97 (br d, 1H, J = 10.5), 3.51 (dq, 1H, J = 6.5, 2.4 Hz), 3.03 (s, 3H), 2.86 
(dd, 1H, J = 14.7, 6.2,), 2.55 (dd, 1H, J = 14.7, 8.4), 2.42-2.38 (m, 1H), 2.05-2.00 
(m, 2H), 1.92-1.85 (m, 1H), 0.98 (d, 3H, J = 6.5). 
13C NMR (125.8 MHz, CDCl3): 
8 171.4, 138.7, 138.3, 133.1 , 128.6, 127.8, 125.8, 118.5, 114.8, 82.0, 71.8, 59.5, 
40.4, 37.5, 34.0, 28.8, 13.4. 
IR (neat): 
2978, 1640, 1146, 913, 759, 700 cm-1• 
MS (APCI, positive): 
m/z258.1 (7), 300.1 (M+1, 100). 
HRMS (CI, methane): 
mlz 300.1968 (300.1964 calc. for. C,9H26N02, M+H). 
Enantiomeric excess (HPLC): 
Chiralpak AD-H column, hexane/isopropyl alcohol 98:2, flow rate 1 mL/min, lR 
(major): 7.6 min., lR (minor): 8.4 min., 98% ee. 
[a]23o =- 48 (c 1, CH2Cb). 
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(2R)-2-Allyl-2-hydroxy-N-metbylhex-5-enamide (65): 
To anhydrous liquid ammonia (distilled over sodium) was added Na (0.68 g, 29.4 
mmol) at - 78 °C and the mixture was stirred for 15 min. To the resulting blue solution 
was added a solution of 68 (1.15 g, 4.2 mmol) in anhydrous THF (2.5 mL) and the 
mixture was stirred for 4.5 min. A mixture of 2/1 methanol/water (3mL) was added and 
the reaction mixture was brought to ambient temperature and stirred for 30 min to remove 
ammonia. The resulting solution was concentrated under reduced pressure and the residue 
was purified by flash column chromatography on silica gel (3/2 ethyl acetate/hexane) to 
yield 65 (620 mg, 81 %) as a white solid. 
Mp: 75-76 °C. 
1H NMR (500 MHz, CDCh): 
8 6.90 (bs, 1H), 5.84-5.73 (m, 2H), 5.17 (br m, 2H), 5.02 (br dd, 1H, J = 8.8, 1.6), 
4.95 (br d, 1H, J= 10.1 Hz,), 3.05 (s, 1H), 2.82 (d, 3H, J = 5.4 Hz), 2.68 (dd, 1H, 
J = 14.3, 6.7), 2.34 (dd, 1H, J = 14.3, 8.2), 2.24-2.16 (m, 1H), 2.03-1.94 (m, 2H), 
1.69-1.63 (m, 1H). 
13C NMR (125.77 MHz, CDCh): 
8 175.2, 138.3, 132.8, 120.0, 114.9, 77.5, 44.2, 38.4, 28.1 , 26.0. 
IR (solid): 
3346, 2949, 1641 , 1550, 1127,993,953, 903 cm-1• 
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MS (APCI, positive): 
184.1 (M+1, 100). 
HRMS (CI, methane): 
m/z 184.1335 (184.1338 calc. for C10H1sN02, M+H). 
(2R)-2-AIIyl-2-hydroxyhex-5-enoic acid (69): 
~OH ol;~ 
Iodine (610 mg, 2.4 mmol) was added to a solution of 65 (200 mg, 1.1mmol) in 
1:1 THF-H20 (6 mL) and the solution was stirred in the dark for 12 h. The solution was 
then extracted with ethyl acetate (3 x 10 mL) and the combined organic layers were 
washed with saturated aqueous sodium thiosulphate, dried (Na2S04) and concentrated 
under reduced pressure to yield 240 mg of yellow oil. This was dissolved in 3: 1 isopropyl 
alcohol:water (12 mL) and zinc (240 mg, 3.7 mmol) was added. The mixture was heated 
to reflux for 4 h and cooled to room temperature and filtered. The residue was washed 
with acetone (4 x 10mL) and the combined filtrates were concentrated under reduced 
pressure. The resulting solid was dissolved in ethyl acetate (20 mL) and the solution was 
extracted with saturated aqueous sodium bicarbonate (3 x 1 OmL). The combined extracts 
were acidified with 3 N HCl and the acidic solution was extracted with ethyl acetate (3 x 
15 mL). The combined extracts were dried (Na2S04) and concentrated under reduced 
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pressure to yield 170 mg (91 %) of 69 as a white solid. This material was pure eH NMR) 
and was used directly in the next step. 
Mp: 90-91 °C. 
1H NMR (500 MHz, CDCh): 
8 5.87-5.78 (m, 2H), 5.21-5 .00 (br m, 1 H), 5.19 (d, 1H, J = 5.9), 5.07 (br dd, 1H 
J = 15.6, 1.4), 4.99 (dd, 1H, J = 8.7, 1.4), 3.00 (broad, 1H), 2.60 (dd, 1H, J = 6.8, 
13.8), 2.46 (dd, 1H, J = 13.8, 7.2), 2.32-2.25 (m, 1H), 2.06 (s, 1H), 2.10-2.01 ((m, 
1H), 1.94 (m, 1H), 1.82 (m, 1H). 
13C NMR (125.77 MHz, CD2Ch): 
8 177.7, 138.3, 132.4, 120.3, 115.5, 77.7, 44.3, 38.3, 28.5. 
IR (solid): 
3078, 2954, 1718, 1642, 1094, 995, 915 cm-1• 
MS (APCI, negative): 
169.1 (M-1 , 100). 
HRMS (CI, methane): 
m/z 169.0866 (169.0865 calc. for. C9H1303, M-H). 
[a]230 = -10.6 (c 1, CH2Cb). 
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(R)-5-Carboxy-5-carbo:xymethyl-dihydrofuran-2(3H)-one (42): 
To a solution of 69 (120 mg, 0.71 mmol) in acetone (3 mL) was added a solution 
of KMn04 (34 mg, 0.22 mmol) in water (20 mL). The mixture was stirred for 10 min, 
solid Nal04 (1 .8 g, 8.5 mol) was added and the purple mixture was stirred for 48 h at 
ambient temperature. Methanol (5 mL) and cone. HCl (0.4 mL) were added and the 
mixture was stirred vigorously for 15 min. The resulting brick red mixture was filtered, 
the solids were washed with acetone and the combined filtrates were concentrated under 
reduced pressure. The residue obtained was dissolved in saturated aqueous sodium 
bicarbonate the solution was washed with ethyl acetate (2 x 15 mL). The aqueous layer 
was acidified with aqueous 6 N HCl and the acidic solution was concentrated to dryness. 
The residue was extracted with acetone (3 x 15mL) and the combined acetone extracts 
were concentrated under reduced pressure. The solid obtained was purified by flash 
chromatography on a short silica gel column (211 hexane/acetone) to yield 85 mg (64%) 
of 42 as a white solid. 
Mp: 146-147 oc (Lit. 1 mp: 146-148 °C;). 
1H NMR (500 MHz, D20): 
o 3.22 (d, 1H, J = 16Hz), 2.96 (d, 1H, J = 16Hz), 2.72 (br t, 2H, J = 7.5), 2.37-
2.33 (m, 1H), 2.33-2.29 (m, 1H). 
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1H NMR (500 MHz, d6 acetone): 
8 3.21 (d, 1H, J = 17.1), 3.02 (d, 1H, J = 17.1), 2.71-2.68 (m, 2H), 2.57-2.52 (m, 
1 H), 2.49-2.42 (m, 1 H). 
13C NMR (125.77 MHz, d6 acetone): 
8 176.9, 174.2, 171.1 , 83.9, 42.3, 32.4, 28.9. 
IR (neat): 
2952, 1793, 1683, 995, 945 cm-1• 
MS (APCI, negative): 187.1 (M-1 , 100). 
[a]230 = -57.0 (c 1, H20); lit.2 (a]20o = -48.9 (c 0.38, H20 ). 
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Appendix 1: 
1H and 13C NMR Spectra for Chapter 2 
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Chapter 3 
Enantioselective Synthesis of Functionalized Medium-Sized 
Oxacycles 
Part of the work described in this chapter has been published in 
Organic Letters 2006, 8, 5897 
-·- ·--------- ---------
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Introduction 
A significant number of natural products contain medium-sized oxacycles in their 
molecular framework. These natural products range from complex ladder-like polyethers 
such as brevetoxin, to other functionalized monocycles such as laurencin, lobatrienol and 
rogioloxepane (Figure 1 ). Several members of this class are under pharmacological 
investigations owing to their high ion-channel blocking, 1 antivira12 and antifungal 
. . . 3 
activities. 
0 
brevetoxin B 
::P···q-OH 
Br /''·b 
Aco-\___j--= 
( + )-rogioloxepane ( + )-lobatrienol ( + )-laurencin 
Figure 1. Natural products having the medium-sized oxacycle framework. 
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From a synthetic perspective, assembling these medium-sized scaffolds (especially 
eight-membered rings) is difficult primarily due to the following factors: 4 
);;> Entropic disfavour (making the ends of the ring meet) 
);;> Imperfectly staggered conformations (Pitzer strain) 
);;> Bond angle deformations (Baeyer strain) 
);;> Destabilizing transannular interactions ( enthalpic disfavour) 
Nevertheless, these issues have been addressed and, both general5 and target-oriented6 
strategies that address the stereoselective assembly of medium-sized oxacycles are 
reported in the literature. Several reviews covering this topic are available. 7 The following 
summary provides an overview of recently reported, general approaches to the 
stereo selective synthesis of medium-ring ethers. 
Recent developments m the stereoselective synthesis of medium-ring 
ethers. 
• Cyclization by C-C bond formation. 
·~.. Palenzuela and co-workers) reported an enantioselective synthesis of the a,~,a'-
trisubstituted cyclic ethers. Their approach starts with a hetero Diels-Alder reaction and 
the resulting adduct is transformed into a linear ether which in turn is cyclized to give the 
corresponding oxacycle. Thus, reaction of the diene 1 with the aldehyde 2 gave the 
dihydropyrans 3 and 4 as a 2.6:1 mixture of diastereomers (Scheme 1). The cycloaddition 
products were treated with ozone, followed by NaBH4 reduction, and the resulting 
mixture was methylated using diazomethane to yield a mixture of diastereomeric hydroxy 
-- ------ ---------------------------- ·-
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esters 5. At this point the diastereomers were separated by HPLC and the major isomer 5 
was converted into the epoxide 6. Treatment of the linear ether 6 with LDA effected the 
cyclization to afford the oxepane 7. Synthesis of an oxocane (8-membered ring) and an 
oxonane (9-membered ring) related to 7 was also demonstrated by using the appropriate 
dienes as starting materials. 
Scheme 1 
[
Ts 
TBDMSO 
+ 
1 
7 
LDA, THF 
-65 oc 
96% 
2 
BF3_Et20 
Et20, -25 oc 
82% 
1.03, CH2CI2, 
MeOH/NaBH4 
2. CH2N2, Et20 
3. HPLC 
48% 
Takeda5f reported a [3+4] annulation-based strategy for the construction of 
eight-membered oxacycles. In this method, the reaction of ~-substituted acryloylsilane 9 
and the enolate of 6-oxacyclohept-2-en-1-one 8 (Scheme 2) was utilized to generate the 
bicyclic derivative 10. Cleavage of the internal tether in 10 was achieved by sequential a-
hydroxylation of the ester and oxidative cleavage thereby generating the eight-membered 
oxygen heterocycle 12 as a single diastereomer. Although the synthesis is 
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diastereoselective, the development of an enantioselective protocol by using this method 
has not been demonstrated. 
Scheme 2 
NaHMDS (5 + R;SiMe,tBu __ _..TBSO~ 
CPME, -95 oc 
TBSO 9 10 8 
1) NaHMDS, 18-crown-6, THF 
then 
MeOOC 
TBSO'() 
TBSO CHO 12 
Pb(OAc)4 TBSOII}~~ ~ 
TBSO 11 
benzene-MeOH 
An intramolecular silicon-assisted cross-coupling reaction for the synthesis of 
medium-sized rings having a 1 ,3-cis-cis-diene unit was revealed by Denmark. 6r The 
substrate 13 (prepared in seven steps from propargyl alcohol) was subjected to a RCM 
reaction using Shrock' s molybdenum complex 14 as the catalyst (Scheme 3). The 
resulting cyclic ether 15 was then subjected to a Pd-catalyzed cross coupling reaction by 
employing allylpalladium chloride (APC) dimer as the catalyst to obtain the nine-
membered heterocycle 16 in good yield (77%). The method employed mild reaction 
conditions and provided an easy access to medium-sized rings having a 1 ,3-cis-cis-diene 
unit. 
Scheme 3 
C ~ 14 (10 mol%) I I 0 o~s(""" -b-e-nz-e-ne_,_rt_. 
13 15 
14 
• Cyclization by C-0 bond formation. 
APC (7.5 mol%) 
TBAF (1 0 eq.) 
THF/ 0.1 M I rt 
16 
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Suzuki and co-workers5b reported a stereospecific synthesis of eight- and rune-
membered cyclic ring ethers via Lewis acid mediated cyclization of hydroxy epoxides. 
This conceptually simple method was demonstrated by treating cis-alkenes such as 17 
with Eu(fod)3 to provide the corresponding cyclic ethers 18 in good yield (76-97%, 
Scheme 4). 
Scheme 4 
Eu(fod3) (1 eq.) 
toluene, 11 0 oc 
n = 1, 2 
0 H BnOlfOH 
OMPM 
n 
18 
Kotsuki revealed an interesting route to medium-sized oxacycles via chiral acyclic 
cis-alkene intermediates like 19.8 Transformation of 19 to the bicyclic ketal 20 was 
achieved by treatment of 19 with a catalytic amount of p-TsOH. Reduction of the ester in 
20 followed by protection of the resulting alcohol as a benzyl ether gave 21. Interestingly, 
it was shown that predominant generation of either the cis or trans a , a' -disubstituted 
oxacycles could be achieved from 21 by using different reducing reagents. Thus the 
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combination of TiC14 and trimethylsilane gave predominantly the cis isomer 23 (71 %) 
whereas DIBAL reduction of21 gave the trans isomer 22 (89%). 
Scheme 5 
"f-o 
0~COOEt 
0 
p-TsOH.H20 
CICH2CH2CI 
n -COOEt _1)~LA_H___ ~OBo H>,-o~ 2) NaH, BnBr H ~ O ~0 :::.---19 20 21 
0 ·"'"--osn + 
: 0 
~OBn 
: 0 
HO-- 23 HO-- 22 
Et3SiH, TiCI4 = 98.5 : 1.5 
DIBAL = 3: 97 
Fotch and Chamberlin9 have described a method involving intramolecular opening 
of the epoxide in keto epoxide 24 by the carbonyl oxygen (Scheme 6). The resulting 
oxocarbenium species is reduced in situ to generate the cyclic ether 25 in good yields. 
Scheme 6 
~ H :. -
+ OBF3 
_8_1_%~Me~ 
H H :. 
OH 
24 25 
Martin and co-workers 10 have demonstrated the synthesis of oxepanes by an 
intramolecular hetero-Michael reaction (Scheme 7). Interestingly, the stereochemistry of 
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the cyclization could be controlled by the double bond geometry of the Michael acceptor, 
and therefore either diastereomer of the oxepane can be readily accessed. The cis-double 
bond in the substrate was necessary for successful cyclization. 
Scheme 7 
~Bz TBAF, THF 
'I ~ 57% 
TBSO COOMe 
26 
('YOBz 
'I ~COOMe 
TBSO 
28 
TBAF, THF 
75% 
a OBz \ 
H COOMe 
27 
MacDonald5c reported an accidental discovery of a novel route to seven 
membered oxacycles via endo-selective alkynol cycloisomerization. Attempted 
cyclization of the alkynyl diol 30 in the presence of W(C0)6 did not provide the expected 
pyranose glycal analogue 32 (Scheme 8) but rather gave the seven-membered ring glycal 
31 in 68% isolated yield. However, this protocol is limited to the synthesis of oxepanes 
only. 
Scheme 8 
OH 
0 
:0 15% W(CO)s Ho·· O + Et3N, THF, 
ox a 0 : hu (350 nm) ~~2 65 oc 31 
68% >2% 
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• Ring expansion 
Batchelor and Hoberg6e demonstrated a diastereoselective synthesis of seven-
membered oxacycles by ring-expansion of cyclopropanated galactal. Galactal 33 could be 
reacted with a nucleophile in the presence of TMSOTf to afford the seven-membered 
cyclic ethers 34 in good-to-excellent yield, and moderate-to-high diastereoselectivity (68-
91%, 43-97% de, Scheme 9). 
Scheme 9 
0~0)> 
(tsuhsL ..... 0,,·y 
OAc 
33 
TMSOTf 
+0Tf 0):) I -....;: (tBuhSi, 
'0'' " -
Nuc 
Nuc = Nucleophile = TMSallyl, TMSN3 , TMSSPh etc. 
34 
The application of a Claisen rearrangement of ketene acetals in the synthesis of 
nine-membered oxacylces was demonstrated by Holmes. 11 The easily prepared (79% over 
six steps) selenyl ether 35 was isolated as a mixture of three diastereoisomers. These were 
oxidized to the selenoxides and immediately heated to give the ketene acetals 36 which 
underwent Claisen rearrangement to give the lactone 37. Notably, the ketene acetal 
(presumably a mixture of diastereoisomers) reacted to give lactone 37 as a single 
diastereomer (Scheme 10). Recently, the same group has used this method for the 
synthesis of fused bicyclic medium-ring oxacycles. 12 
97 
Scheme 10 
OTBS ~ ... / 
0)-0 
Nal04 , NaHC03 
MeOH, H20 
DBU, toluene 
~SePh -
35 36 37 
• Ring-closing metathesis (RCM) 
The scope of the methods described above is limited to specific medium-sized 
frameworks and is largely defined by the ring-closing transformation. Fortunately, with 
recent advances in the field of organometallic catalysis for the ring-closing metatheses 
(RCM) reaction, a more general approach to these systems is now available. 13 In a typical 
example of RCM, two double bonds in an acyclic precursor I undergo metathesis in the 
presence of an organometallic catalyst to yield II with the evolution of ethane gas (Figure 
2). 
RCM catalyst 
sovent Q 
II 
Figure 2. The ring closing metathesis strategy for the synthesis of medium-sized 
oxacycles. 
Thus, with a relatively simple disconnection, one can easily define an acyclic 
intermediate that can provide the necessary target. Moreover, the reaction conditions are 
generally mild and product isolation is simple. Indeed, the metathesis protocol has just 
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been a boon to organic synthesis on a small scale, but also for preparations on industrial 
scale. Several RCM catalysts are commercially available. 14 
Nonetheless, the challenge of synthesis of the medium-sized oxacycles now lies in 
the construction of the acyclic RCM substrate and, not surprisingly, this has been the 
focus of some recent studies.sb,ij,6a,c,d At the outset of these studies towards the synthesis 
of functionalized medium-sized oxacycles, it was decided to focus on the synthesis of 
chiral dienes and rely on the RCM reaction for generation ofthe cyclic ethers. 
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Objective: 
The objective of this investigation was to explore the applicability of the 
ephedrine-based methodology described earlier (Chapter 1 and Chapter 2) for the 
enantioselective construction of functionalized seven-, eight-, and nine-membered 
oxacyles. 
Results and discussion 
From the viewpoint of retrosynthetic analysis of the medium-sized oxacycles, 
acyclic diene V was identified as the primary target. It was envisioned that the diene V 
could be obtained from epoxide VI via an epoxide opening/allylation sequence. The 
cyclization of the diene V can be acheived by employing the RCM protocol to provide the 
unsaturated oxacycle IV (Figure 3). 
Ill IV VI 
Figure 3. Retrosynthetic strategy for functionalized medium-sized oxacycles. 
Removal of the ephedrine portion in IV would reveal oxacycle III having the versatile 
chiral a-hydroxy amide functionality, which in turn, can be used as a handle for further 
functionalization of the framework via transannular reactions. 15 
The first task was the synthesis of the spiro-epoxide 40 (Scheme 11). The 
synthesis of 40 began with the ephedrine-derived morpholine-dione 38 which was readily 
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prepared (85%) from commercially available (1R,2S)-ephedrine hydrochloride and ethyl 
oxalyl chloride, as described earlier (Chapter 1). 
Scheme 11 
'N~Ph 1) EtMgBr, ether 'N~Ph mCPBA 
0~0 2) BF30Et2 oA( CH2CI2 
0 95% 85% 
38 39 40 
A Grignard reaction of 38 with ethylmagnesium bromide gave the hemiacetal 
derived from addition to the lactone carbonyl in 38. Dehydration of the hemiacetal was 
readily achieved by treatment with BF3.Et20 to provide the alkylidene morpholine 39 
(Scheme 11 ). Based on previous studies in this group, the trisubstituted olefin 39 was 
assigned the Z geometry on the basis of the chemical shift of the olefinic methine proton 
(b 6.12 in 39) as compared to its upfield shift in theE isomer (b 5.75). 16•17 With the olefin 
39 in hand, the stage was set for an epoxidation reaction. Epoxidation of 39 was readily 
achieved with m-CPBA and provided 40 in excellent yield (85 %). 
Notably, the epoxide 40 was found to be quite a stable intermediate, and it could 
be easily purified by flash column chromatography and stored in the fridge for extended 
periods (>4 months). The planned transformations of the epoxide necessitated the 
determination of its absolute stereochemistry. Fortunately, due to its stability and 
crystalline nature, X-ray crystallographic analysis of epoxide 40 was possible. The 
ORTEP representation of 40 (VII) is shown in Figure 4 (see Appendix 3 for details). 18 As 
anticipated, the epoxidation of 39 had occurred anti to the phenyl and methyl groups in 
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the morpholine ring. Thus, having developed an easy access to 40 and ascertained its 
stereochemistry, it was now time to explore various strategies to open the epoxide ring. 
40 
VII 
Figure 4. X-ray crystal structure of the epoxide 40 
The spuo epoxide was expected to behave as an ambident electrophile. 
Nucleophilic ring-opening of the epoxide in 40 was expected to proceed at the less 
hindered terminal carbon. In addition, in the absence of a Lewis acid, this reaction was 
anticipated to proceed with inversion of configuration (Figure 5). 19 On the other hand, 
Lewis acid- mediated ring-opening of 40 (Figure 5) should proceed via an oxocarbenium 
ion intermediate. The stereochemical course of nucleophilic substitution at this 
oxocarbenium ion (IX) was assumed to be identical to that in related oxocarbenium ions 
(see Chapter 1 and Chapter 2). In addition, previous studies on related systems also 
suggested that the stereoselectivity of nucleophilic addition to the oxocarbenium ion was 
dictated by the chiral morpholinone and not by the exocyclic stereocenter. 20 
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Nu VIII 
Nu = nucleophile 
Lewis acid (LA) 
'N 1 Ph Nu- "'j -a-xi-al_a_tt-ac-lk~ oJy,.~Nu 
) .,'OH 
Figure 5. Possible ring opening reactions of epoxide 40. 
The ring opening of 40 was initially explored with vinyl- and butenyl magnesium 
bromide at low temperature ( -78 °C) was explored first. Surprisingly no reaction was 
observed. Organocopper reagents were not beneficial, and byproducts predominated 
when zinc chloride or BF3•etherate was employed as a Lewis acid in these reactions 
(Scheme 12). 
Scheme 12 
no reaction 
RMgBr, CuCN 
4 )( 
R = vinyl or 3-butenyl 
Lewis acid = BF3-Et20 or ZnCI2 
RMgBr 
>< .. no reaction 
40 ! RMgBr , Lew;s add 
byproducts 
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Attempted allylation of 40 with TiCLJallyltrimethylsilane provided the chloroalcohol 41 
arising from epoxide ring-opening with the chloride ion at the hemiacetal carbon (Scheme 
13). Fortunately, the use ofBF3-EhO as a Lewis acid proved effective. The epoxide could 
be readily opened at the acetal carbon with excellent diastereocontrol (> 19:1 , Scheme 13) 
at ambient temperature to afford the alcohol 42 ( 40 %) 
Scheme 13 
The secondary alcohol 42 was treated with sodium hydride and the resulting 
sodium salt was reacted with allyl bromide to furnish the diene 43 (88 %, Scheme 14 ). 
The diene 43 was then subjected to a RCM reaction using the Grubbs generation I 
catalyst to generate the oxepane 44 (70%). At this point, it was unclear whether the allyl 
ether moiety would survive the usual dissolving metal reduction protocol for removal of 
the ephedrine portion since the cleavage of allyl ethers under these conditions has been 
documented in the literature.21'22 Fortunately, the ephedrine portion in 44 could be 
removed selectively by subjecting 44 to a dissolving metal reduction, which generated the 
a-hydroxy amide 45 in moderate yield (47%). Although no other product was isolated, it 
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was possible that concomitant allyl ether cleavage was responsible for the diminished 
yield of 45. 
Scheme 14 
'N5yPh 'N5yPh 
0~ NaH, allyl bromide 0~ THF, 0 octo rt 
OH '\::: 88% 0 '\::: 
42 4~ 
CI,.~Cy3 
Grubbs I l Grubbs I= Ru\ CH2CI2, rt ~I 
Cl PCy3 Ph 70% 
" 'N5yPh NH D Na,NH3 THF, -78 oc 0~ 47% o I 
45 44 
Efforts to open the epoxide 40 at the terminal carbon were successful when 
alkoxide nucleophiles were used (Scheme 15). Thus treating the epoxide 40 with the 
sodium salt of 3-methyl-3-buten-1-ol, or propargyl alcohol cleanly generated the 
hemiacetals 46 and 47, respectively. It was assumed that the epoxide opening occured 
with inversion of configuration. 
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Scheme 15 
~OH 
83% 
Ethers 46 and 47 could be allylated by usmg BF3.Et20 and allyltrimethylsilane to 
generate compounds 48 (63%) and 49 (43%) respectively with excellent diastereomeric 
excess (>19:1, Scheme 16). The stereochemistry at the spiro center in 48 and 49 was 
assigned by analogy to the reactions of other ephedrine-derived hemiacetals. 16'20 
Scheme 16 
46 
43% 
47 49 
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The above results indicated that the alkoxide opening/allylation procedure could 
be used to provide the diastereomer of the product obtained by an allylation/0-alkylation 
reaction sequence with 40. In addition, the use of an enantiomerically pure secondary 
alcohol in the epoxide opening reaction should allow for the control of two stereocenters 
adjacent to the ether oxygen, a structural motif that is found in the laurencin, obtusan, and 
lauthisan classes of marine natural products? 3 
The diene 48 was successfully converted into the oxocane SO by a RCM reaction 
(87%) using Grubbs generation II catalyst (Scheme 17). Dissolving metal reduction of 
SO gave the hydroxy amide ring 51 (79%) as a single diastereomer (94% ee). At this 
stage, the utility of the carboxamide for transannular functionalization was demonstrated 
by bromolactonization of 51 to provide the functionalized dioxabicyclo[ 5 .2.1 ]decanone 
52 as a single diastereomer (Scheme 17). 
Scheme 17 
{\ 
Mes-NYN-Mes 
Cl, Ph 
·Ru=-' 
~, 
Cl PCy3 
Grubbs II 
0 
HO /J 
... ___ u··''"\ . ,0 
0 .' 
52 
·., Br 
-:. 
Grubbs II 
87% 
Na/NH3, THF 1 
-78 °C, 3 min 
79% 
"NH 
... ~0~0H '·. 0 !J NBS 54% 
single diastereomer 
51 (94% ee) 
single diastereomer 
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In a related sequence, generation of the diene 53 (90%) via enyne metathesis 
could be achieved by utilizing the Grubbs generation I catalyst (Scheme 18). Subsequent 
dissolving metal reduction of 53 generated a complex mixture of products and the 
required product 54 could not be detected. Presumably, the diene functionality in 53 is 
susceptible to reduction under the dissolving metal reduction conditions. 
Scheme 18 
Grubbs I 
90% 
'- I Ph J_,. l Na/NH3, THF 
0::::;.--fQ, 0 '-' 11•• · • A • 
0 ~ 
53 -
" NH 
-I '~Q-:..OH 
' • 
0 ..1 
54 -
In addition to the epoxide-based routes described above, the utility of the 
alkylidene morpholinone 39 for the preparation of functionalized dienes has also 
examined. In this direction, the Prins reaction24 of 39 with formaldehyde provided the 
spirodioxane 55 as a single diastereomer (Scheme 19). The absolute configuration of the 
newly generated stereocenters in 55 is assigned on the basis of earlier studies in Pansare 
group, which had demonstrated that the Prins reaction of alkylidene morpholinones such 
as 39 was stereospecific and proceeds with retention of the alkene stereochemistry.20 
Scheme 19 
39 
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Treatment of 55 with excess allyltrimethylsilane/BF3 etherate provided the 
diastereomerically pure bis(allylation) product 56 (76%). The bis(allylation) reaction 
presumably proceeds through the sequential generation of endocyclic and exocyclic 
oxocarbeniurn ions derived from the spiromorpholinone (Scheme 20). The exact sequence 
of events is not known at present. 
Scheme 20 
, ~Ph 
.J O BF3.0Et2 ~J 76% 
55 (dr>19/1) 56 (dr>19/1) 
Further in the sequence, the ring closure of 56 by treatment with the Grubbs I 
catalyst gave the spiro oxonane 57 (74%). Removal ofthe chiral controller in 57 revealed 
the nine-membered oxacycle 58 (66% over two steps, 99% ee, Scheme 21). 
Scheme 21 
'N1yPh 'N1yPh "NH 
0~ Grubbs I t5 Na/NH3, THF t5 CH2CI2, rt, 42 h -78 °C, 3 min o I 74% 89% 0 
56 57 58 (99% ee) 
The spiromorpholinone 56 by treatment with Grubbs I catalyst was also utilized in 
the synthesis of a functionalized oxocane (74%). To this effect, treatment of 56 with BBr3 
gave the alcohol 59 (76%), which could be converted into ether 60 by alkylation with 
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allyl bromide (91 %, Scheme 22). As anticipated, the ring-closing metathesis of 60 with 
the Grubbs I catalyst yielded oxocane 61 (72%). 
Scheme 22 
'N~Ph 'N~Ph 0~ BBr3, CH2CI2 -78 acto rt 0~ 21 h 
76% OH 
56 
,I l 59 NaH, ./Si~ 
0 octo rt, 2 h 
'N~Ph 91% 'N~Ph 1:5 Grubbs I ~ reflux, 21 h 72% 61 60 0~ 
Previous results with oxepane 44 (Scheme 15) had suggested that the allyl ether 
funtionality in 61 would survive dissolving metal reduction conditions. However, 
treatment of 61 with Na!NH3 failed to give the desired product and a complex, 
inseparable mixture was obtained instead. It was then decided to use calcium as an 
alternative to ~odium in the reduction of oxocane 61. It is known that Ca in NH3 is a 
milder reducing agent that Na in NH3.25 For example, Ca/NH3 exhibits better selectivity 
for debenzylation in the presence of other reducible functionalities. Therefore, the 
selective reduction of the phenyl ring in the morpholinone 61 with Ca/NH3 over the allyl 
ether was anticipated. However, actual implementation of these conditions yielded the 
olefin 62 ( 40%, Scheme 23) instead, suggesting that the reduction of the phenyl ring was 
accompanied by reduction of the C-0 bond in the allylic ether functionality _26 
------- - ------·--------------
Scheme 23 
Complex mixture Na/NH3, THF 
-78 °C, 3 min 
-NH 
I OH ~ ~H) 
62 
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Given the difficulties encountered in the dissolving metal reduction of 61, it was 
decided to examine the functionalization of the double bond in 61 prior to the removal of 
the ephedrine portion. Accordingly, dihydroxylation of 61 (Os04, NMO, H20 /THF) 
provided the diol 63 in good yield and diastereoselectivity (83%, 78% de, Scheme 24). 
Exposure of 63 to Na/NH3 gave triol 64 (30%) as a single diastereomer, possibly due to 
losses during the isolation/purification process. Notably, triol 64 was found to be highly 
water soluble. 
Scheme 24 
Na /NH3 
-78 °C, 2 min 
30% 
61 
\ 
NH 
-1 0-~ OH 
u."OH 
'/oH 
64 (96% ee) 
The major diastereomer in 63 was assigned the shown stereochemistry on the 
basis of a preferred conformation for 61 that was determined by molecular modeling 
studies with the Spartan software (MM2 calculation). In this conformation, the top face of 
the double bond in 61 is shielded by the phenyl ring in the morpholinone portion of the 
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spirocycle (Figure 8). The chirality of the ephedrine can thus be utilized not only for 
stereochemical control in the morpholinone ring but also for remote stereocontrol in the 
appended oxacycle. 
~favoured 
Figure 8. Proposed origin of stereoselectivity for the dihydroxylation of 61. 
Conclusion: 
In conclusion, versatile approaches to functionalized, enantiomerically pure 
oxacycles have been developed. The overall strategy is quite flexible and permits the 
construction of seven-, eight- or nine-membered oxacycles from readily available chiral 
precursors, namely the alkylidene morpholinone 39 and the epoxide 40. Incorporation of 
unsaturation and positioning of the ring oxygen at specific locations in the ring are 
achieved by the judicious choice of starting materials. The overall efficiency of this 
protocol coupled with the high enantioselectivity strongly advocates an investigation on 
the application of these methods in the synthesis of selected, naturally occurring 
oxacycles and their analogues. 
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Experimental 
General experimental techniques that have been described in the experimental section 
of Chapter 2 were followed. 
(Z,SS,6R)-2-Ethylidene-4,5-dimethyl-6-phenylmorpholin-3-one (39): 16 
To a suspension of the dione 38 (2.87 g, 13.2 mmol) in ether (25 mL) was added 
ethylmagnesium bromide (prepared from magnesium metal (0.740 g, 30.4 mmol) and 
ethyl iodide (2.22 mL, 27.3 mmol) in ether (10 mL)) at 0 °C and the mixture was stirred 
at room temperature for 3 h. A saturated aqueous solution of ammonium chloride was 
added and the mixture was extracted with ethyl acetate (3 x 10 mL). The combined 
extracts were dried (Na2S04) and concentrated to provide 3.2 g (98%) of the hemiacetal. 
This was dissolved in dichloromethane (60 mL), the solution was cooled to -78 °C and 
BF3 etherate (5 mL, 38.5 mmol) was added. The solution was stirred at room temperature 
for 18 h. and cold water (35 mL) was added. The mixture was extracted with 
dichloromethane (3 x 30 mL) and the combined extracts were dried (Na2S04) and 
concentrated to provide the crude product. Purification by flash chromatography on silica 
gel (2/1 ethyl acetate/hexane) furnished 2.90 g (95% over 2 steps) of 39 as a pale yellow 
gum. Spectroscopic data for 39 was identical to the reported data. 16 
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(2S,3S,SR,6S)-5-Phenyl-2,6, 7 -trimethyl-1,4,dioxa-7 -azaspiro [2,5] octan-8-one ( 40): 
To a solution of 39 (1.00 g, 4.30 mmol) in dichloromethane (15 mL) was added 
mCPBA (1.20 g, 6.90 mmol) at -78 °C and the mixture was warmed to room temperature 
and stirred for 45 min. Saturated NaHC03 solution was added and the mixture was 
extracted with ethyl acetate (3 x 20 mL) and the combined organic layers were dried and 
concentrated under reduced pressure. The residue obtained was purified by flash 
chromatography on silica gel (ethyl acetate) to give 0.860 g (80 %) of 40 as a white, 
crystalline solid. 
Mp: 141-142 °C. 
1H NMR (500 MHz, CDCh): 
8 7.39-7.36 (m, 2H), 7.33-7.30 (m, 3H), 5.48 (d, 1H, J = 2.2), 3.84 (q, 1H, J = 
5.2), 3.64 (dq, 1H, J= 3.5, 6.3), 3.10 (s, 3H), 1.51 (d, 3H, J = 5.2) 1.03 (d, 3H, J 
= 6.3). 
13C NMR (125.77 MHz, CDCh): 
8 163.4, 136.6, 128.5, 128.1 125.4, 82.0, 75.9, 59.2, 58.5, 33.8, 12.8, 12.4. 
IR (solid): 
2360, 2344, 1665, 1291 , 923, 891 cm-1• 
MS (APCI): 
248.1 (M+ l , 100). 
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HRMS (CI): 
m/z 247.1202 (247.1208 calc. for C14H11N03, M+). 
(2R,SS,6R)-2-Chloro-2-(1-hydroxyethyl)-4,5-dimethyl-6-phenylmorpholin-3-one 
(41): 
To a solution of 3 (0.710 g, 2.90 mmol) in dichloromethane (35 mL) at - 78 oc 
was added TiC14 (1.90 mL, 17.4 mmol) and allyltrimethylsilane (2.80 mL, 17.4 mmol). 
The mixture was gradually warmed to - 40 oc and allowed to stir at this temperature for 9 
h. Saturated N~Cl was added and the mixture was warmed to ambient temperature. 
Water was added, the biphase was separated and the aqueous layer was extracted with 
CH2Ch (3 x 10 mL). The combined extracts were dried (Na2S04) and concentrated. The 
residue was purified by flash chromatography on silica (2/1 ethyl acetate/hexane) to give 
0.350 g (43%) of 41 as a colorless gum. 
1H NMR (500 MHz, CDCh): 
8 7.42-7.29 (m, 1H), 5.65 (d, 1H, J = 3.3), 4.36-4.31 (m, 2H), 3.64 (qd, 1H, J = 
3.3, 6.6), 3.08 (s, 1H), 1.44 (d, 1H, J = 6.1), 0.99 (d, 1H, J = 6.6) 
13C NMR (125.8 MHz, CDCh): 
8 165.2, 135.6, 128.4, 128.2, 125.5, 101.3, 73.8, 71.8, 58.3, 34.1 , 16.6, 13.2. 
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MS (APCI): 
284.1 (M+ 1, 1 00). 
(2S,SS,6R)-2-Allyl-2-( (S)-1-hydroxyethy 1)-4,5-dimethy 1-6-pheny lmorp holin-3-one 
(42): 
To a solution of 40 (0.770 g, 3.1 mmol) in dichloromethane (25 mL) at -78 °C was 
added allytrimethylsilane (3.00 mL, 18.6 mmol) followed by BF3.Et20 (2.30 mL, 18.6 
mmol). The mixture was stirred at -78 °C for 15 min and then warmed to ambient 
temperature and stirred for 3 h. Cold water was added and the resulting mixture was 
extracted with dichloromethane (3 x 25 mL). The combined organic layers were 
concentrated under reduced pressure and the residue was purified by flash 
chromatography on silica gel (2/1 ethyl acetate/hexane) to provide 0.360 g (40%) of 42 as 
a white solid. 
1H NMR (500 MHz, CDCh): 
8 7.40-7.37 (m, 2H), 7.33-7.27 (m, 3H), 5.95 (m, 1H), 5.41 (d, 1H, J = 2.2), 5.17 
(dd, 1H, J= 1.4, 16.1), 5.05 (d, 1H, J = 10.3), 4.05 (dq, 1H, J = 6.5, 2.7), 3.88 (d, 
1H, J = 2.7), 3.52 (dq, 1H, J = 6.6, 2.2), 3.06 (s, 3H), 2.96 (m, 1H), 2 .65 (dd, 1H, 
J = 7.9, 14.9), 1.37 (d, 3H, J = 6.5), 0.98 (d, 3H, J = 6.6). 
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13C NMR (125.77 MHz, CDCh): 
8 171.6, 137.9, 134.3, 128.6, 127.9, 125.7, 118.4, 81.9, 73.2, 72.0, 59.3, 37.0, 
33.9, 16.9, 13.0. 
IR (solid): 
3394, 2974, 2936, 2896, 1622, 978, 887 cm-1• 
MS (APCI): 
290.1 (M+1 , 100). 
HRMS (CI): 
m/z 289.1669 (289.1678 calc. for C17H23N03, M+). 
(2S,5S,6R)-2-Allyl-2-( (S)-1-( ally loxy )ethy 1)-4,5-dimethyl-6-pheny lmorpho lin-3-one 
(43): 
To a solution of the alcohol 42 (0.300 g, 1.04 mmol) in THF (15 mL) at 0 °C was 
added KH (0.0500 g, 1.25 mmol). The mixture was stirred at 0 oc for 15 min and allyl 
bromide (0.270 mL, 3.12 mmol) was added dropwise. The mixture was then warmed up 
to ambient temperature, stirred for 3.5 h and cold water was added. The mixture was 
extracted with ethyl acetate (3 x 20 mL) and the combined organic layers were dried and 
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concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica gel (211 ethyl acetate/hexane) to provide 0.30 g (88 %) of 43 as a yellow gum. 
1H NMR (500 MHz, CDCh): 
8 7.39-7.29 (m, 5H), 6.0-5.91 (m, 2H), 5.31-5 .26 (m, 2H), 5.17-5 .02 (m, 3H), 
4.20-4.16 (m, 1H), 4.10-4.06 (m, 1H), 3.81 (q, 1H, J = 6.5), 3.50-3.47 (dq, 1H, J = 
6.1 , 2.9), 3.04 (s, 3H), 2.83 (dd, 1H, 2 .6, 6.5), 2.72 (dd, 1H, J = 6.5, 6.7), 1.37 (d, 
3H, J = 6.5), 1.02 (d, 3H, J = 6.1). 
13C NMR (125.77 MHz, CDCh): 
() 169.6, 138.5, 135.6, 133.8, 128.5, 127.7, 125.9, 118.0, 116.9, 84.6, 79.9, 72.4, 
71.7, 59.3, 38.8, 34.0, 15.4, 12.9. 
IR (neat): 
2980, 1636, 1451, 1379, 1071 , 1030, 919 cm-1• 
MS (APCI): 
330.2 (M+1, 100). 
HRMS (CI): 
m/z 329.1982 (329.1991 calc. for C2oH27N03, M+). 
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(2R,3S,6S, 7 S)-2-Phenyl-3,4, 7-Trimethy 1-1 ,8-dioxa-4-azaspiro(5.6] dodec-1 0-en-5-one 
(44): 
To a solution of 43 (0.220 g, 0.670 mmol) in dichloromethane (90 mL) was added 
Grubbs I catalyst (0.0250 g, 0.0300 mmol, 4.50 mol%). The mixture was stirred at room 
temperature for 5 h and the solvent was removed under reduced pressure. The residue was 
purified by flash chromatography on silica gel to give 0.140 g (70 %) of 44 as a pale 
yellow oil. 
1H NMR (500 MHz, CDCl3): 
o 7.37-7.36 (m, 4H), 7.30-7.27 (m, 1H), 5.71-5.68 (m, IH), 5.65-5.62 (m, 1H), 
5.16 (d, 1H, J= 3.5), 4.34-4.46 (m, 2H), 4.26-4.22 (m 1H), 3.53 (dq, 1H, J = 6.1, 
3.4), 3.01 (s, 3H), 2.89 (dq, 2H, J = 6.6, 4.7), 1.31 (d, 3H, J = 6.2), 0.97 (d, 3H, J 
= 6.1). 
13C NMR (125.77 MHz, CDCh): 
0 170.5, 138.2, 130.5, 128.5, 127.7, 125.7, 125.4, 83.8, 80.7, 71.2, 69.1 , 59.1 , 
33.9, 33.8, 16.8, 13.4. 
IR (neat): 
2938, 1628, 1448, 1402, 1380, 1027, 900 cm-1• 
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MS (APCI): 
302.1 (M+1, 100). 
HRMS (CI): 
m/z 301.1670 (301.1678 calc. for CtsH23N03, M+). 
(Z,2S,3S)-2,3,4, 7-Tetrahydro-3-hydroxy-N,2-dimethyloxepine-3-carboxamide ( 45): 
" NH D 
To anhydrous liquid ammonia (distilled over sodium) was added Na metal (0.0640 
g, 2. 79 mmol) at - 78 oc and the mixture was stirred for 15 min. To the resulting blue 
solution was added a solution of 44 (0.120 g, 0.400 mmol) in anhydrous THF (2.5 mL) 
and the mixture was stirred for 3 min. A mixture of 211 methanol/water (3 mL) was added 
and the reaction mixture was brought to ambient temperature and stirred for 30 min to 
remove ammonia. The resulting solution was concentrated under reduced pressure and the 
residue was purified by flash column chromatography on silica gel (3/2, ethyl 
acetate/hexane) to provide 0.0350 g (47%) of 45 as a white solid. 
1H NMR (500 MHz, CDCh): 
o 6.91 (s, 1H), 5.96-5.91 (m, 1H), 5.76-5.71 (m, 1H), 4.32 (dd, 1H, J = 9.6, 5.8), 
4.12 (m, 1H), 3.98 (q, 1H, J = 6.3), 3.12 (s, 1H), 2.94 (m, 1H), 2.83 (d, 3H, J = 
4.3), 2.46 (dd, 1H, J = 16.7, 8.1), 1.12 (d, 3H, J = 6.3). 
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13C NMR (125.77 MHz, CDC~)): 
8 174.1, 131.3, 128.3, 82.6, 76.4, 69.2, 38.9, 25.8, 17.4. 
IR (neat): 
3435, 3015, 1737, 1686, 1537, 1215, 745 cm-1• 
MS (APCI): 
186.1 (M+1, 100). 
HRMS (CI): 
m/z 185.1043 (185.1052 calc. for C9H1 sN03, M+). 
(2S,5S,6R)-2-( (S)-1-(3-Methylbu t-3-eny loxy )ethy 1)-2-hydroxy -4,5-dimethy 1-6-
phenylmorpholin-3-one ( 46): 
To a solution of 3-methyl-3-butene-1-ol (0.442 mL, 4.40 mmol) in THF (35 mL) 
at 0 oc was added NaH (0.121 g, 5.04 mmol). The mixture was then stirred for 15 min at 
0 oc and the epoxide 40 (0.900 g, 3.60 mmol) was added as a solid. The reaction mixture 
was warmed to ambient temperature, stirred for 3 h, cold water was added, and the 
mixture was extracted with ethyl acetate (3 x 20 mL). The combined organic layers were 
dried and concentrated under reduced pressure. The residue was purified by flash 
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chromatography on silica gel (111 ethyl acetate/hexane) to provide 1.00 g (83 %) of 46 as 
a colorless gum. 
1H NMR (500 MHz, CDCh): 
8 7.37-7.33 (m, 4H), 7.31-7.27 (m, 1H), 5.38 (d, 1H, J = 2.6), 4.71 (s, 1H), 4.67 
(s, 1H), 4.04 (s, 1H), 3.88 (q, 1H, J = 6.4), 3.67 (m, 1H), 3.46-3.41 (m, 2H), 3.02 
(s, 3H), 2.23-2.20 (m, 2H), 1.70 (s, 3H), 1.36 (d, 3H, J = 6.4), 1.03 (d, 3H, J = 
6.2). 
13C NMR (125.77 MHz, CDCh): 
8 168.8, 143.0, 137.0, 128.5, 127.8, 126.1 , 111.5, 97.6, 79.2, 72.9, 68.3, 59.8, 
38.4, 33 .7, 22.7, 12.1 , 12.0. 
IR (neat): 
3347, 2940, 1641 , 1452, 1109, 1024, 891 cm-1• 
MS (APCI): 
334.2 (M+1 , 100). 
HRMS (CI): 
m/z 333.1933 (333.1940 calc. for C19H27N04, M+). 
r:--~----------------------------------
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(2S,SS,6R)-2-Hydroxy-4,5-dimethyl-6-phenyi-2-((S)l-(prop-2-
ynyloxy)ethyl)morpholin-3-one (47): 
To a solution ofpropargyl alcohol (0.200 mL, 3.40 mmol) in THF (15 mL) at 0 °C 
was added NaH (0.190 g, 7.94 mmol). The reaction mixture was stirred at 0 oc for 15 min 
and the epoxide 40 (0.700 g, 2.83 mmol) was added as a solid. The reaction mixture was 
warmed to ambient temperature, stirred for 2.5 hand cold water was added. The mixture 
was extracted with ethyl acetate (3 x 15 mL) and the combined organic layers were dried 
and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (1 /1 ethyl acetate/hexane) to provide 0.650 g (76%) of 47 as 
a white solid. 
Mp: 133-134 °C. 
1H NMR (500 MHz, CDCh): 
8 7.37-7.32 (m, 4H), 7.28-7.26 (m, 1H), 5.42 (d, 1H, J = 2.7), 5.1 (s, 1H), 4.15 (d 
of AB, 2H, J= 15.0, 2.0), 4.07 (q, 1H, J = 6.5), 3.44-3.40 (dq, J = 2.7, 7.1), 3.01 
(s, 3H), 2.39 (t, 1H, J = 2.0), 1.43 (d, 3H, J = 6.5), 1.03 (d, J = 7.1). 
13C NMR (125.77 MHz, CDCh): 
8 168.9, 137.7, 128.4, 127.8, 126.0, 97.2, 80.3, 78.8, 74.0, 72.4, 59.6, 57.7, 33.8, 
12.7, 12.0. 
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IR (solid): 
3294, 1658, 1449, 1195, 1148, 1078, 1014, 967 cm-1• 
MS (APCI): 
304.1 (M+1 , 100). 
HRMS (CI): 
m/z 303.1481 (303.1471 calc. for C17H21N04, M+). 
(2S,SS,6R)-2-( (R)-1-(3-Me thy lbu t-3-eny loxy )ethy 1)-2-ally 1-4,5-dimethyl-6-
phenylmorpholin-3-one ( 48): 
To a solution of 46 (0.500 g, 1.5 mmol) in dichloromethane (20 mL) at -78 oc was 
added allytrimethylsilane (1.50 mL, 9 mmol) followed by BF3.Et20 (1.10 mL, 9 mmol). 
The mixture was stirred at -78 oc for 15 min and then warmed to ambient temperature 
and stirred for 36 h. Cold water was added and the mixture was extracted with 
dichloromethane (3 x 20 mL). The combined organic layers were dried and concentrated 
under reduced pressure. The residue was purified by flash chromatography on silica gel 
(1 /1 ethyl acetate/hexane) to provide 0.232 g (43%, 63% based on recovered starting 
material (0 .160 g)) of 48 as a colorless oil. 
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1H NMR (500 MHz, CDCh): 
8 7.38-7.34 (m, 4H), 7.30-7.27 (m, 1H), 6.02-5.96 (m, 1H), 5.30 (d,1H, J = 2.5), 
5.09 (dd, 1H, J= 13.3, 1.0), 4.70 (d, 1H, J = 10.1), 4.72 (s, 1H), 4.67 (s, 1H), 3.81 
(q, 1H, J= 6.3), 3.68-3 .63 (m, lH), 3.46-3.40 (m, 2H), 3.02 (s, 3H), 2.63 (dd, 1H, 
J = 14.1, 7.4), 2.53 (dd, 1H, J = 14.1 , 7.2), 2.21 (brt, 2H, J = 6.5), 1.72 (s, 3H), 
1.32 (d, 3H, J= 6.3), 1.01 (d, 3H, J = 6.2). 
13C NMR (125.77 MHz, CDCb): 
8 170.1 , 143.2, 138.9, 134.5, 128.4, 127.6, 126.0, 117.8, 111.4, 84.0, 80.4, 73.4, 
68.4, 59.5, 40.8, 38.5, 33.8, 22.8, 13.0, 12.2. 
IR (neat): 
2982, 1737, 1605, 1402, 1310, 1166, 1090, 1068, 852 cm-1• 
MS (APCI): 
358.3 (M+ 1, 1 00). 
HRMS (CI): 
m/z 357.2305 (357.2304 calc. for Cz2H3tN03, M+). 
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(2S,SS,6R)-2-Allyl-4,5-dimethyl-6-pheny 1-2-( (R)-1-(prop-2-yny loxy )ethy l)mo rpholin-
3-one (49): 
To a solution of 47 (0.430 g, 1.42 mmol) in dichloromethane (20 mL) at -78 °C 
was added allyltrimethylsilane (1.35 mL, 8.52 mmol) followed by BF3.Et20 (1.10 mL, 
8.52 mmol). The mixture was stirred at -78 °C for 15 min and then warmed to ambient 
temperature and stirred for 3 days. Cold water was added and the resulting mixture was 
extracted with dichloromethane (3 x 20mL). The combined organic layers were dried and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica gel (111 ethyl acetate/hexane) to provide 0.0600 g (43% based on recovered 
starting material (0.300 g) of 49 as a colorless oil. 
1H NMR (500 MHz, CDC~)): 
8 7.35-7.34 (m, 4H), 7.29-1.27 (m, 1H), 6.01-5.93 (m, 1H), 5.32 (d, 1H, J = 2.6), 
5.10 (d 1H, J = 16.6, 1H5.16 (d, 1H, J = 10, lH), 4.15 (d of AB, 2H, J= 16, 2.0) 
3.96 (q, 1H, J = 6.5), 3.40 (dq, J = 2.6, 7.2), 3.03 (s, 3H), 2.65-2.61 (dd, 1H, J = 
14, 7.2), 2.53-2.50 (dd, 1H, J = 14, 7.2) 2.36 (br t, 1H, J = 2), 1.38 (d, 3H, J = 
6.5), 1.04 (d, J = 7.2). 
13C NMR (125.77 MHz, CDC~)): 
8 169.8, 138.7, 128.4, 127.7, 126.0, 118.0, 83.9, 80.8, 80.7 80.6, 73.6, 73.4, 59.9, 
40.7, 40.5, 33.9. 
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IR (solid): 
1703,1580,1421,1389,1135,1054, 1010cm-1• 
MS (APCI): 
328.3 (M+1, 100). 
HRMS (CI): 
m/z 327.1835 (327.1834 calc. for C2oH2sN03, M+). 
(2R,3S,6S, 7S)-3,4, 7,11-Tetramethyl-2-phenyl-1,8-dioxa-4-azaspiro[5. 7]tridec-11-en-
5-one (50): 
To a solution of 48 (0.100 g, 0.280 mmol) in dichloromethane (28 mL) was added 
the Grubbs II catalyst (0.0560 g, 0.0700 mmol, 20 mol %). The reaction mixture was 
stirred at room temperature for 48 h and the solvent was removed under reduced pressure. 
The residue was purified by flash chromatography on silica gel to give 0.0800 g (87 %) of 
50 as colorless oil. 
1H NMR (500 MHz, CDCh): 
8 7.39-7.28 (m, 5H), 5.25 (br, 2H), 4.17 (br dt, 1H, J = 12.0, 2.8), 3.58 (q, 1H, J = 
6.3), 3.51 (dq, 1H, J= 6.7, 3.1), 3.41 (t, 1H, J = 12.0), 3.17 (dd, 1H, J = 14, 10.4), 
3.01 (s, 3H), 2.89 (br t, 1H, J = 12), 2.60 (dd, 1H, J = 5.8, 14), 1.78 (s, 3H), 1.75 
(dd, 1H, J = 12.2, 2.8), 1.19 (d, 3H, J = 6.3), 0.92 (d, 3H, J = 6.7). 
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13C NMR (125.77 MHz, CDCl3): 
158.9, 145.4, 136.7, 128.6, 128.2, 125.5, 111.9, 77.5, 66.2, 58.6, 58.1, 33.7, 11.8. 
IR (neat): 
2933, 1642, 1450, 1111, 1093, 959, 900, 847 cm-1• 
MS (APCI): 
330.2 (M+1, 100). 
HRMS (CI): 
m/z 329.1993 (329.1991 calc. for C2oH27N03, M+). 
(Z,2R ,3S)-3,4, 7,8-T etrahydro-3-hydroxy-N,2,6-trim ethyl-2H -oxocine-3-ca rboxa mide 
(51): 
" NH 20=::{. OH '•. 0 !J 
To anhydrous liquid ammonia (distilled over sodium) was added Na metal (0.0380 
g, 1.66 mmol) at - 78 oc and the mixture was stirred for 15 min. To the resulting blue 
solution was added a solution of 50 (0.0780 g, 0.240 mmol) in anhydrous THF (2.5 mL) 
and the mixture was stirred for 3 min. A mixture of 211 methanol/water (3 mL) was added 
and the reaction mixture was brought to ambient temperature and stirred for 30 min to 
remove ammonia. The resulting solution was concentrated under reduced pressure and the 
residue was purified by flash column chromatography on silica gel (ethyl acetate) to 
provide 0.0400 g (79%) of 51 as a white solid. 
----~------~------- ------- ---------~--
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Mp: 
102-103 °C; 
tH NMR (500 MHz, CDCh): 
o 6.72 (br s, 1H), 5.32 (br s, 1H), 4.22 (br s, 1H), 4.01 (br s, 1H), 4.68 (br q, 1H), 
3.53 (br t, 1H), 2.89 (d, 3H, J = 5.4), 2.75 (br s, 2H), 2.17 (br s, 1H), 1.84 (br s, 
4H), 1.02 (d, 3H, J = 6.3); a satisfactory 13C spectrum could not be obtained due 
to atropisomerism resulting in peak broadening. 
IR (solid): 
3354, 2920, 1700, 1684, 1540, 1088, 968, 895 cm-1. 
23 1 [a.] n: -109 (c 1, CH2C 2). 
MS (APCI): 
214.1 (M+ 1, 100). 
HRMS (CI): 
rnlz 213.1371 (213.1365 calc. for CIIH19N03, M+). 
(1S,2S,6R, 7 S)-2-Bromo-7 -hydroxy-2,6-dimethyl-5,9-dioxa-bicyclo [5.2.1] decan-8-one 
(52): 
0 
HO /J 
----u·''''\ . ,0 0 .' 
·'-:.... Br 
To a solution of 51 (0.0400 g, 0.190 mmol) in THF (1 mL) was added N-
bromosuccinimide (0.0500 g, 0.280 mmol) and the solution was stirred for 3 h at room 
temperature. Saturated aqueous NaHS03 solution (1.5 mL) was added and the mixture 
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was extracted with ethyl acetate (3 x 3 mL). The combined organic layers were dried 
(Na2S04), concentrated and the residue was purified by flash chromatography on silica 
gel (7/3 ethyl acetate/hexane) to give 0.0270 g (54%) of 52 as a colorless gum. 
1H NMR (500 MHz, CDCh): 
8 4.77 (dd, 1H, J = 11.5, 1.5), 4. 12 (ddd, 1H, J = 13, 6, 2), 3.8 (dd, 1H, J= 13.0, 
9.0), 3.76 (q, 1H, J= 6.3), 3.20 (dd, 1H, J = 15.5, 2), 2.78 (dd, 1H, J= 15.5, 11), 
2.72 (br s, 1H), 2.36 (ddd, 1H, J = 16.5, 10.0, 2.0), 2.25 (dd, 1H, J = 16.5, 6.0), 
1.95 (s, 3H), 1.37 (d, 3H, J = 6.3). 
13C NMR (125.77 MHz, CDCh): 
8 177.7, 83.5, 81.4, 76.4, 68.6, 67.7, 44.4, 38.8, 34.2, 15.9. 
(2R,3S,6S, 7 S)-3,4, 7-Trimetbyl-2-phenyl-1 0-vinyl-1 ,8-dioxa-4-azaspiro [5.6] dodec-1 0-
en-S-one (53): 
To a solution of 49 (0.0500 g, 0.150 mmol) in dichloromethane (15 mL) was 
added Grubbs I catalyst (0.0150 g, 0.0200 mmol, 10 mol%). The mixture was stirred at 
room temperature for 48 h and the solvent was removed under reduced pressure. The 
residue was purified by flash chromatography on silica gel to give 0.045 g (90%) of 53 as 
colorless oil. 
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1H NMR (500 MHz, CDCh): 
o 7.39-7.28 (m, 5H), 6.23 (dd, 1H, J = 9.2, 6.9), 5.61 (t, J = 6.4), 5.16 (d, 1H, J = 
3.6), 4.93 (d, 1H, J = 13), 4.90 (d, 1H, J = 18.5), 4.78 (br d, 2H), 4.54 (dd, 1H, J = 
13.3, 2.6), 3.79 (q, 1H, J = 6.8), 3.51 (dq, J = 3.6, 6.5, 1H), 3.47-3.44 (m, 1H), 3.0 
(s, 3H), 2.60 (q, 1H, J = 15, 9.0), 1.28 (d, 1H, J = 6.8), 0.95 (d, 3H, J = 6.5). 
13C NMR (125.77 MHz, CDCl)): 
0 169.6, 138.0, 138.0, 128.5, 127.8, 127.0, 125.8, 111.4, 89.3, 79.5 , 72.8, 72.3, 
59.0, 33 .7, 30.5, 17.0, 12.5. 
IR (neat): 
1646, 1452, 1399, 1380, 1253, 1146, 11 23, 1097, 991 cm-1• 
[a]23o: +24 (c 1, CH2Ch). 
MS (APCI): 
28.3 (M+1, 100). 
HRMS (CI): 
mlz 327.1834 (327.1834 calc. for C2oH2sN03, M+). 
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(5R,6R,8R,9S)-8-Phenyl-5,9,10-trimethyl-1,3,7-trioxa-10-azaspiro[5,5]undecan-11-
one (55): 
To a solution of 39 (0.562 g, 2.40 mmoles) in glacial acetic acid (10 mL) was 
added formaldehyde (0.406 g, 13.5 mmoles) and H2S04 (0.1 mL). The reaction mixture 
was stirred at 85 oc for 8 h and saturated NaHC03 solution was added and the mixture 
was extracted with ethyl acetate (3 x 20 mL). The combined organic layers were dried 
(Na2S04) and concentrated under reduced pressure. The resulting residue was purified by 
flash chromatography on silica gel (2/3 ethyl acetate/hexanes) to provide 0.340 g (45%) 
of 55 as a white solid. 
Mp: 134-135 °C. 
1H NMR (500 MHz, CDCh): 
o 7.44-7.28 (m, 5H), 5.51 (d, 1H, J= 3.5), 4.81 (d, 1H, J = 5.8), 5.04 (d, 1H, J = 
5.8), 3.90 (dd, J = 11, 5), 3.80 (t, J = 11), 3.54 (dq, 1H, J = 6.1 , 3.5), 3.07 (s, 3H), 
3.01 (m, 1H), 0.99 (d, 1H, J = 6.1), 0.89 (d, 1H, J = 6.7). 
13C NMR (125.77 MHz, CDCh): 
0 164.7, 137.4, 128.8, 128.1 , 125.6, 100.0, 96.8, 70.4, 68.1 , 59.2, 34.7, 34.1, 13.0, 
11.7. 
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IR (neat): 
2977,1756, 1663, 1153, 985, 967,881 cm-1• 
MS (APCI): 
292.1 (M+1 , 100). 
HRMS (CI): 
rnlz 291.1472 (291.1471 calc. for C16H21N04, M+). 
(2S,5S,6R)-2-Ally 1-2-( (S)-1-(bu t -3-eny loxy )propan-2-yl)-4,5-d imethyl-6-
phenylmorpholin-3-one (56): 
To a solution of 55 (0.31 0 g, 1.06 mmol) in dichloromethane (3.5 mL) at -78 °C 
was added allytrimethylsilane (3.40 mL, 21.2 mmol) followed by BF3.Et20 (2.65 mL, 
21.2 mmol). The mixture was stirred at - 78 °C for 15 min and then at ambient 
temperature for 96 h. Cold water was added and the resulting mixture was extracted with 
dichloromethane (3 x 20mL). The combined organic layers were dried, concentrated 
under reduced pressure and the residue was purified by flash chromatography on silica 
gel (1/1 ethyl acetate/hexane) to provide 0.290 g (76%) of 56 as a yellow oil. 
IR (neat): 
2978, 1643, 1452, 1398, 1378 1246, 1103, 1001 , 913 cm-1• 
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1H NMR (500 MHz, CDC~)): 
8 7.38-7.27 (m, 5H), 5.99-5 .94 (m, 1H), 5.87-5.81 (m, 1H), 5.32 (d, 1H, J = 2.7), 
5.09 (d, 2H, J = 16.8), 5.02 (d, 2H, J = 10.5), 3.84 (dd, 1H, J = 4.9, 2.1) 3.54-3.40 
(m, 4H) 3.01 (s, 3H), 2.80 (dd, IH, J = 7, 14.6), 2.72 (dd, IH, J = 7, 14.6), 2.44-
2.41 (m, 1H), 2.36-2.32 (m, 2H), 1.20 (d, 1H, J = 6.5), 0.94 (d, 1H, J = 6.8). 
13C NMR (125.77 MHz, CDCh): 
8 170.7, 138.4, 135.7, 134.4, 128.5, 127.7, 125.7, 117.7, 116.3, 82.9, 71.7, 71.6, 
70.4 60.6, 59.2, 40.7, 34.5, 33.8, 14.2, 13.2. 
MS (APCI): 
358.3 (M+1, 100). 
HRMS (CI): 
m/z 357.2300 (357.2304 calc. for C22H31N03, M+). 
(2R,3S,6S, 7 R)-3,4, 7-Trimethyl-2-phenyl-1 ,9-dioxa-4-azaspiro [5.8) tetradec-12-en-5-
one (57): 
To a solution of 56 (0.0500 g, 0.140 mmol) in dichloromethane (36 mL) was 
added Grubbs I catalyst (0.0350 g, 0.043 mmol, 30.3 mol %). The reaction mixture was 
heated to relux for 42 h and then concentrated under reduced pressure. The residue was 
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purified by flash chromatography on silica gel to provide 0.0340 g (74 %) of 57 as pale 
yellow oil. 
1H NMR (500 MHz, CDCl)): 
8 7.4-7.3 (m, 5H), 5.8 (m, 2H), 5.34 (d, 1H, J = 3.5), 4.1 (t, 1H, J = 11.5), 3.85-
3.82 (brm, 1H), 3.54 (dq, 1H, J = 6.7, 3.1), 3.35-3.30 (m, 2H), 3.07-3.05 (m, 1H), 
3.05 (s, 3H), 2.95-2.89 (m, 1H), 2.68 (m, 1H), 2.32-2.27 (m, 1H), 2.16-2.10 (m, 
1H), 0.95 (d, 3H, J= 6), 0.80 (d, 3H, J = 6.7). 
13C NMR (125 .77 MHz, CDCh): 
8 138.8, 135.7, 129.8, 129.3, 128.4, 128.0, 126.0, 83.3 , 73.3 , 71.0, 70.7, 60.1, 
59.1, 57.7, 34.9, 33.8, 29.5, 13.4. 
IR (neat): 
2920,2852, 1742, 1640, 1451 , 1379, 1124, 1036 cm- 1• 
MS (APCI): 
330.2 (M+1, 100). 
HRMS (CI): 
m/z 329.1986 (329.1991 calc. for C2oH21N03, M+). 
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(Z,3R,4S)-2,3,4,5,8,9-Hexahydro-4-hydroxy-N,3-dimethyloxonine-4-carboxamide 
(58): 
'NH 
~ 6J 
To anhydrous liquid ammonia (distilled over sodium) was added Na metal (0.0590 
g, 2.50 mmol) at - 78 oc and the mixture was stirred for 15 min. To the resulting blue 
solution was added a solution of ring closing metathesis product 57 (0.0400 g, 0.120 
mmol) in anhydrous THF (2.5 mL) and the mixture was stirred for 3 min. A mixture of 
2/1 methanol/water (3 mL) was added and the reaction mixture was brought to ambient 
temperature and stirred for 30 min to remove ammonia. The resulting solution was 
concentrated under reduced pressure and the residue was purified by flash column 
chromatography on silica gel (3/2, ethyl acetate/hexane) to provide 0.0230 g (89%) of 58 
as a white solid. 
1H NMR (500 MHz, CDCh): 
8 6.72 (bs, 1H), 5.85-5.78 (m, 2H), 3.87-3 .83 (m, 1H), 3.69-3.65 (dd, 1H, J = 8.9, 
11.8), 3.54-3.50 (dd, 1H, J = 4.6, 11.8), 3.26-3.22 (m, 1H), 2.95-2.91 (m, 2H), 
2.84 (d, 3H, J = 5.2), 2.48-2.41 (m, 2H), 2.29-2.21 (m, 2H), 0.70 (d, 3H, J = 6.8). 
13C NMR (125.77 MHz, CDCh): 
8 176.0, 129.5, 129.2, 79.4, 72.5, 69.9, 38.3, 36.3, 27.8, 25.9, 12.4. 
IR (neat): 
3422, 2936, 2866, 1656, 1650, 1562, 1121 , 958, 911 cm-1• 
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MS (APCI): 
214.1 (M+1, 100). 
HRMS (CI): 
m/z 213.1361 (213.1365 calc. for CttH19N03, M+). 
(2S,5S,6R)-2-Ailyl-2-[(S)-l-(allyloxy)propan-2-yl]-6-phenyl-4,5-dimethylmorpholin-
3-one (59): 
To a solution of 56 (0.250 g, 0.700 mmol) in dichloromethane at -78 °C was added 
BBr3 (0.330 mL, 3.50 mmol) dropwise. The mixture was then brought to ambient 
temperature and stirred for 21 h. Saturated sodium bicarbonate solution was added and 
the mixture was extracted with ethyl acetate (3 x 15 mL). The combined organic layers 
were dried and concentrated under reduced pressure and the residue obtained was purified 
by flash chromatography on silica gel to yield 0.180 g (85 %) of the primary alcohol 59 as 
a white solid. 
1H NMR (500 MHz, CDCh): 
() 7.39-7.26 (m, 5H), 5.95 (m, 1H), 5.36 (d, 1H, J = 2.8), 5.16-5 .06 (m, 2H), 3.96-
3.92 (m, 1H), 3.80-3.76 (m, 1H), 3.52-3.45 (m, 1H), 3.04 (s, 3H), 2.83 (m, 2H), 
2.61 (m, 1H), 2.31 (m, 1H), 1.20 (d, 3H, J = 7.1), 1.01 (d, 3H, J = 6.6). 
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13C NMR (125.8 MHz, CDCh): 
8 171.0, 137.8, 133.9, 128.7, 128.0, 125.7, 118.4, 84.7, 72.8, 64.6, 59.3, 42.6, 
40.1 , 34.1, 13.8, 13.2. 
(2S,SS,6R)-2-Ally 1-2-[ (S)-1-( allyloxy )propan-2-y I] -6-phenyl-4,5-dimethylmorpholin-
3-one (60): 
To a solution of the alcohol 59 (0.105 g, 0.0350 mmol) in THF (15 mL) at 0 °C 
was added KH (0.0170 g, 0.420 mmol). The mixture was then stirred at 0 °C for 15 min 
and allylbromide (0.0900 mL, 1.21 mmol) was added dropwise. The mixture was then 
warmed up to ambient temperature, stirred for 2 h and cold water was added. The mixture 
was extracted with ethyl acetate (3 x 10 mL) and the combined organic layers were dried 
and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (60/40 ethyl acetate/hexane) to provide 0.090 g (75%) of 60 
as a yellow gum. 
1H NMR (500 MHz, CDCh): 
8 7.39-7.28 (m, 5H), 6.0-5.91 (m, 2H), 5.33 (d, 2H, J = 3.3), 5.30 (dd, 1H, J = 
17.9, 1.6), 5.17 (dd, 1H, J = 9.8, 1.4), 5.11 (dd, 1H, J = 1.2, 17.9), 5.04 (d, J = 
9.8), 4.00-3.98 (m, 2H), 3.87 (dd, 1H, J = 9.3, 4.1), 3.50 (dq, 1H, J = 3.1 , 7.0), 
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3.44 (t, 1H, J = 9.3), 3.02 (s, 3H), 2.81 (dd, 1H, J = 15, 8.2), 2.74 (dd, J = 15, 6.6), 
2.46-2.42 (m, 1H), 1.16 (d, 3H, J = 7.4), 0.96 (d, 3H, J = 7.0). 
13C NMR (125.77 MHz, CDCh): 
8 170.7, 138.4, 135.3, 134.3, 128.5 , 127.7, 125.7, 117.8, 116.6, 82.9, 71.9, 71.8, 
71.2, 59.2, 40.8, 40.2, 33.8, 14.2, 13.2. 
IR (neat): 
2979, 1737, 1643, 1497, 1398, 1379, 1243, 1143, 1088, 1030, 918 cm-1. 
MS (APCI): 
344.3 (M+1 , 100). 
HRMS (CI): 
m/z 343 .2155 (343.2147 calc. for C21H29N03, M+). 
(2R,3S,6S, 7 R)-3,4, 7-Trimethyl-2-phenyl-1 ,9-dioxa-4-azaspiro [ 5. 7]tridec-11-en-5-one 
(61): 
To a solution ofthe diene 25 (0.0710 g, 0.210 mmol) in dichloromethane (40 mL) 
was added the Grubbs I catalyst (0.0510 g, 0.0600 mmol, 30.3 mol %). The mixture was 
heated to reflux for 21 h and then the solvent was removed under pressure. The residue 
was purified by flash chromatography on silica gel to give 0.0500 g (77 %) of 61 as a pale 
yellow oil. 
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1H NMR (500 MHz, CDC~)): 
8 7.60-7.47 (m, 5H), 5.83-5.75 (m, 2H), 5.47 (d, 1H, J= 3.7), 4.68 (br d, 1H, J = 
17.4), 4.33 (dd, 1H, J = 17.4, 1.8), 4.27 (t, 1H, J = 11.8), 3.75 (dq, 1H, J = 6.9, 
3.2), 3.69 (dd, 1H, J = 11.8, 3.7), 3.42-3.38 (m, 1H), 3.24 (s, 3H), 3.23-3.13 (m, 
2H), 1.17 (d, 3H, J = 9.8), 1.06 (d, 3H, J= 6.9). 
13C NMR (125 .77 MHz, CDCh): 
8 172.1 , 138.6, 132.0, 128.5, 127.7, 125.7, 123.8, 82.2, 73.7, 71.4, 71.0, 59.1 , 
37.3, 33.8, 33.7, 13.3, 13.1. 
IR (neat): 
2940, 1636, 1452, 1380, 1146, 1132, 1037 cm-1. 
MS (APCI): 
316.3 (M+1, 100); 
HRMS (CI): 
m/z 315.1830 (315.1834 calc. for C19H2sN03, M+). 
(S,E)-2-Hydroxy-2-( (R)-1-hydroxypropan-2-yi)-N-methylhex-4-enamide ( 62): 
-NH 
I OH ~ ~H) 
To refluxing anhydrous liquid ammonia (distilled over sodium) was added Ca 
metal (0.0530 g, 1.33 mmol) at - 33 oc and the mixture was stirred for 15 min. To the 
resulting blue solution was added a solution of 61 (0.0600 g, 0.400 mmol) in anhydrous 
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THF (1 mL) and the refluxing mixture was stirred for 40 mm. A mixture of 2/1 
methanol/water (3 mL) was added and the reaction mixture was brought to ambient 
temperature and stirred for 30 min to remove the ammonia. The resulting solution was 
concentrated under reduced pressure and the residue was purified by flash column 
chromatography on silica gel (ethyl acetate) to provide 0.0150 g (40%) of 62 as a 
colourless oil. 
1H NMR (500 MHz, CDCi)): 
8 6.85 (bs, 1H), 5.66 (m, 1H), 5.41 (m, 1H), 4.07 (m, 1H), 3.91 (s, 1H), 3.73 (m, 
1H), 2.82 (d, 3H, J = 5.0), 2.61 (m, 2H), 2.38 (m, 1H), 2.10 (m, lH), 1.65 (m, 
3H), 1.05 (d, 3H, J = 7.2). 
13C NMR (125 .8 MHz, CDCh): 
8 175.3, 128.0, 124.5, 81.3, 65.6, 40.3, 35.2, 25.9, 13.3, 13.0. 
MS (APCI): 
202.1 (M+1 , 100). 
(2R,3S,6S, 7 R,11S,12R)-11 ,12-Dihydroxy-3,4, 7 -trimethyl-2-phenyl-1,9-dioxa-4 
azaspiro[5.7]tridecan-5-one (63): 
To a solution of61 (0.0600 g, 0.190 mmol) in acetone:water (3:1 , 0.400 mL) was 
added NMO (0.0470 g, 0.400 mmol) followed by Os04 (20.0 ~L (4% soln. in water) 3.00 
141 
)lmol). The reaction was stirred for 3 h at room temperature and the solvent was 
evaporated under reduced pressure. Saturated sodium bicarbonate solution was added to 
the residue and the resulting mixture was extracted with ethyl acetate (3 x 5 mL). The 
combined organic layers were dried and concentrated under reduced pressure and the 
residue was purified by flash chromatography on silica gel (95/5, 
dichloromethane/methanol) to give 0.0550 g (83%) of 63 as a colourless gum. 
1H NMR (500 MHz, CDCh): 
8 7.39-7.28 (m, 5H), 5.31 (d, 1H, J = 2.8), 4.52 (d, 1H, J = 7.3), 4.05 (dd, 1H, J = 
13.1 , 2.43.99 (t, 1H, J = 12.1), 3.79 (br s, 1H), 3.60 (dd, 1H, J = 1.4, 13.1), 3.52 
(dq, 1H, J = 7.3, 3.2), 3.40 (dd, 1H, J = 12.1 , 4.1), 3.02 (s, 3H), 2.83 (br q, 2H, J = 
8.1), 2.69 (m, 1H), 2.23 (d, 1H), 2.18 (s, 1H), 0.94 (d, 3H, J = 6.7), 0.83 (d, 3H, J 
= 7.3). 
Visible peaks of the minor diastereomer: 8 5.28 (d), 3.05 (s), 0.97 (d), 0.83 (d). 
13C NMR (125.77 MHz, CDCh): 
8 172.6, 138.3, 128.5, 127.7, 125.7, 79.8, 72.9, 71.5, 70.8, 70.5, 69.0, 59.3, 39.9, 
34.9, 33.8, 13.1, 12.9. 
Visible peaks of other isomer: 
8 128.7, 128.0, 71.4, 59.2, 31.1 , 13.2. 
IR (neat): 
3403, 2937, 1626, 1452, 1380, 1258, 1140, 1059, 1039, 755 cm-1• 
MS (APCI): 
350.1 (M+1 , 100). 
HRMS (CI): 
142 
m/z 349.1881 (349.1889 calc. for C19H27NOs, M+). 
(3R,4S,6S, 7 R)-4,6, 7-Trihydroxy-N,3-dimethyloxocane-4-carboxamide (64): 
To anhydrous liquid ammonia (distilled over sodium) was added Na (0.0160 g, 
0.700 mmol) at -78 oc and the mixture was stirred for 15 min. To the resulting blue 
solution was added a solution of the dihydroxylation product obtained from 63 (0.350 g, 
0.100 mmol) in anhydrous THF (2.5 mL) and the mixture was stirred for 3 min. A 
mixture of2/1 methanol/water (3 mL) was added and the reaction mixture was brought to 
ambient temperature and stirred for 30 min to remove ammonia. The resulting solution 
was concentrated under reduced pressure and the residue was purified by flash column 
chromatography on silica gel (3/2, ethyl acetate/hexane) to provide 8.00 mg (34%) of 64 
as a colourless gum. This compound is very water soluble. 
1H NMR (500 MHz, CDCh): 
o 7.16 (br q, lH, J = 5), 5.47 (br s, lH), 4.7 (br m, lH), 3.96 (br dd, lH, J= 11.0, 
3.0), 3.8 (br s, lH), 3.68 (br t, lH, J = 11.0), 3.60 (br d, lH, J = 12.0), 3.39 (dd, 
1H, J = 12.0, 4.0), 2.81 (d, 3H, J = 5.0), 2.80 (m, 1H), 2.53-2.48 (m, 1H), 2.02 (s, 
lH, OH), 1.77 (br d, lH), 0.65 (d, 3H, J = 7.0). 
13C NMR (125.77 MHz, CDC~)): 
0 177.0, 78.3, 76.4, 72.9, 72.1 , 70.5, 69.5, 29.9, 25.9, 11.4. 
IR (neat): 
3375, 1646, 1540, 1458, 1412, 1264, 1145, 1093, 1055, 1019, 977 cm-1• 
MS (APCI): 
234.1 (M+ 1, 1 00). 
HRMS (CI): 
m/z 233 .1259 (233.1 263 calc. for CIOH19NOs, M+). 
[a]230 = -3.8 (c 0.8, CH2Cb). 
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1H and 13C NMR Spectra for Chapter 3 
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Chapter 4 
Formal Total Synthesis of (+)-Laurencin 
Part of the work described in this chapter has been published in 
Org. Biomol. Chern. 2008 ,6, 2011 
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Introduction 
The stereo selective construction of medium-sized oxacycles 1 continues to be an 
area of active interest and target-oriented2 as well as general3 strategies for assembling 
such ring systems and have been extensively investigated in recent years. In particular, 
medium-ring ether-containing marine natural products4 isolated from red algae have 
attracted considerable synthetic effort. The halogenated oxocenes laurencin5 (1), 
prelaureatin (2),6 pannosallene7 (3) and laurenyne8 (4) are representative examples of the 
impressive array of red algae metabolites that have been the focus of intense synthetic 
investigations in recent years (Figure 1 ). 
Laurencin (1) Prelaureatin (2) 
Pannosallene (3) Laurenyne (4) 
Figure 1. Medium-ring ether-containing halogenated marine natural products. 
Apart from the oxocene ring, other stmcturally salient features of the above-
mentioned marine natural products are; 1) the a, a' -disubstituted ether functionality and 
2) the presence of a halogen atom at the ~ position with respect to the ether oxygen. 
Interestingly, though the elucidation of biosynthesis of these molecules is still incomplete, 
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it has now been shown that haloperoxidase enzymes may play a crucial role in the 
biosynthesis of these molecules from terpenes. Butler and coworkers9 have shown that the 
vanadium bromoperoxidase (V-BrPO)-catalyzed bromination of nerol (5) leads to 
cyclization, yielding the monobromo eight-membered cyclic ether 6 (Scheme 1). 
Scheme 1. 
~ HO 5% Br 
nerol (5) 6 
From a historical perspective, general strategies towards the halogenated oxocene 
natural products were virtually non-existent until 1986 when Holmes and Carling devised 
a protocol based on the Baeyer-Villiger oxidation of cycloheptanones for the synthesis of 
2,8-disubstituted oxocane derivatives.10 It was shown that substituted heptanolides 8 
obtained from Bayer-Villiger oxidation of cycloheptanones 7, (Scheme 2) could be 
methylenated with the Tebbe reagent to provide oxocanes 9. Hydroboration/oxidation of 
9 gave predominantly the cis-oxocane 10 (38-49%). The trans-isomer 11 was obtained as 
the minor product. 
Scheme 2 
QR 
0 
7 
12 = 
CF3COOH 
Na2HP04 , 
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9 
(39-49%) (3-5%) 
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In the last decade, several strategies for the enantioselective synthesis of 
functionalized medium-sized oxacycles have been documented and an overview of these 
methods was provided in Chapter 3. Although a significant number of natural products 
with the oxocane core are known, the synthesis of laurencin (1) has served to showcase 
new methodologies for the stereoselective construction of substituted eight-membered 
oxacycles. Several successful strategies targeting laurencin have been reported and a 
summary of the reported enantioselective syntheses of ( + )-laurencin follows. 
Enantioselective syntheses of (+)-laurencin: 
Murai's synthesis of (+)-laurencin 11 
Murai and Tsushima reported the first total synthesis of (+)-laurencin. Their 
strategy for the construction of the medium-sized oxacycle relied on a ring expansion 
reaction of a four-membered ring fused to a funtionalized tetrahydropyran. The starting 
material 15 was obtained from silyloxycyclobutanone 13 and the alkyl bromide 14 in 
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three steps (Scheme 3). Acid hydrolysis of the acetonide in 15 followed by protection of 
the resulting primary alcohol gave hemiacetal 16. Oxidative cleavage of 16 yielded the 
eight-memebered oxacycle 17. The ketone in 17 was then treated with TBSOTf in 
presence ofEt3N to give a separable mixture ofsilyl enol ethers 18 and 19. 
Scheme 3 
c(OTBS + 
0 
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Compound 18 was treated with LHMDS and the resulting enolate reacted with 
PhNTf2 to give the dienol triflate 20 (Scheme 4). Subsequent treatment of 20 with 
Et2CuLi gave the ethyl derivative 21. A sequence of reactions comprised of removal of 
silyl protection on the enol ether by exposing it to TBAF, reduction of the resulting 
ketone with NaBH4, and protection of the alcohol as a silyl ether by reacting it with 
TBSOTf gave 22. The double bond in 22 was then subjected to a hydroboration/oxidation 
sequence followed by oxidation of the resulting secondary alcohol to afford ketone 23. 
The cis-configuration at the o.,o.' -postions was thus installed. 
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Deprotection of the alcohol in 23 followed by dehydration gave a mixture of 
unsaturated ketones 24 and 25. The unwanted product 24 could be converted into the 
desired compound 25 by treating the former with DBU. Stereoselective reduction of the 
ketone in 25 was achieved by using L-Selectride® (Scheme 5) to obtain alcohol 26 which 
in turn could be converted to compound 27 over 3 steps. The aldehyde in 27 was then 
reacted with (3E)-5-bromo-3-pentene-1-ynyltrimethylsilane in the presence of Smh to 
obtain a mixture of enyne alcohols 28 and 29 in a ratio of 44:55. Oxidation of the 
undesired isomer 29 followed by reduction with L-Selectride® generated the alcohol 28 in 
a combined yield of 88%. Compound 28 could then be transformed into 1 over three 
steps. Thus, the 27-step sequence was carried out with an overall yield of2.5%. 
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Scheme 5 
rro 
PvOJo\ 
L-Selectride, THF ~H 
PvO 
26 
~TBS 
OHC 
25 27 
.,,(),,~ 
-:: OAc OH 
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The Overman synthesis of (+)-laurencin12 
This synthesis starts with asymmetric allylboration of propanal with the 
allyldiisopinocampheylborane (generated in situ by sequential reaction of allyl ether 30 
with s-BuLi, (-)-B-methoxydiisopinocampheylborane, Scheme 6) and the resulting 
alcohol was converted to the tert-butyldimethylsilyl (TBDMS) ether derivative 31. 
Suzuki coupling13 of 31 with (1-bromovinyl)phenylsulfane and removal of the TBDMS 
protecting group gave 32. Treatment of the alcohol in 32 with 4-bromo-4-methoxybutyl 
pi val ate gave the mixed acetal 33. Deprotection of the silyl ether followed by acylation of 
the resulting alcohol gave 34. The key acetal-vinyl sulphide cyclization was carried out 
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by using BF3•Et20 as a Lewis acid in t-BuOMe as a solvent at -10 °C to give the oxocene 
35 (Scheme 6). 14 
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Oxocane 35 was then transformed to compound 36 in seven steps (Scheme 7). The 
allyl alcohol in 36 served as a substrate for Sharpless epoxidation to yield the epoxy 
aldehyde 37 in high yield (85%) and good stereoselectivity. The primary alcohol was then 
oxidised by using Dess-Martin periodinane 15 to generate the aldehyde 37 which could be 
condensed with the ylide obtained from the phosphonium salt of (3-bromoprop-1-
ynyl)triisopropylsilane to afford the alkenes 38 and 39 as a 3:1 mixture of E and Z 
stereoisomers respectively. Palladium catalyzed hydrogenolysis 16 of the epoxides 38 and 
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39 yielded the alcohols as a 4:1 mixture of E and Z isomers respectively. The required E-
alkene 40 was separated and converted to ( + )-laurencin over four steps. The target was 
thus obtained with an overall yield of ~2% (24 steps). 
Scheme 7 
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The Palenzuela approach to (+)-laurencin 17 
38 = E isomer 
39 = Z Isomer 
Palenzuela and co-workers reported a synthesis that started with a hetero Diels-
Alder reaction between the diene 41 and aldehyde 42 18 to obtain the cycloadducts 43 and 
44 as an 88:12 mixture of isomers (Scheme 8). Ozonolysis of the mixture followed by 
esterification gave a mixture of stereoisomeric esters which were separated by HPLC to 
secure the desired isomer 45 in 69% yield. Conversion of compound 45 to the epoxide 46 
was then achieved in three steps. 
Scheme 8 
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Epoxide 46 was subjected to a base-induced ring opening at the terminal carbon to 
form the eight-membered oxacycle 47 (Scheme 9). The alcohol in 47 was then oxidized 
and the resulting ketone was treated with DBU to afford oxocene 48. This in turn was 
transformed to the compound 36 which was also an intermediate in Overman's 
synthesis12 of (+)-laurencin (Scheme 7). 
Scheme 9 
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The Holmes approach to (+)-laurencin19 
This approach originated with (R)-malic acid and both the starting materials 49 
and 50 were obtained from this source (Scheme 1 0). Wittig reaction of 49 with 50 was 
effected by using nBuLi as a base to give the cis-alkene 51. The alcohol 52 was then 
obtained from 51 via a protection/deprotection sequence. 
Scheme 10 
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Formation of the eight-membered nng was achieved by subjecting 52 to 
Yamaguchi lactonization20 to yield the lactone 53 in excellent yield (84%, Scheme 11 ). 
After replacing the BOM group with TMS, the lactone in the resulting compound was 
converted into the vinyl ether 54 by employing the Petasis reagent. Funtionalization of the 
double bond was achieved by an intramolecular hydrosilation reaction.21 Thus, replacing 
the TMS protection on the secondary alcohol in 55 by dimethylsilyl hydride followed by 
the treatment of the resulting ether 56 with the platinum complex [Pt(DVS)2] 22 gave 
compounds 57 and 58 as a 58:42 mixture of diastereomers. Compound 57 was then 
converted into 59. Also, it was shown that aldehyde 59 could also be obtained from 58, 
albeit in low yield, by oxidation ofthe secondary alcohol in 58 followed by epimerization 
of the C2 carbon as shown by Murai 11 and Palenzuela. 17 
-- ----------------------- ---------------------------------------------
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n 1) K2C03, MeOH n 
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The end game of this synthesis resembles the one in Murai ' s synthesis of 
laurencin. A Barbier-type alkylation of the aldehyde 59 (Scheme 12) with (3E)-5-bromo-
3-pentene-1-ynyltrimethylsilane in the presence of samarium(II) iodide, provided 
alcohols 60 and 61 as a mixture of diastereomers. These products had to be separated by 
HPLC and the undesired alcohol 60 could be recycled into the desired alcohol 61 by 
following an oxidation/reduction sequence. (+)-Laurencin was then obtained from the 
alcohol61. 
Scheme 12 
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The Hoffmann approach to (+)-laurencin23 
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The Hoffmann synthesis started with the known ester 62 (obtained from (R)-malic 
acid)24 which was transformed into the aldehyde 63 (Scheme 13). A Wittig reaction of 63 
with the known phosphorane 6425 gave the cis-alkene 65. One-pot conversion of the 4-
methyl-2,6,7-trioxabicyclo[2.2.2]octane (OBO) ester in 65 to the Weinreb amide was 
achieved by hydrolysis to the acid and DCC coupling with N-methoxy-N-methylamine to 
provide the Weinreb amide 66. 
Scheme 13 
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DIBAL reduction of the Weinreb amide 66 (Scheme 14) followed by metalation 
with sec-butyllithium, borylation with pinacol borate ester and, finally, liberation of both 
the aldehyde and allylboronate function by aqueous pH 7 buffer solution generated 
aldehyde 67 which spontaneously cyclized to the desired oxocane 68. Selective reduction 
of the terminal double bond by simple hydrogenation in presence of catalytic amounts of 
palladium on carbon secured the oxocene 69. The TBDMS group in 69 was replaced with 
TPS to give compound 57. Since the intermediate 57 was previously reported in Holmes 
synthesis (Scheme 12) of laurencin19 this synthesis constituted a formal total synthesis of 
the molecule. 
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Crimmins reported a formal synthesis of laurencin utilizing an aldol reaction-
RCM strategy. The readily-available alcohol 7027 was treated with NaH and the resulting 
sodium salt was alkylated with the sodium salt of bromoacetic acid to furnish 71 (Scheme 
15). The acid 71 was treated with oxalyl chloride, and the resultant acid chloride was 
added to (S)-4-benzyloxazolidine-2-thione and triethylamine to obtain the 
acyloxazolidinethione 72a. 
----- ---- - - --- ------------ ---- ------- -
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The corresponding oxazolidinone 72b was prepared similarly by exposure of the 
acid chloride to the lithium salt of (S)-4-benzyloxazolidine-2-one. Enolization of the 
acyloxazolidinethione 72a was achieved by using TiC14 and and (-)-sparteine and that of 
72b with TiC14 and Hunig's base. Reaction of the enolates of 72a and 72b with 3-butenal 
gave the aldol products 73a and 73b in good yields and diastereoselectivity (90% yield at 
30% conversion for 73a and 65% yield for 73b, >96% de for both 73a and 73b). 
Reductive removal of the chiral auxiliaries in 73a and 73b provided the diol 74 in good 
yield (86%). Acetylation of the diol afforded the diacetate which was then subjected to a 
RCM reaction to furnish the eight-membered oxacycle 75, which was then transformed to 
the intermediate 57 previously reported in the Holmes synthesis (Scheme 11) of 
laurencin. 19 
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The Crimmins synthesis of (+)-laurencin28 
In the same year, Crimmins reported the total synthesis of laurencin. This route 
relied on an asymmetric glycolate alkylation29 protocol for installation of the 
stereocenters and on a RCM reaction for construction of the the oxocene core. The 
synthesis started with the oxazolidinone 76 (Scheme 16) which was stereoselectively 
alkylated to give compound 77. The chiral auxiliary in 77 was removed by employing 
LiBH4 as the reducing agent. The resulting primary alcohol 78, was oxidised to give an 
aldehyde which, in turn, was subjected to a chelation-controlled addition of 
ethylmagnesium bromide to provide 79. 0-Alkylation of 79 with bromoacetic acid gave 
80. 
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The acid in 80 was converted to a mixed anhydride which was then exposed to lithiated 
(S)-4-benzyloxazolidine-2-one to give the acyl oxazolidinone 81. Enolization of 81 with 
NaHMDS followed by treatment with allyl iodide gave the diene 82 with excellent 
stereoselectivity (>90% de, Scheme 17). Exposure of the diene 82 to the Grubbs 
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generation I catalyst led to a successful ring closing metathesis reaction to afford the 
oxocene 83, which could then be converted into aldehyde 84 in four steps. 
Scheme 17 
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The strategy for installation of the side-chain included an asymmetric acetate aldol 
reaction of the aldehyde in 84 with (S)-(+)-3-acetyl-4-isobutyl-2-thiazolidinethione 
(Scheme 18) to give a 3.3 : 1 mixture of diastereomers in favour of the desired isomer 85. 
Reductive removal of the chiral auxiliary and reaction of the ensuing aldehyde with the 
phoshonium salt 86 gave a mixture of isomeric alkenes with the desired trans-enyne 87 as 
the major product. The enyne 87 was then converted to (+)-laurencin in three steps. 
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The Kim synthesis of (+)-laurencin30 
Kim and co-workers started their synthesis (Scheme 19) by using a sequence 
similar to the Crimmins protocol ( chiral glycolate alkylation and chelation-controlled 
addition of ethylmagnesium bromide, Scheme 16). Alkylation of oxazolidinone 76 
(Crimmins approach, Scheme 16) with allylic iodide 88 gave 89, which could be 
converted into the methyl ester 90. A one-pot conversion of 90 to 91 was achieved by 
DIBAL reduction and in situ addition ofEtMgBr.31 The alcohol91 was then converted to 
amide 92, which, in turn, when treated KHMDS gave the oxocene 93 in excellent yield 
and diastereoselectivity (dr > 25:1, 94%). 
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The elaboration of the enyne side chain (Scheme 20) began with a novel 
transformation. The authors successfully demonstrated the addition of an acetonitrile 
anion to the a-alk.oxy amide in 93 to yield the ketone 94. Reduction of the ketone 
followed by conversion of the nitrile function to an aldehyde gave 95. Reaction of the 
aldehyde 95 with the phosphorane 86 (Scheme 18, Crimmins approach) gave a 9:1 
mixture of EIZ isomers in favour of the enyne 96 which was then transformed to ( + )-
laurencin in three steps (Scheme 20). 
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95 
Fujiwara reported a total synthesis of(+)-laurencin by employing a ring-expansion 
strategy. The chiral C-glycoside derivative 9733 obtained from o-galactose pentaacetate 
was transformed into the primary alcohol 98 over six steps (Scheme 21). Swern oxidation 
of the alcohol in 98 followed by treatment of the resulting aldehyde with excess 
allylmagnesium chloride yielded a 1: 1 mixture of diastereomeric dienes 99a and 99b in 
quantitative yield. Since the stereochemistry of the secondary alcohol was 
inconsequential to the synthesis, the above mixture was used directly in the next step. 
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The diene in 99a and 99b was subjected to a ring closing metathesis reaction by 
using the Grubbs generation II catalyst (Scheme 22) to afford the funtionalized oxacycles 
100a and 100b. Oxidation of 100a/b provided the ketone 101 which was stereoselectively 
reduced using L-Selectride® and the resulting alcohol was treated with PPh3 and CBr4 in 
toluene to provide the bromoether 102. Epoxide 103 could be obtained from compound 
102 in three steps. 
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The enyne side chain was installed next by reaction of 103 with a vinyllithium 
reagent (obtained from stannane 104 in situ) to provide 105, which was transfonned in 
two steps (desilylation/acetylation) to (+)-laurencin (Scheme 22). 
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Objectives 
The objective of this study was to examine the utility of the epoxide opening I 
RCM protocol (Chapter 3)34 for the synthesis of the oxocene core in (+)-laurencin. 
Specifically, we targeted the ketone (+)-48 (Fig. 2), which is an advanced intermediate in 
the Palenzuela synthesis 17 of ( + )-laurencin. 
"~'0 0 ·. 
48 --OH 
Figure 2. The Palenzuela intermediate for the synthesis of ( + )-laurencin 
Results and discussions 
The retrosynthetic plan (Scheme 23) was based on the use of the ephedrine-
derived template (Chapter 3) for stereocontrol, and on a ring-closing metathesis reaction 
to achieve the oxocene formation. It was reasoned that the target ketone 48 could be 
obtained from the spiro-system 106, which, in turn, would be the outcome of the ring-
closing metathesis reaction of the diene 107 obtained by allylation of the hemiacetal 108. 
It was hoped that a direct entry to the a,a'-disubstituted ether motif in 107 could be 
achieved by an epoxide ring-opening of the spiro-epoxide 110 with a secondary alcohol 
109. Epoxide 110 could be obtained from the alkene 111,34 which, in turn, should be 
accessible from the diane 112.35·36 
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The synthesis of the functionalized oxocene core in laurencin began with the 
morpholine-dione 112 which was readily prepared (85%) from commercially available 
(1R,2S)-ephedrine hydrochloride and ethyloxalyl chloride. Treatment of 112 with 
propylmagnesiurn bromide and dehydration of the resulting hemiacetal cleanly generated 
the alkylidene morpholinone 111 (95%, Scheme 24). Reaction of 111 with mCPBA 
provided the epoxide 110 (85%) as a single diastereomer, which was stable to 
chromatography. At this stage, the stereochemistry of 110 was assigned by analogy to the 
epoxidation of a similar substrate (Scheme 11 , Chapter 3). 
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Scheme 24 
With epoxide 110 in hand, it was time to examine the proposed epoxide opening 
with a secondary alcohol such as 109. The secondary alcohol 109 could be synthesized 
from racemic benzylglycidyl ether (113) by adaptation of the reported procedure (Scheme 
25). A hydrolytic kinetic resolution of racemic 113 employing the Jacobsen protoco137 
provided (R)-113 in excellent yield (48%). Treatment of (R)-113 with vinylmagnesium 
bromide in the presence of a catalytic amount of cuprous iodide provided the secondary 
alcoho1109 in good yield (85%)?7 
Scheme 25 
~OBn 
(±)-113 
114 
AcOH, H20 , THF 
48% 
~OBn 
(R)-113 
~MgBr OH -----~~OBn 
Cui (cat.) 
THF, 0 oc 109 
85% 
Several examples of nucleophilic additions of alcohols to epoxides are known.38 
However, practically all of these reactions are conducted in the presence of Lewis acids 
and, as such, cannot be applied for this synthesis. It may be noted that Lewis acid-
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mediated reactions of 110 will almost certainly proceed via nucleophilic addition to the 
acetal carbon.38 Consequently, direct nucleophilic ring-opening of epoxide 110 at the 
terminal carbon was the only alternative. While the ring-opening of substituted epoxides 
with secondary alkoxides is uncommon, it was gratifying to see that epoxide 110 reacted 
with the potassium salt of alcohol 109 to furnish the hemiacetal115 (60%). Tllis key step 
assembled the two stereocenters adjacent to the oxygen in the oxocene core of laurencin 
(Scheme 26). 
Scheme 26 
KH , THF, 
ooc tort 
60% 
It was anticipated that allylation of the hemiacetal in 115 would provide the diene 
precursor for the required oxocene. However, attempted allylation of 115 with 
allyltrimethylsilane in the presence of BF3•etherate provided the spiro-acetal 116 as the 
major product (90%, Scheme 27) and only a trace amount (3%) of the desired allylation 
product 117 was obtained. 
Scheme 27 
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Attempts to allylate the spiroacetal 116 by with allyltrimethylsilane-BF3•etherate 
at 40 °C, with allyltributyltin-BF3•etherate at 0 oc and at 40 °C, with 
allyltrimethylsilane-TiC14 at -40 °C and with allyltributyltin-TiC14 at -40 °C were 
unsuccessful and unreacted starting material was recovered from these experiments. 
Formation of the chloro-morpholinone 118 (50%) was observed when TiC14 was 
employed as a Lewis acid at room temperature (Scheme 28). 
Scheme 28 
I 
~Si:: , TiCI4 
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50% 
Attempted allylation of hemiacetal 115 with TiC14 as the Lewis acid was also not 
beneficial and provided 119 (arising from debenzylation of 115) in low yield (Scheme 
29). 
Scheme 29 
'N~Ph 
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Clearly, the benzyl ether in 115 was unsuitable for the required transformation and 
an alternative was necessary. At this point, it was decided to employ the p-
methoxyphenyl (PMP) protecting group as it was expected to be relatively unreactive 
under the Lewis acidic conditions necessary for the allylation reaction. At the same time 
deprotection of the PMP-ether was expected to proceed under mild conditions. 
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Accordingly, the alcohol 121 was prepared from commercially available (S)-glycidol 
(Scheme 30).39 A Mitsonobu reaction of (S)-glycidol with 4-methoxyphenol provided the 
epoxyether 120 which was readily converted to the alcohol 121 by a copper-catalyzed 
reaction with vinylmagnesium bromide (78%). 
Scheme 30 
OH \ 
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The potassium alkoxide of 121 was reacted with the epoxide 110 to provide the 
hemiacetal 122 in moderate yield (50%). As projected, allylation of 122 proceeded 
smoothly to provide the diene 123 (60%, Scheme 31) as a single diastereomer. 
Scheme 31 
\ 'N I Ph I 'N~Ph ~0 OJ0~6y ~Si~ 
O ?H ~ _ _ K_H,_T_H_F. __ HO . ..-<~ _B_F..:.3 ._Et..:.2o_._ 
0 +~0 
. o~~rt o~~rt 
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A ring closing metathesis reaction of 123 by using the Grubbs generation II catalyst gave 
the oxocene 124 in good yield (85%, Scheme 32). 
------ ------ --- - ------------------
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Scheme 32 
Grubbs (II) 
PMPO_.. 123 
Having constructed the oxacycle framework, removal the ephedrine portion of the 
morpholinone in 124 remained. Attention to experimental detail was necessary in this 
step. Normally, removal of the ephedrine portion in morpholinones such as 124 is readily 
effected with dissolving metal reduction (Na/NH3) . 34•35 In the present case, competing, 
albeit slow, reduction of the electron-rich p-methoxyphenyl protecting group was a 
distinct possibility. Indeed, it was observed that benzylic C- 0 bond cleavage was faster 
than reduction of the p-methoxyphenyl group and a rapid quenching of the reaction (1 
min) provided the hydroxy amide 125 in excellent yield (96%, Scheme 33). Longer 
reaction times resulted in partial reduction of the p-methoxyphenyl protecting group as 
well. 
Scheme 33 
~NH 
ad-o,· OH 
THF, -78 oc j"~. ~ 
96% 
PMPO-,·· 
125 
Only a few functional group transformations were required to reach the target. 
The a.-hydroxy amide in 125 was reduced by LAH to afford the amino alcohol 126 in 
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good yield (84%, Scheme 34). Oxidative cleavage of 126 with Nai04 gave the ketone 
127. Finally, removal of the PMP group by eerie ammonium nitrate provided the target 
ketone 48 (85% over two steps). 
Scheme 34 
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127 
Given the moderate yields of the epoxide opening and allylation reactions, the 
possibility of employing an intramolecular allylation reaction for a more direct 
construction of the oxocane target was also explored (Scheme 35). 
Scheme 35 
128 129 
LA = Lewis acid 
Towards this end the required alcohol 13040 was prepared by alkylation of 
allyltrimethylsilane with (R)-benzylglycidyl ether (Scheme 36). 
Scheme 36 
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Ph./'-..0~ 
130 OH r< 
Unfortunately, all attempts to convert epoxide 110 to 128 were unsuccessful 
(Scheme 37). It was noted that although unreacted 110 was recovered from these 
reactions, none of the alcohol 130 could be recovered. It is possible that the alkoxide 
derived from allylsilane 130 undergoes a C to 0 silyl group migration (Brook 
rearrangement41 ) , effectively destroying the starting material. 
Scheme 37 
130, KH y 
, .. 
THF, 0 oc 
Conclusion 
In conclusion, an efficient enantioselective route to an advanced intermediate ( 48) 
in the synthesis of ( + )-laurencin has been established. The present route was shorter ( 1 0 
steps) and provided 48 in higher overall yield (11.3%) compared to the reported 
synthesis 10 (21 steps, 4.3% overall yield from commercially available starting materials). 
A notable advantage of the methodology was the ready availability of both enantiomers 
of ephedrine and glycidol. This should enable the assembly of all possible stereoisomers 
of disubstituted oxocenes such as 48 to provide access to analogues of laurencin and its 
congeners. 
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Experimental 
General 
General experimental techniques that have been described in the experimental section 
of Chapter 2 were followed. 
(2S,3S,5R,6S)-2-Ethyl-6, 7 -dimethyl-5-phenyl-1,4-dioxa-7 -azaspiro [2.5) octan-8-one 
(110): 
To a solution of 111 (2.00 g, 8.20 mmol) in dichloromethane (30 mL) was added 
mCPBA (1.83 g, 10.6 mmol) at -78 oc and the mixture was warmed to ambient 
temperature and stirred for 40 min. Saturated aqueous NaHC03 was added, the mixture 
was extracted with ethyl acetate (3 x 20 rnL) and the combined organic layers were dried 
and concentrated under reduced pressure. The residue obtained was immediately 
subjected to purification by flash chromatography on silica gel (3/1 ethyl acetate/hexane) 
to give 1.70 g (80%) of 110 as a colourless gum. 
1H NMR (500 MHz CDCh): 
8 7.39-7.36 (m, 2H), 7.33-7.27 (m, 3H), 5.47 (d, 1H, J = 3.0), 3.69 (t, lH, J = 6.5), 
3.65 (dq, lH, J = 6.5, 3.0), 3.11 (s, 3H), 1.91-1.80 (m, 2H), 1.12 (t, 3H, J = 7.5), 
1.03 ( d, 3H, J = 6.5). 
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13C NMR (125.77 MHz, CDC~)): 
0 163.6, 136.7, 128.7, 128.2, 125.5, 82.2, 76.0, 63.5, 59.4, 34.0, 21.0, 12.5, 10.3. 
IR (neat): 
2976, 1669,1294, 1195, 930, 700 cm-1. 
[a] 0 23 = -115.5 (c 2, CHCI3); 
MS (APCI): 
262.1 (M+1, 100); 
HRMS (CI): 
m/z 262.1451 (262.1443 calc. for C 1sH2oN03, M+H). 
(2S,5S,6R)-2-( (R)-1-( (R)-1-(beozyloxy )pent-4-en-2-yloxy)propyl)-2-hydroxy-4,5-
dimethyl-6-phenylmorpholin-3-one (115): 
'N~Ph 
o)~Xo,o_ ~ Ho__;· r 
BnO 
To a solution ofthe alcohol109 (0.880 g, 4.21 mmol) in THF (20 mL) at 0 °C was 
added KH (0.252 g (obtained by washing a 30 wt.% dispersion in mineral oil with 
hexane), 6.30 mmol, as a suspension in THF (2 mL)). The mixture was then stirred for 10 
min at 0 °C and a solution of the epoxide 110 (1.1 0 g, 4.20 mmol) in THF (5 mL) was 
added. The reaction mixture was then warmed up to ambient temperature, stirred for 4.5 
h, cold water (10 mL) was added, and the mixture was extracted with ethyl acetate (3 x 20 
mL). The combined organic layers were dried and concentrated under reduced pressure. 
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The residue was purified by flash chromatography on silica gel (2/1 ethyl acetate/hexane) 
to provide 1.00 g (60%) of 115 as a yellow oil. 
1H NMR (500 MHz, CDC~)) : 
8 7.36-7.22 (m, 10H), 5.85-5.78 (m, 1H), 5.44 (d, 1H, J = 2.7), 5.08-5 .02 (m, 2H), 
4.90 (br s, 1H), 4.59-4.50 (AB, 2H, J = 12.1), 3.86-3 .82 (m, 1H), 3.67-3.64 (m, 
1H), 3.52-3.49 (m, 1H), 3.43-3.38 (m, 2H), 2.94 (s, 3H), 2.36-2.34 (m, 2H), 1.92-
1.87 (m, 1H), 1.71-1.65 (m, 1H), 1.11 (t, 3H, J = 7.3), 0.98 (d, 3H, J = 7). 
13C NMR (125 .77 MHz, CDC~]): 
8 168.3, 138.3, 137.8, 134.5, 128.5, 128.4, 127.9, 127.8, 127.7, 126.0, 117.5, 98.4, 
83.9, 79.1, 73 .6, 72.5, 72.0, 59.4, 37.0, 33.5, 23.2, 12.3, 11.6. 
IR (neat): 
3326, 2976, 1739, 1636, 1242, 1086 cm-1• 
[a] 0 23 = -105.6 (c 1, CHCI]). 
MS (APCI): 
454.2 (M+ 1, 1 00). 
HRMS (EI): 
m/z 453.2509 (453.2515 calc. for C27H3sNOs, M+). 
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(3R,5R,6S,8R,9S)-3-Allyl-9,1 0-dimethyl-5-ethyl-8-phenyl-1 ,4, 7 -trioxa-1 0-
azaspiro[5.5]undecan-11-one (116): 
To a solution of 115 (0.320 g, 0.700 mmol) in dichloromethane (15 mL) at -78 °C 
was added allyltrimethylsilane (0.670 mL, 4.20 mmol) followed by BF3•etherate (0.520 
mL, 4.21 mmol). The mixture was stirred at -78 °C for 15 min and then warmed to 
ambient temperature and stirred for 22 h. Cold water was added and the mixture was 
extracted with dichloromethane (3 x 25 mL). The combined organic layers were dried and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica gel (113 ethyl acetate/hexane) to provide 0.220 g (90%) of 116 as a colourless 
oil. 
1H NMR (500 MHz, CDC~)): 
8 7.40-7.36 (m, 3H), 7.34-7.31 (m, 1H), 5.89-5.83 (m, IH), 5.21 (d, lH, J = 2.3), 
5.16-5.07 (m, 2H), 4.21 (dd, 1H, J = 7.3, 5.5), 4.05-4.00 (apparent t, 1H, J = 10), 
3.88-3.82 (m, 1H), 3.67 (dd, lH, J = 11.2, 2.7), 3.46 (dq, 1H, J = 13.2, 3.0), 3.07 
(s, 3H), 2.40-2.34 (m, 1H), 2.22-2.16 (m, 1H), 1.55-1.49 (m, 2H), 1.12 (d, 3H, J = 
5.9), 0.98 (t, J = 7.3, 3H). 
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13C NMR (125.77 MHz, CDCh): 
8 165.1 , 138, 133.8, 128.6, 128.1, 126.1 , 117.3, 95.3, 80.5, 78.0, 74.7, 64.6, 59.4, 
36.3, 23.3, 12.3, 10.3. 
IR (neat): 
2925, 1663, 1496, 1042, 700 cm-1. 
[a] 0 23 = -45.9 (c 1, CHCh). 
MS (APCI): 
346.3 (M+ 1, 1 00). 
HRMS (EI): 
m/z 345.1940 (345.1940 calc. for C2oH27N04, M+). 
(2S,SS,6R)-2-((R)-1-( (R)-1-( 4-Methoxyphenoxy )pen t-4-en-2-yloxy)propyl)-2-
hydroxy-4,5-dimethyl-6-phenylmorpholin-3-one (122): 
'NlyPh 
o)~~o,q) H~_/'5-' 
PMPO 
To a solution of (R)-1-(4-methoxyphenoxy)-3-buten-2-ol14 (0.88 g, 4.2 mmol) in 
THF (20 mL) at 0 °C was added KH (0.252 g, 6.30 mmol). The mixture was then stirred 
for 10 min at 0 °C and a solution ofthe epoxide 110 (1.10 g, 4.20 mmol) in THF (5 mL) 
was added. The reaction mixture was then warmed up to ambient temperature, stirred for 
4.5 h, cold water (10 mL) was added, and the mixture was extracted with ethyl acetate (3 
x 20 mL). The combined organic layers were dried and concentrated under reduced 
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pressure. The residue was purified by flash chromatography on silica gel (2/1 ethyl 
acetate/hexane) to provide 1.00 g (50%) of 122 as a yellow oil. 
1H NMR (500 MHz, CDCh): 
o 7.37-7.31 (m, 4H), 7.30-7.26 (m, 1H), 6.85-6.81 (m, 4H) 5.82-5.74 (m, 1H), 
5.40 (br s, 1H), 5.09-5.02 (m, 2H), 3.95-3.91 (m, 3H), 3.87-3.84 (m, 1H), 3.75 (s, 
3H), 3.47 (dq, 1H, J = 6, 2.5), 3.06 (s, 3H), 2.42-2.32 (m, 2H), 2.03-1.97 (m, 1H), 
1.85-1.79 (m, 1H), 1.10 (t, 3H, J = 8), 1.08 (d, 3H, J = 7). 
13C NMR (125.77 MHz, CDCb): 
o 169 (NC=O), 154.0 (p-oMeArCOCH3), 153.3 (p-oMeArCOCH2), 137.7 (ArCipso), 
134.4 (CH=CH2), 128.5 (ArCH), 127.9 (ArCH), 126.1 (ArCH), 117.9 (p_ 
OMeArCH), 115.7 (p-oMeArCH), 114.8 (CH=CH2), 98.6 (O=CCO), 83.3 
(CH3CH2CHO), 78.0 (PhCH), 76.9 (p-oMeArCH2), 72.8 (p-oMeArCH2CH), 69.9 
(OCH), 59.9 (NCH), 55.9 (OCH3), 36.5 (CH2CH=C), 33.9 (NCH3), 22.3 
(CH3CH2), 12.4 (CH3CHN), 11.2 (CH3CH2). 
IR (neat): 
3327, 2936, 1633, 1507, 1230, 756 cm-1; 
[a] 0 23 = -60 (c 1, CHCb). 
MS (APCI): 
470.2 (M+l , 100). 
HRMS (EI): 
m/z 469.2467 (469.2464 calc. for C27H3sN06, M+). 
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(2S,SS,6R)-2-Allyi-((R)-1-((R)-1-(4-methoxyphenoxy)pent-4-en-2-yloxy)propyl)-4,5-
dimethyl-6-phenylmorpholin-3-one (123): 
'N~Ph ), oy 
,,,,q 
-. 
PMPO 
To a solution of 122 (0.660 g, 1.40 mmol) in dichloromethane (15 mL) at -78 °C 
was added allytrimethylsilane (1.40 mL, 8.50 mmol) followed by BF3•etherate (1.1 0 mL, 
8.50 mmol). The mixture was stirred at -78 °C for 15 min and then warmed to ambient 
temperature and stirred for 18 h. Cold water was added and the mixture was extracted 
with dichloromethane (3 x 25 mL). The combined organic layers were dried and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica gel (1/3 ethyl acetate/hexane) to provide 0.232 g (60%) of 123 as a colourless 
oil. 
1H NMR (500 MHz, CDC~)): 
8 7.36-7.32 (m, 3H), 7.29-7.26 (m, 2H), 6.85-6.80 (m, 4H), 6.04-5.95 (m, 1H), 
5.83-5.75 (m, 1H), 5.31 (d, 1H, J = 3.5), 5.11-5.01 (m, 4H), 3.96-3.90 (m, 3H), 
3.83 (m, 1H), 3.76 (s, 3H), 3.43 (dq, 1H, J = 3.5, 7.0), 3.05 (s, 3H), 2.68 (dd, 1H, 
J = 14, 7.5), 2.59 (dd, 1H, J =14.5, 7.5), 2.40-2.37 (m, 2H), 1.95-1.88 (m, 1H), 
1.87-1.78 (m, 1H), 1.09 (t, 3H, J = 7), 1.06 (d, 3H, J = 7). 
13C NMR (125.77 MHz, CDCl3): 
8 170.2 (NC=O), 154.0 (p-MeoArCOCH3), 153.4 (p-MeoArCO), 138.8 (ArCipso), 
134.6 ( CH=CH2) , 134.5 ( CH=CH2), 128.4 (ArC), 127.6 (ArC), 126.1 (ArC), 117.9 
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(p-MeoArC), 117.6 (p-MeoArC), 115.7 (CH=CHz), 114.8 (CH=CHz), 85.4 (O=CCO), 
84.0 (PhCH), 77.4 (OCHz), 73 .7 (p-oMeArCHz), 69.8 (CHO), 59.7 (NCH), 55.9 
(OCH3), 41.4 (CH2CH=C), 36.2 (CHzCH=C), 34.0 (NCH3), 22.8 (CH3CH2), 12.7 
(CH3CHO), 11.3 (CH3CHN). 
IR (neat): 
2934, 1643, 1508, 1230, 1043,823 cm-1• 
[a.]o23 = -63 (c 1, CHCb). 
MS (APCI): 
494.2 (M+ 1, 1 00). 
HRMS (EI): 
m/z 493.2824 (493.2828 calc. for C3oH39NOs, M+). 
(2R,3S,6S, 7 R,9 R, 11Z)-3,4-Dimethyl-7 -ethyl-9-( ( 4-methoxyphenoxy )methyl)-2-
phenyl-1,8-dioxa-4-azaspiro[S. 7]tridec-11-en-5-one (124): 
To a solution of 123 (0.350 g, 0.709 mmol) in dichloromethane (290 mL) was 
added the Grubbs (II) catalyst (43 mg, 0.05 mmol, 10 mol%). The reaction mixture was 
stirred at room temperature for 28 h and the solvent was removed under reduced pressure. 
The residue was purified by flash chromatography on silica gel (1 / 1 ethyl acetate/hexane) 
to give 0.280 g (85%) of 124 as a white solid. 
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Mp: 67-69 OC. 
1H NMR (500 MHz, CDCh): 
8 7.41-7.35 (m, 2H), 7.33-7.31 (m, 3H), 6.86-6.82 (m, 4H), 6.02-5.97 (m, 1H), 
5.62-5.59 (m, 1H), 5.28 (d, 1H, J= 3.0), 4.19 (dd, 1H, J = 9.0, 5.0), 3.86 (dd, 1H, 
J= 9.0, 7.5), 3.77 (s, 3H), 3.74-3.72 (m, 1H), 3.56-3.52 (m, 2H), 3.32 (dd, 1H, J = 
13.0, 5.5), 3.01(s, 3H), 2.68 (dd, 1H, J= 13.0, 5.5), 2.51-2.47 (m, 1H), 2.43-2.38 
(m, 1H), 1.78-1.75 (m, 1H), 1.42-1.37 (m, 1H), 1.10 (t, 3H, J = 7.5), 0.96 (d, 3H, J 
= 7.0). 
13C NMR (125.77 MHz, CDCh): 
8 170.3, 154.0, 153.1, 138.1 , 130.2, 128.7, 128.6, 127.8, 125.7, 115.4, 115.0, 87.7, 
85.7, 83.4, 72.0, 71.5, 58.9, 56.0, 33.6, 32.1 , 30.0, 24.9, 13.0, 11.3. 
IR (neat): 
2958, 1646, 1507, 1230, 823 em·'. 
[a] 0 23 = +13.5 (c 1, CHCh). 
MS (APCI): 
466.2 (M+ 1, 1 00). 
HRMS (EI): 
m/z 465.2524 (465.2515 calc. for C28H3sNOs, M+). 
(2R,3S,5Z,8R)-2-Ethyi-8-((4-Methoxyphenoxy)methyl)-3,4,7,8-tetrahydro-3-
hydroxy-N-methyi-2H-oxocine-3-carboxamide (125): 
""-NH 
Oj.o·· OH !""' 
0 ~ 
PMPQ_,,.· 
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To anhydrous liquid ammonia (15 mL, distilled over sodium) was added Na metal 
(0.0870 g, 3.78 mmol) at - 78 oc and the mixture was stirred for 15 min. To the resulting 
blue solution was added rapidly a solution of 124 (0.250 g, 0.537 mmol) in anhydrous 
THF (3 mL) and the mixture was stirred for 1 min. A mixture of methanol/water (3/1, 5 
mL) was added and the reaction mixture was brought to ambient temperature and stirred 
for 30 min to remove ammonia. The resulting solution was concentrated under reduced 
pressure and the residue was purified by flash column chromatography on silica gel (ethyl 
acetate) to provide 0.180 g (96%) of 125 as a colourless gum. 
1H NMR (500 MHz, CDCh): 
8 6.88-6.84 (m, 4H), 6.54 (br s, 1H), 6.07-6.02 (m, 1H), 5.91-5.85 (m, 1H), 4.27 
(s, 1H), 4.03 (dd, 1H, J = 5, 9.5), 3.95 (dd, 1H, J = 4.5, 9.5), 3.85-3.81 (m, 1H), 
3.78 (s, 3H), 3.63 (m, 1H), 2.85 (d, 3H, J = 4), 2.85-2.82 (m, 1H), 2.57-2.51 (m, 
1H), 2.35-2.31 (m, 1H), 2.26-2.22 (m, 1H), 1.68-1.63 (m, 1H), 1.16-1.08 (m, 1H), 
1.01 (t, 3H, J = 7.0). 
13C NMR (125.77 MHz, CDCh): 
8 176.3, 154.2 , 153.2, 129.7, 129.4, 115.6, 115.0, 84.1 , 82.3, 79.1 , 71.9, 56.0, 
37.8, 31.4, 26.7, 23.6, 10.9. 
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IR (neat): 
3392,2928, 1663, 1507, 1231 , 1068, 1035, 824 cm-1• 
[a] 0 23 = +27 (c 1, CHCI)). 
MS (APCI): 
350.1 (M+ 1, 100) 
HRMS (EI): 
m/z 349.1897 (349.1889 calc. for C 19H27N05, M+). 
(2R,3S,5Z,8R)-8-( ( 4-Methoxyphenoxy )methyl)-2-ethyl-3,4, 7 ,8-tetrahydro-3-
((methylamino )methyi)-2H-oxocin-3-ol (126): 
To a stirred solution of 125 (0.180 g, 0.514 mmol) in THF (10 mL) at 0 °C was 
slowly added lithium aluminum hydride (0.157 g, 4.10 mmol). The mixture was then 
brought to room temperature and heated to reflux for 50 h. The reaction mixture was then 
cooled to room temperature and 3 M HCl (5 mL) was added. The resulting solution was 
washed with ethyl acetate (2 x 15 mL). The aqueous layer was cooled (<5 °C), basified 
(pH = 1 0) with 6 M sodium hydroxide and concentrated under reduced pressure. The 
residual solids were extracted with ethyl acetate (5 x 15 mL) and the combined organic 
layers were dried and concentrated under reduced pressure. The residue was purified by 
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flash chromatography on silica gel (113 ethyl acetate/hexane) to provide 0.145 g (84%) of 
126 as a colourless oil. 
1H NMR (500 MHz, CDC~)): 
8 6.85-6.81 (m, 4H), 5.98-5.93 (m, 1H), 5.89-5.84 (m, 1H), 3.99 (m, 1H), 3.77-
3.75 (m, 2H), 3.72 (s, 3H), 3.50 (dd, 1H, J = 10.8, 1.1), 2.70 (d, 1H, J = 13), 2.69 
(m, 1H), 2.58 (d, 1H, J = 13.0), 2.46 (s, 3H), 2.38-2.27 (m, 2H), 2.14 (dd, 1H, J = 
12.5, 6.5), 1.69-1.65 (m, 1H), 1.27-1.19 (m, 1H), 1.04 (t, 3H, J = 7.0). 
13C NMR (125.77 MHz, CDC~)): 
8 154.0, 153.2, 130.1 , 129.2, 115.5, 114.8, 85.4, 80.6, 76.9, 71.7, 56.5, 55.9, 37.7, 
36.6, 31.4, 24.0, 11.4. 
IR (neat): 
2930, 1737, 1507, 1231 , 1039,823 cm-1. 
[a]0 23 = +85 (c 1, CHCh). 
MS (APCI): 
336.2 (M+ 1, 100). 
HRMS (CI): 
mlz 336.2193 (336.2175 calc. for C19H3oN04, M+H). 
r;---------------------- ~-------
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(2R,SZ,8R)-2-Ethyl-7 ,8-dihydro-8-( ( 4-Methoxyphenoxy)methyi)-2H-oxocin-3( 4H)-
one (127): 
To a stirred solution of 126 (0.1 00 g, 0.298 rnmol) in a mixture of methanol-water 
(100:1 , 4 mL) at 0 °C was added Nal04 (0.255 g, 1.23 rnmol). The reaction mixture was 
maintained at tllis temperature for 15 min and then warmed to room temperature and 
stirred for 2.5 h. A cold saturated aqueous solution of sodium bicarbonate was added and 
the mixture was extracted with ethyl acetate (3 x 15 mL). The combined organic layers 
were dried (sodiwn sulphate) and concentrated under reduced pressure. The residue was 
purified by flash chromatography on silica gel (1/3 ethyl acetate/hexane) to provide 
0.0850 mg (98%) of the ketone 127 as a colourless gum. 
1H NMR (500 MHz, CDCh): 
o 6.87-6.83 (m, 4H), 5.89-5.84 (m, 1H), 5.71-5.66 (m, 1H), 4.06 (dd, 1H, J = 9.1, 
5.9), 3.97-3.90 (m, 2H), 3.82-3.78 (m, 2H), 3.78 (s, 3H), 2.82 (dd, 1H, J = 12, 
4.5), 2.45 (dd, 2H, J = 7.1 , 4.5), 1.79-1.73 (m, 1H), 1.63-1.57 (m, lH), 1.02 (t, 3H, 
J = 7.0). 
13C NMR (125.77 MHz, CDCh): 
0 213.8, 154.3, 153.0, 128.4, 126.5, 115.7, 114.9, 87.6, 82.1 , 71.1 , 56.0, 41.3, 
30.4, 26.4, 10.4. 
IR (neat): 
2930, 1715, 1508, 1231 , 1044, 823 em-' . 
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[a]0 23 = +513 (c 1, CHCh). 
MS (APCI): 
291.1 (M+1 , 100) 
HRMS (CI): 
rnlz 290.1519 (290.1518 calc. for C 17H22N04, M+). 
(2R,SZ,8R)-2-Ethyl-7 ,8-dihydro-8-(hydroxymethyi)-2H-oxocin-3( 4H)-one ( 48): 17 
To a stirred solution of the ketone 127 (0.030 mg, 0.103 mmol) in 
acetonitrile/water (4/1, 2.5 mL) at 0 °C was added eerie ammonium nitrate (0.164 g, 0.314 
mmol). The resulting orange coloured reaction mixture was stirred at 0 oc for 10 min and 
then diluted with dichloromethane (10 mL). The aqueous layer was extracted with 
dichloromethane (2 x 10 mL) and the combined organic layers were dried (sodium 
sulphate) and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (1/2 ethyl acetate/hexane) to provide 0.0200 g (87%) of 48 
as a white solid. 
Mp: 71-72 °C; 
1H NMR (500 MHz, CDCh): 
8 5.86-5.81 (m, 1H), 5.68-5.63 (m, 1H), 3.89 (dd, 1H, J= 12.5, 7.5), 3.83 (dd, 1H, 
J = 8, 4.5), 3.69-3.62 (m, 2H), 3.60-3.56 (m, lH), 2.83 (dd, lH, J = 12.5, 7.5), 
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2.36-2.34 (m, 2H), 2.00 (m, 1H), 1.81-1.74 (m, 1H), 1.73-1.63 (m, 1H), 1.00 (t 
3H, J = 7.5). 
13C NMR (125.77 MHz, CDCh): 
8 213.2 (C=O), 128.3 (O=CCH2CH=CH), 126.2 (O=CCH2CH=CH), 87.0 
(C2H5CH), 84.3 (OCH), 66.1 (CH20H), 41.2(0=CCH2), 30.2 (CH2CH=), 26.3 
(CH3CH2), 10.2 (CH3CH2). 
IR (solid): 
3440, 3026, 1710, 1645, 1095, 1063, 755 cm-1• 
[a]o23 = +610 (c 1, CHCh) (lit. 17 [a]o25 = +568 (c 0.81, CHCh). 
MS (APCI): 
183.1 (M-1, 100). 
219 
References 
1. (a) For reviews see: Fujiwara, K. Top. Heterocycl. Chern., 2006, 5, 97; (b) Nakamura, 
1.; Yamamoto, Y.; Chern. Rev. 2004, 104, 2127; (c) Elliot, M. C.; J Chern. Soc., Perkin 
Trans. 1, 2002, 2301; (d) Elliot, M. C.; Williams, E. J Chern. Soc. , Perkin Trans. 1, 
2001, 2303. 
2. (a) Recent reports: Miyakoshi, N.; Ohgaki, Y.; Masui, K.; Mukai, C.; Heterocycles, 
2007, 74, 185; (b) Ortega, N .; Martin, T. ; Martin, V. S. Org. Lett., 2006, 8, 871 ; (c) 
Carreno, C. M.; DesMazery, R.; Urbano, A.; Colobert, F.; Solladie, G. Org. Lett., 2005, 
7, 2039; (d) Lee, H.; Kim, H.; Yoon, T.; Kim, B.; Kim, S. ; Kim, H.-D; Kim, D. J Org. 
Chern., 2005, 70, 8723; (e) Posner, G. H.; Hatcher, M.A.; Maio, W. A. Org. Lett., 2005, 
7, 4301; (j) Kadota, 1.; Uyehara, H.; Yamamoto, Y. Tetrahedron, 2004, 60, 7361; (g) 
Batchelor, R.; Hoberg, J. 0. Tetrahedron Lett., 2003, 44, 9043; (h) Denmark, S. E.; 
Yang, S. M.;J Am. Chern. Soc., 2002, 124, 15196. 
3. (a) Recent reports: Burton, J. W.; Anderson, E. A. ; O ' Sullivan, P. T .; Collins, I. ; 
Davies, J. E.; Bond, A. D.; Feeder, N. ; Holmes, A. B.; Org. Biomol. Chern., 2008, 6, 
693; (b) Mandai, S. K.; Roy, S. C. Tetrahedron, 2007, 63, 11341 ; (c) Basu, S.; 
Waldmann, H. J Org. Chern., 2006, 71, 3977; (d) Shing, T. K. M. ; Zhong, Y.-L. 
Synlett, 2006, 1205; (e) Perez, M. ; Canoa, P. ; Gomez, G. ; Teijeira, M.; Fall, Y. 
Synthesis, 2005, 411; (j) Fujiwara, K.; Goto, A.; Sato, D. ; Kawai. H.,; Suzuki, T. 
Tetrahedron Lett., 2005, 46, 3465; (g) Mukai, C.; Ohta, M.; Yamashita, H. ; Kitagaki, V. 
J Org. Chern., 2004, 69, 6867; (h) Sibi, M. P. ; Patil, K.; Rheault, T. R. Eur. J Org. 
Chern., 2004, 372; (i) Alcazar, E.; Pletcher, J. M.; McDonald, F. E. Org. Lett., 2004, 6, 
220 
3877; (j) Sawada, Y.; Sasaki, M.; Takeda, V. Org. Lett. , 2004, 6, 2277; (k) Martin, M.; 
Afonso, M. M.; Galindo, V. ; Palenzuela, J. A. Synlett, 2001, 117; (l) Saitoh, T. ; Suzuki, 
T.; Onodera, V.; Sekiguchi, H.; Hagiwara, H.; Hoshi, T. Tetrahedron Lett., 2003, 44, 
2709; (m) Prasad, K. R. K. ; Hoppe, D. Synlett, 2000, 1067. 
4. (a) Recent reviews: Blunt, J. W.; Copp, B. R. ; Hu, W.-P. ; Munro, M. H. G. ; Northcote, 
P. T.; Prinsep, M. R. Nat.Prod.Rep., 2007, 24, 31 ; (b) Morris, J. C. ; Nicholas, V.; 
Phillips, A. J. Nat. Prod. Rep. , 2007, 24, 87; (c) Yeung, K.-S.; Paterson, 1.; Chem. Rev., 
2005, 105, 4237 and references therein. 
5. Irie, T. ; Suzuki, M.; Masamune, T. Tetrahedron Lett. , 1965, 6, 1091. 
6. Fukuzawa, A.; Takasugi, Y. ; Murai, A. Tetrahedron Lett., 1991 , 32, 5597. 
7. Suzuki, M.; Takahashi, Y. ; Matsuo, Y.; Masuda, M. Phytochemistry, 1996, 41 , 1101 
8. Falshaw, C. P.; King, T. J. ; Irnre, S.; Islimyeli, S. ; Thomson, R. H. Tetrahedron Lett., 
1980, 21' 4951. 
9. Carter-Franklin, J. N. ; Parrish, J. D. ; Tschirret-Guth, R. A. ; Little, D. R. ; Butler, A. J 
Am. Chern. Soc., 2003, 125, 3688. 
10. Carling, R.W.; Holmes, A. B. J Chem. Soc., Chem. Cornmun. 1986, 565. 
11. Tsushima, K. ; Murai, A. Tetrahedron Lett. , 1992, 33, 4345. 
12. Bratz, M. ; Bullock, W. H.; Overman, L. E.; Takemoto, T.; J Am. Chem. Soc. , 1995, 
11 7, 5958 
13. (a) Ishiyama, T. ; Miyaura, N; Suzuki, A. Org. Synth. 1992, 71, 89. (b) Ishiyan1a, T. ; 
Miyaura, N; Suzuki, A. Tetrahedron Lett. 1988, 29, 3983 . 
221 
14. Blumenkopf, T. A.; Bratz, M.; Castafieda, A. ; Look, G. C. ; Overman, L. E.; 
Rodriguez, D.; Thompson, A. S. JAm. Chern. Soc. 1990, I I2, 4386 
15. (a) Dess, D. B.; Martin, J. C. J Org. Chem. 1983, 48, 4156. 
16. (a) Oshima, M; Yamazaki, H.; Shimizu, I; Nisar, M.; Tsuji, J. J Am. Chem. Soc. 
1989, I I I , 6280. (b) Shimizu, I; Hayashi, K. ; Ide, N.; Oshima, M. Tetrahedron 1991, 
47, 2991. 
17. Mujica, M. T.; Alfonso, M. M.; Galindo, A. ; Palenzuela, J. A. Synlett 1996, 983 . 
18. Hubschwerlen, C.; Specklin, J.-L. ; Higelin, J. In Organic Syntheses; Coffen, D. L. 
Ed; Organic Syntheses, Inc., 1993, 72, 1. 
19. Burton, J . W.; Clark, J. S. ; Derrer, S.; Stork, T. C.; Bendall, J . G.; Holmes, A. B. J 
Am. Chem. Soc., 1997, 119, 7483. 
20. !nanga, J.; Hirata, K.; Hiroko, S.; Katsuki, T.; Yamaguchi, M. Bull. Chem.Soc. Jpn. 
1979, 52, 1989. 
21. Tamao, K. ; Nakagava, Y.; Ito, Y.Organometallics 1993, 12, 2297. 
22. (a) Karstedt, B. D. (General Electric Co.), U.S. Appl. 226,928, 16 Feb 1972. Chem. 
Abstr. 1974, 80, P16134j. (b) Karstedt, B. D. (General Electric Co.), Ger. Offen ., 
2,307,085, 23 Aug 1973. Chern. Abstr. 1974, 80, P16134j. (c) Tamao, K .; Ishida, N. ; 
Tanaka, T.; Kumada, M. Organometallics 1983, 2, 1694. 
23. Krueger, J.; Hoffmann, R.W. J Am. Chem. Soc., 1997, I I9, 7499. 
24. Saito, S.; Ishikawa, T.; Kuroda, A. ; Koga, K. ; Moriwake, T. Tetrahedron 1992, 48, 
4067. 
25. Corey, E. J.; Shimoji, K. JAm. Chern. Soc. , 1983, I05, 1662. 
222 
26. Crimmins, M. T.; Choy, A. L. JAm. Chern. Soc., 1999, 121,5653. 
27. Crimmins, M. T.; Tabet, E. A. JAm. Chern. Soc. , 2000, 122,5473 . 
28. Crimmins, M. T. ; Emmitte, K. A.; Org. Lett., 1999, 1, 2029. 
29. Evans, D. A.; Cage, J. R.; Leighton, J. L.; Kim, A. S. J Org. Chern. 1992, 57, 1961. 
30. Baek, S.; Jo, H.; Kim, H. ; Kim, H.; Kim, S.; Kim, D. Org. Lett., 2005, 7, 75. 
31. (a) Still, W. C.; McDonald, J. H., III. Tetrahedron Lett. 1980, 21, 1031. (b) Comins, 
D. L.; Herrick, J. J . Tetrahedron Lett. 1984, 25, 1321. (c) Burke, S.D.; Deaton, D. N.; 
Olsen, R. J.; Armistead, D. M.; Blough, B. E. Tetrahedron Lett. 1987, 28, 3905. 
32. Fujiwara, K.; Yoshimoto, S.; Takizawa, A.; Souma, S.; Mishima, H.; Murai, A.; 
Kawai, H.; Suzuki, T. Tetrahedron Lett., 2005, 46,6819. 
33. Fujiwara, K.; Souma, S. ; Mishima, H.; Murai, A. Synlett 2002, 1493. 
34. Pansare, S. V.; Adsool, V. A. Org. Lett., 2006,8, 5897. 
35. Pansare, S. V.; Ravi, R. G. ; R. P. Jain, J Org. Chern., 1998, 63,4120. 
36. (a) Rudchenko, V . F.; Shtamburg, V. G. ; Pleshkova, A. P.; Kostyanovskii, R. G. 
Bull. Acad. Sci. USSR Div. Chern. Sci. (Engl. Trans!.) , 1981, 30, 825; (b) Pansare, S. 
V. ; Shinkre, B. A.; Bhattacharyya, A. Tetrahedron, 2002, 58, 8985. 
37. Schaus, S. E. ; Brandes, B. D.; Larrow, J . F. ; Tokunaga, M.; Hansen, K. B.; Gould, A. 
E.; Furrow, M. E.; Jacobsen, E. N. JAm. Chern. Soc., 2002, 124, 1307-1315. 
38. For regioselective ring opening of glucose-derived spiro epoxides under acidic or 
basic conditions, see: Lay, L.; Nicotra, F. ; Panza, L. ; Russo, G. Synlett, 1995, 167. 
For a recent review on the chemistry of epoxides see: Kas'yan, L. 1. ; Kas'yan, A. 0 .; 
Okovityi, S. I. Russ. J Org. Chern., 2006, 42, 307. 
------------------------
223 
39.Prepared from commercially available (R)-glycidol by adapting the literature 
procedure: Cossy, J. ; Pradaux, F.; BouzBouz, S. Org. Lett. , 2001, 3, 2233. 
40. Nowak, A.; Schaumann, E. Synthesis, 1998, 899. 
41. Brook, A. G. JAm. Chem. Soc. 1958,80, 1886. 
Appendix 3: 
1H and 13C NMR Spectra for Chapter 4 
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Chapter 5 
Studies on Enantioselective Synthesis of Functionalized 
Pyrrolidines 
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Introduction. 
Nitrogen heterocycles, especially pyrrolidines, are represented in a large class of 
biologically active natural products. 1 Selected examples are kainic acid,2 kaitocephalin,3 
plakoridine4 and anisomycin5 (Figure 1). Not surprisingly, the synthesis offunctionalized 
pyrrolidines has been actively investigated and several strategies for the synthesis of 
stereochemically defined, substituted pyrrolidines have been repOiied in the literature. 6 
0 
Meo--4. OH 0 ~C1sH33 
¢ 
OH 
plakoridine 
anisomycin 
==4. ~~02H 
~C02H 
H 
kainic acid 
Figure 1. Pyrrolidine-based natural products. 
kaitocephalin 
In continuation of the studies on the applications of the ephedrine-derived 
morpholine-dione template (described in Chapters 2, 3 and 4 ), it was decided to explore a 
general route for the enantioselective synthesis of functionalized pyrrolidines via this 
starting material. From a retrosynthetic perspective, the plan can be explained as follows 
(Scheme 1): the target compounds such as pyrrolidines 1, could be obtained by subjecting 
the morpholinone portion in 2 to dissolving metal reduction. The pyrrolidine ring in the 
pyrrolidino-morpholinone 2 could be obtained from hemiacetals such as 3 via an 
intramolecular ene-type ring closing reaction or from hemiacetals such as 4 via an 
--------------------------------------
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intramolecular aldol-type reaction. In the synthetic direction, treatment of the hemiacetals 
3 or 4 with a Lewis acid could simultaneously achieve the formation of the oxocarbenium 
ion and activation of the pendant nucleophile thereby facilitating an intramolecular ring-
closing reaction. Also, based on the earlier studies (Chapter 3, 4) on nucleophilic 
additions to chiral morpholinone-based oxocarbenium ions, it was anticipated the 
proposed intermolecular ring closing to be a highly stereoselective process. 
Scheme 1 
1 
acetal-ene 
reaction.# 
dissoving metal 'N 1 Ph ~ 
reduction & "j 
==h=yd=r=o=ly=si=s==~ UJ''·· 0 R4 • R 
• * 
NH 
2 al~ 
reaction 
~te 
add it/ion 
epoxide 
opening 
'N~Ph 
0~~ 6 
R 
5 
Hemiacetals 3 can be obtained by alkylation of the amme in 5. Likewise, a 
conjugate addition of the amine in 5 to a,~-unsaturated ketones can provide easy access to 
4. The amine 5 can be obtained by the epoxide-opening of 6 by an appropriate amine. As 
discussed earlier in this thesis (see Chapter 3 and Chapter 4) the epoxide 6 can be 
obtained from morpholinedione 8 via alkylidene morpholine 7. 
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An alternate strategy that involved the aziridine 10 which should be accessible 
from 7 was also envisioned. Based on the observations with the epoxidation of alkenes 
such as 7 it was reasonable to assume that aziridination would proceed form the Si face of 
the double bond. Lewis acid-mediated aziridine ring opening would then give 9. The 
amine 9 is similar to the amine 5 (Scheme 1) except for the newly-generated stereocenter 
in 9 which would be opposite in configuration to that in 5. 
Scheme 2 
, ~Ph Lewis acid 
, mediated 
?eN aziridine 0 0 ring-opening HO HN''. R aziridination 
I 9 
R1 
Results 
Exploration began with the synthesis of the epoxide 13 (Scheme 3). The 
alkylidene morpholinone 11 (80%) was prepared from dione 8 by following a procedure 
previously reported by this group. 7 Reduction of the ester in 11 with DIBAL gave t~e 
alcohol 12 (60%). Protection of the alcohol in 12 as a benzyl ether followed by 
epoxidation of the alkene with m-CPBA using the conditions reported earlier (Chapter 3 
and Chapter 4) gave the epoxide 13 in reasonable yield (60%). 
,-----,-----------------------------~----- --~-- --
Scheme 3 
Ph3PCHC00Et 
CH2CI2 
80% 
DIBAL l 
CH2CI2, -78 oc 
60% 
1) KH, BnBr, THF 
2) mCPBA, CH2CI2 
60%, 2 steps 
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The next task was the crucial epoxide-opening with a nitrogen-containing 
nucleophile. After some experimentation, it was determined that treatment of 13 with 
benzyl -amine in THF at reflux temperature for 8 h provided the hydroxyamine 14 (63%, 
Scheme 4). Michael addition of the amine in 14 to 3-butene-2-one in water8 yielded the 
aminoketone 15 in good yield (86%). 
Scheme 4 
trll "~N~ 
0 
OBn 
13 
F\__;NH2 J rll 
~ "N~ 
THF, reflux 0 ),)("o 
8h HO~OBn 
63o' BnHN ~ 10 H 14 
0 
~ 
H20, rt 
24 h 
86% 
trll 
"N~ "~~~ OBn ;r~X: 
0 NBn 15 
At this point, it was reasoned that simultaneous in situ generation of the 
oxocarbenium from the hemiacetal and enolate from the ketone in 15 should be possible 
by treating 15 with a Lewis acid (Figure 2). The enolate would then react with the 
---~----~------------------- --- --- --- -- ---
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oxocarbenium ion to provide the functionlalized pyrrolidine 16. It was hoped that the 
chiral morpholinone ring would influence the stereochemistry at the chiral center in the 
morpholinone ring. Prediction of the configuration of the a-keto stereocenter was 
difficult, and was left for experimental evaluation. 
,(ll 
'N~ 
"~~~ OBn !/z_x:; 
O NBn 
15 
LA 
·---------
LA = Lewis acid 
,(ll 
'N~ ------~.J.,, 0 0" '· 
• ., OBn 
''H 
O NBn 
16 
Figure 2. Intramolecular aldol-type reaction of 15. 
Reaction of 15 with BF3•etherate (-78 oc to rt) showed a steady progress and 
complete consumption of the starting material was observed after 4 d (Scheme 5). 
Disappointingly, none of the required product 16 was formed. Instead, product 17 arising 
from debenzylation of the ether in 15 was obtained. The stereochemistry at the acetal 
carbons in 17 was not determined. One of the several possible pathways leading to 17 is 
shown in Scheme 5. 
Scheme 5 
CH2CI2 
-78 octo rt 
4d 
84% 
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It was therefore decided to use the more robust methyl ether analogue of 15. The 
required methyl ether 18 was readily obtained by methylation of the alcohol in 12 (KH, 
Mel). The aminoketone 21 was then obtained from 18 (Scheme 6) by following a reaction 
sequence similar to that for aminoketone 15 (Scheme 4). 
Scheme 6 
'N~Ph 
a A( I OH 
12 
KH, Mel 'N~Ph 
THF, 0 oc a A( I OMe 86% 
0 
~ 
H20 , rt 
24 h 
88% 
18 
m-CPBA 'N~Ph 
CH2CI2 ~ 89% 0 OMe 
19 
--------------------------- ---
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Unfortunately, no reaction was observed when 21 was treated with BF3•etherate at 
room temperature or under reflux conditions and the starting material could be recovered. 
Use ofTiC14 or aqueous 2M HCl resulted in dealkylation of the 2-butanone side-chain to 
give back the amine 20 (Scheme 7). A survey of other Lewis acids to effect the desired 
transformation remains to be done. 
Scheme 7 
TiCI4 , CH2CI2 
-78 octo- 40 oc, 2 h (85%) 
OR 
2M, HCI, rt, 20 h 
(99%) 
An acetal-ene9 cyclization approach was also explored. It was reasoned that 
treatment of 22 with a Lewis acid would generate an oxocarbenium ion that would then 
facilitate the proposed acetal-ene reaction with the 3-methylbut-2-ene side-chain serving 
as a nucleophile to provide the pyrrolidine 23 (Figure 3). 
Lewis acid 
------------
·-----Conditions 
22 23 
Figure 3. Synthesis of pyrrolidine 23. 
Compound 22 was prepared in moderate yield (55%) by N-alkylation10 of the 
secondary amine 25, which was obtained from the epoxide 24 (Scheme 8). 
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Scheme 8 
Unfortunately, treatment of 22 with varwus Lewis acids (Table 1) failed to 
provide the desired product and in most of the reactions, the starting material was 
recovered. The only exception was a reaction with TiCl4 at room temperature, which 
resulted in N-dealkylation of 22 to provide 25. These studies are still incomplete and will 
be pursued further in our group. 
Table 1: Attempeted acetal-ene reaction of22. 
'N~ 
u?C Lewis acid )f conditions 
I 
Bn 22 
Entry Lewis acid Conditions Time 
1. BF3•Et20 Ether, reflux 36 h 
2. ZnCb CH2Cb, reflux 36 h 
3. TFA CH2Cb, reflux 36 h 
4. TiCl4 CH2Cb, -40 oc 10 h 
5. TiCl4 CH2Ch, rt 2h 
Result 
No reaction 
No reaction 
No reaction 
No reaction 
N-dealkylation 
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Aziridination of ephedrine-derived alkylidene-morpholinones. 
In a related approach to functionalized pyrrolidines, the stereoselective 
aziridination of alkylidene morpholinone 24 (Chapters 3,4) was examined. The objective 
was to prepare aminohemiacetals or aminoacetals similar to 14 or 25 by an aziridination 
reaction instead of a two-step epoxidationlaminolysis protocol (Figure 4). Asymmetric 
aziridination of the double bond followed by regioselective ring opening at the acetal 
would install the ~-amino functionality in 26 (Figure 4). 
'N~Ph aziridination 'N~Ph Lewis acid 'N~Ph 0~ 0~R ------ o~·~ Nucleophile ·'' (Nu) Nu 
RNH" H 
24 25 26 
Figure 4. Aziridination of alkene 24 and Lewis Acid mediated reaction of the aziridine. 
To begin the protocol reported by Dauban 11 for the aziridination of 24 was 
employed. Thus, reaction of the alkene in 24 with the iminoiodinane generated in situ 
from tosyl amide and iodosobenzene in the presence of methanol gave the aminomethoxy 
morpholinone 27 as a mixture of diastereomers (Scheme 9). Presumably, the aziridine 
undergoes in situ ring opening to generate an oxocarbenium that is trapped with 
methanol. Assuming that aziridination of the alkene proceeds at the Si face, the ~-amino 
functionality in 27 should have the shown configuration. It may be noted that this 
configuration was opposite to that of the amine 14 (Scheme 4) 
---------- ------------------~--~------------
Scheme 9 
Cu(CH3CN)4PF6 , MeOH 
CH2CI2 
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MeOH 
The use of methanol for the aziridination reaction is necessary for solubilizing 
iodosobenzene and hence for the in situ generation of the aziridinating reagent, (N-(p-
toluenesulfonyl)imino)phenyliodinane (Phi=NTs). It was not clear if methanol was 
promoting the decomposition of the aziridine, and therefore conducted an experiment 
with pre-formed iminoiodinane 12 (Scheme 10). However, a complex mixture of products 
was obtained from this reaction. This observation suggested that the aziridine is unstable 
under the reaction conditions. 
Scheme 10 
'N~Ph 
O~IC O __ C_u_(_CH_
3
_C_N_)
4
-P-F
6
-.--C-H_
3
_C_N __ ~ 
~ 24 CH2CI2 
Complex mixture 
The aminomethoxylation product 27 was N-alkylated with 1-bromo-3-methylbut-
2-ene to give 28 (Scheme 11 ), which was subjected to a variety of Lewis acids in order to 
induce the acetal-ene reaction. However, as observed for the structurally similar 
compound 22, this reaction failed to give the desired product 29. The results from these 
studies are summarized in Table 2. 
----~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~-----
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Scheme 11 
NaH, THF then, Lewis acid 
Br~ conditions 
69% 
29 
Table 2: Attempeted acetal-ene reaction of27. 
Entry Lewis acid Conditions Time Result 
1. -78 octo rt 2.5 h Decomposition 
2. -15 oc 48 h Starting material + 
N-dealkylation 
3. 36 h No reaction 
4. TFA 3h N-dealkylation 
5. 10 h N-dealkylation 
An allylation-iodocyclization strategy for the synthesis of pyrrolidines from 27 
was also considered. It was anticipated that allylation at the acetal carbon in 27 would 
give 30. N-Deprotection in 30 followed by iodocyclization would give pyrrolidines 31 
(Figure 5). Notably, the suggested iodoamination reaction was known to proceed without 
the oxidation of the amine by the iodine. 13 
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'NlyPh 
allylation 'N~Ph 1) N-deprotection 'N~Ph 'NlyPh _J 0~ ~ ·~ J5 CH2CI2 , ,\, MeO :: R , R 2) I+ * NH G . R NHTs H N"- H I TsHN H 31 
27 30 
Figure 5. Allylation-haloamination approach to spiro-pyrrolidine 31. 
Unfortunately, the allylation reaction failed to proceed as desired and starting 
material was recovered in most of the cases. However, the use of triethylsilane in the 
presence of BF3•Et20 gave the reduced product 32 (54%, Scheme 12). 14 This observation 
suggested that the allylation reaction may have failed for steric reasons. Interestingly, the 
removal of the ephedrine portion in 32 should provide the a-hydroxy-p-amino acid 33. a-
Hydroxy-p-amino acids such as 33 are of special interest in chemistry and biology due to 
their applications in peptidomimetics. 15 Preliminary results suggested that the usual 
dissolving metal reduction protocol was not useful for the conversion of 32 to 33 (Scheme 
12). Further studies on this approach to a-hydroxy-p-amino acids are planned. 
Scheme 12 
Et3SiH, BF3.Et20 'N~p~ 
--7-8_o_c_to_r_t -9-6-h--l., o.),,,, ( 0 
CH2CI2 ~ 
54% TsHN 32 
·---------.. 
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Conclusions 
While the target pyrrolidines were not synthesized in this study due to time 
restriction, further investigations based on this study may be more fruitful. Nevertheless, it 
should be noted that the epoxide ring-opening and aziridination approaches towards 
functionalized pyrrolidines have provided interesting intermediates, which may also be useful 
for the synthesis of other targets such as a-hydroxy-P-aminoacids. 
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Experimental 
General 
General experimental techniques that have been described in the experimental section 
of Chapter 2 were followed. 
(Z,SS,6R)-2-(2-Hydroxyethylidene)-4,5-dimethyl-6-phenylmorpholin-3-one (12) 
To a stirred solution of 11 (840 mg, 2.90 mmol) in dichloromethane (1 0 mL) at -
78 oc was added DIBAL-H (1.42 g (10.2 mL of 1 M solution in dichloromethane), 10.2 
mmol) dropwise. The resulting mixture was stirred at -78 °C temperature for 6 h and 3 M 
HCl (5 mL) was added. The resulting mixture was warmed to room temperature and was 
extracted with ethyl acetate (2 x 25 mL). The combined organic layers were dried and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica gel (ethyl acetate) to provide 395 mg (60%) of 12 as a colourless oil. 
1H NMR (500 MHz, CDC~)): 
8 7.43-7.31 (m, 5H), 6.22 (t, J = 6.5), 5.28 (br d, 1H, J = 3.5), 4.43 (dAB-system, 
2H, J = 6.5, 14.), 3.56 (dq, 1H, J = 3.5, 6.3), 3.1 0 (s, 3H), 1.01 (d, 3H, J = 6.3). 
13C NMR (125.77 MHz, CDC~)) : 
8 159.2, 145.0, 136.7, 128.8, 128.7, 128.4, 125.7, 114.5, 77.7, 58.8, 57.5, 33 .9, 
12.0. 
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IR (neat): 
3396, 1623, 1303, 1161 , 1002 cm-1• 
MS (APCI): 
248.1 (M+ 1, 1 00). 
HRMS (CI): 
m/z 247.1207 (247.1208 calc. for C 14H 17N03, M+). 
(2S,3S,5R,6S)-2-(2-(Benzyloxy)ethylidene )-6, 7 -dimethyl-5-phenyl-1,4-dioxa-7-
azaspiro [2.5) octan-8-one (13) 
To a solution ofthe alcohol12 (300 mg, 1.21 mmol) in THF (15 mL) at 0 °C was 
added KH (71 mg (obtained by washing a 30 wt% dispersion in mineral oil with hexane), 
1.82 mmol). The mixture was stirred at 0 oc for 15 min and benzyl bromide (0.190 mL 
(obtained by washing a 30 wt% dispersion in mineral oil with hexane), 1.57 mmol) was 
added dropwise. The mixture was then warmed up to ambient temperature, stirred for 3.5 
h and cold water was added. The mixture was extracted with ethyl acetate (3 x 20 mL) 
and the combined organic layers were dried and concentrated under reduced pressure. 
The residue was purified by flash chromatography on silica gel (ethyl acetate) to provide 
300 mg (73%) of the benzyl ether as a colourless gum. 
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1H NMR (500 MHz, CDCh): 
o 7.40-7.21 (m, 10H), 5.46 (br d, 1H, J = 2.5), 4.66 (AB-system, 2H, J = 12.1), 
4.02 (t, 1H, J = 5.0), 3.95 (dd, 1H, J = 11.5, 5.0), 3.84 (dd, 1H, J = 11.5, 5.0), 3.64 
(dq 1H, J = 6.5, 2.5), 3.11 (s, 3H), 1.02 (d, 3H, J = 6.5). 
13C NMR (125.77 MHz, CDCh): 
0 162.4, 137.8, 136.1, 128.6, 128.5, 128.4, 128.1, 127.8, 125.3, 81.3, 76.3, 73.2, 
67.0, 60.1 , 59.1, 33.9, 12.3. 
To a solution of the benzyl ether (281 mg, 0.83 mmol) in dichloromethane (15 
rnL) was added mCPBA (230 mg, 1.33 mmol) at -78 °C and the mixture was warmed to 
room temperature and stirred for 45 min. Saturated aqueous NaHC03 was added, the 
mixture was extracted with ethyl acetate (3 x 20 mL) and the combined organic layers 
were dried and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (ethyl acetate) to give 220 mg (75 %) of 13 as a white, 
crystalline solid. 
1H NMR (500 MHz, CDCh): 
o 7.40-7.21 (m, 10H), 5.46 (b rd, 1H, J = 2.5), 4.66 (AB-system, 2H, J = 12.1), 
4.02 (t, 1H, J = 5.0), 3.95 (dd, 1H, J = 5.0, 11.5), 3.84 (dd, 1H, J = 11.5, 5.0), 3.64 
(dq, 1H, J = 6.5, 2.5), 3.11 (s, 3H), 1.02(d, 3H, J = 6.5). 
13C NMR (125.77 MHz, CDCh): 
0 162.4, 137.8, 136.1, 128.6, 128.5, 128.4, 128.1, 127.8, 125.3, 81.3, 76.3 , 73.2, 
67.0, 60.1 , 59.1, 33.9, 12.3. 
---- ------------------------------
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IR (neat): 
2980, 1669, 1246, 731 cm-1; 
(2S,5S,6R)-2-(1-(Benzy lamino )-2-(benzyloxy )ethyl)-2-hydroxy-4,5-dimethyl-6-
phenylmorpholin-3-one (14) 
To a solution of 13 (300 mg, 0.840 mmol) in THF (5 mL) at 0 °C was added 
benzyl amine (1.50 mL, 1.38 mmol) at room temperature. The reaction mixture was 
heated to reflux for 6h and cooled to room temperature. The solvent was removed under 
reduced pressure and the resulting residue was purified by flash chromatography on silica 
gel (ethyl acetate) to provide 246 mg (63%) of 14 as a pale yellow gum. 
1H NMR (500 MHz, CDCh): 
o 7.38-7.20 (m, ISH), 5.62 (br d, lH, J = 2.5), 4.56 (AB, 2H, J = 12.0), 3.96 (d, 
lH, J =14.0), 3.91 (dd, 1H, J = 8.1 , 9.3), 3.86 (d, 1H, J = 14.0), 3.73 (dd, lH, J = 
5.3, 9.3), 3.54 (dd, 1H, J = 5.3, 8.1), 3.48 (dq, 1H, J = 2.5 6.4), 3.11 (s, 3H, 
NCH3), 0.90 (d, 3H, J = 6.4). 
MS (APCI): 
461.2 (M+1, 100). 
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HRMS (CI): 
(2S,5S,6R)-2-( 4-(Benzy lamino) bu tan-2-one )-2-(benzyloxy )ethy 1)-3-hydroxy -4,5-
dimethyl-6-phenylmorpholin-3-one (15) 
To a suspension of 14 (0.030 g, 0.07 mmol) in water (1 mL) was added methyl 
vinyl ketone (0.008 mL), 0.10 mmol) and the reaction mixture was stirred vigorously for 
30 hat room temperature. The water was removed under reduced pressure and the residue 
was purified by flash chromatography on silica gel (ethyl acetate) to provide 0.030 g 
(86%) of 15 as a pale yellow gum. 
1H NMR (500 MHz, CDCb): 
& 7.41-7.20 (m, ISH), 5.71 (br d, 1H, J = 3.4), 4.66-4.56 (m, 2H), 4.13 (t, IH, J = 
9.1), 3.98 (dd, 1H, J = 6, 9.1), 3.67 (dd, IH, J = 6, 9.1) 3.59 (d, 1H, J = 14.4), 
3.49 (dq, IH, J = 3.4, 6.3), 3.12 (s, 3H), 2.97-2.93 (m, 2H) 2.87-2.81 (m, lH), 
2.67-2.60 (m, 1H), 2.07 (s, 3H), 0.72 (d, 2H, J = 6.3). 
13C NMR (125.77 MHz, CDCh): 
& 208.6, 167.0, 139.8, 138.0, 137.4, 128.7, 128.5, 128.4, 128.1 , 127.8, 127.7, 
127.1 , 125.8, 99.1 , 73.9, 71.4, 66.8, 63.7, 59.0, 54.7, 47.0 42.6, 33 .8, 30.5, 12.8. 
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MS (APCI): 
531.2 (M+l , 100); 
HRMS (EI): 
m/z 531 .2855 (531.2859 calc. for C32H3sNzOs, [M+Ht). 
(SS,S' S,6S,6'S)- 4-(Benzyl)-6' -(phenyl)- 1,4' ,5'-trimethyi-3'H-spiro[7,8-dioxa-4-
azabicyclo[3.2.2]nonane-6,2'-[1,4]oxazinan]-3'-one (17) 
To a solution of 15 (0.030 g, 0.06 mmol) in dichloromethane (1 mL) at -78 oc was 
added BF3•etherate (0.06 mL, 0.45 mmol). The mixture was stirred at -78 °C for 15 min 
and then warmed to ambient temperature and stirred for 48 h. Cold water was added and 
the mixture was extracted with dichloromethane (3 x 2 mL). The combined organic layers 
were dried and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (ethyl acetate) to provide 0.032 g (84%) of 17 as a 
colourless oil. 
1H NMR (500 MHz, CDCi)): 
o 7.54-7.20 (m, lOH), 5.70 (br d, 1H, J = 2.5), 4.76 (dd, IH, J = 10.5, 3.3), 4.33 
(d, lH, J = 10.5), 3.89 (AB, 2H, J = 14), 3.53 (dq, lH, J = 6.5, 2.5), 3.14 (d, J = 
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3.3, 1H), 3.03-3.0 (m, 1H), 2.96-2.91 (m, lH), 2.94 (s, 3H), 2.42 (ddd, J= 4.7, 
10.7, 15, 1H), 1.87 (dt, J = 4.7, 15, 1H), 1.40 (s, 3H), 0.87 (d, J= 6.5, 3H). 
13C NMR (125.77 MHz, CDCh): 
8 167.0, 139.8, 138.5, 128.9, 128.8, 128.5, 127.7, 127.2, 125.8 100.6, 96.1, 70.2, 
61.5, 60.5, 58.9, 57.9, 48.4, 39.0, 34.1, 29.6, 12.7. 
IR (neat); 
2925, 1653, 1191 , 1046, 934 cm-1• 
MS (APCI): 
423.3 (M+1 100). 
HRMS (EI): 
(Z,SS,6R)-2-(2-Methoxyethylidene)-4,5-dimethyl-6-phenylmorpholin-3-one (18) 
To a solution ofthe alcohol12 (135 mg, 0.55 mmol) in THF (15 mL) at 0 °C was 
added KH (0.031 g (obtained by washing a 30 wt% dispersion in mineral oil with 
hexane), 0.770 mmol). The mixture was stirred at 0 °C for 15 min and methyl iodide 
(0.050 mL, 0.720 mmol) was added dropwise. The mixture was then warmed up to 
ambient temperature, stirred for 3.5 h and cold water was added. The mixture was 
extracted with ethyl acetate (3 x 5 mL) and the combined organic layers were dried and 
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concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica gel (ethyl acetate) to provide 123 mg (86 %) of 18 as a colourless gum. 
1H NMR (500 MHz, CDCh): 
8 7.43-7.27 (m, 5H), 6.16 (t, 1H, J = 6.7), 5.27 (brd, 1H, J = 2.6), 4.24 (dAB-
system, 2H, J = 6.7, 18), 3.58-3.56 (dq, 1H, J = 7.5, 2.6), 3.37 (s, 3H), 3.11 (s, 
3H), 1.00 (d, 3H, J = 7.5). 
13C NMR (125.77 MHz, CDCh): 
8 159.1 , 145.4, 136.8, 128.7, 128.5, 128.3, 125.6, 11 2.1 , 77.6, 66.3, 58.8, 58.3, 
33.8, 11.9. 
IR (neat); 
1636, 1304, 1121 , 751 cm-1• 
MS (APCI): 
262.0 (M+1 , 100). 
(2S,3S,SR,6S)-2-(2-Methoxyethylidene )-6, 7 -dimethyl-5-phenyl-1 ,4-dioxa-7-
azaspiro[2.5]octan-8-one (19) 
To a solution of 18 (1 00 mg, 0.400 rnrnol) in dichloromethane (2 mL) was added 
mCPBA (90.0 mg, 0.500 rnrnol) at -78 oc and the mixture was warmed to room 
temperature and stirred for 45 min. Saturated aqueous NaHC03 was added and the 
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mixture was extracted with ethyl acetate (3 x 2 mL). The combined organic layers were 
dried and concentrated under reduced pressure. The residue obtained was purified by 
flash chromatography on silica gel (ethyl acetate) to give 100 mg (89%) of 19 as a white, 
crystalline solid. 
1H NMR (500 MHz, CDCh): 
8 7.41-7.27 (m, 5H), 5.49 (br d, 1H, J = 2.5), 3.94 (dd, 1H, J = 4.5, 6.3), 3.88 (dd, 
1H, J = 11 , 4.5), 3.72 (dd, 1H, J = 6.3, 11), 3.65 (dq, 1H, J =7.0, 2.5), 3.47 (s, 
3H), 3.11 (s, 3H), 1.04 (d, 3H, J = 7.0). 
13C NMR (125.77 MHz, CDCl3): 
8 162.6, 136.3, 128.7, 128.3, 125.4, 81.3, 76.4, 69.6, 60.1, 59.3, 59.3, 34.0, 12.5. 
MS (APCI): 
278.0 (M+ 1, 100); 
HRMS (EI): 
m/z 277.1318 (277.1314 calc. for C 15H 19N04, M+). 
(2S,SS,6R)-2-(1-(Benzylamino )-2-methoxyethyl)-2-hydroxy-4,5-dimethyl-6-
phenylmorpholin-3-one (20) 
To a solution of 19 (1 00 mg, 0.360 rnrnol) in THF (3 mL at 0 °C) was added 
benzyl amine (0.060 mL), 0.540 rnrnol) at room temperature. The mixture was heated to 
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reflux for 6 h, cooled to room temperature and the solvent was removed under reduced 
pressure. The residue was purified by flash chromatography on silica gel (ethyl acetate) to 
provide 101 mg (65%) of20 as a pale yellow gum. 
1H NMR (500 MHz, CDCh): 
o 7.38-7.23 (m, 10H), 5.63 (br d, 1H, J = 4.0), 3.98-3.88 (AB-system, 2H, J = 
12.5), 3.84 (t, 1H, J = 9.0), 3.66 (dd, 1H, J = 5.5, 9.0), 3.52-3.48 (m, 2H), 3.38 (s, 
3H), 3.07 (s, 3H), 0.97 (d, 3H, J = 7.0). 
13C NMR (125. 77 MHz, CDCh): 
0 167.4, 140.6, 138.0, 128.5, 128.3, 127.8, 127.2, 125.8, 98.3, 72.9, 71.6, 60.5, 
59.4, 59.1 , 52.7, 33.8, 12.7. 
MS (APCI): 
385.1 (M+1 , 100). 
(2S,5S,6R)-2-( 4-(Benzy I amino) bu tan-2-one )-2-methoxyethyl)-2-hydroxy-4,5-
dimethyl-6-phenylmorpholin-3-one (21) 
To a suspension of 20 (0.050 g, 0.130 mmol) in water (1 mL) was added methyl 
vinyl ketone (0.002 mL, 0.02 mmol) and the reaction mixture was stirred vigorously at 
room temperature for 30 h. The water was removed under reduced pressure and the 
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residue was purified by flash chromatography on silica gel (ethyl acetate) to provide 
0.037 g (88%) of21 as a pale yellow gum. 
1H NMR (500 MHz, CDCh): 
o 7.39-7.28 (m, 10H), 6.2 (brs, 1H), 5.70 (d, 1H, J = 3.5) , 4.61 (d, 1H, J = 13.0), 
4.01 (t, J= 8.5, 1H), 3.89 (dd, 1H, J = 6, 8.5), 3.60 (m, 2H, OCH2) , 3.50 (m, 1H), 
3.48 (s, 3H) 3.09 (s, 3H), 2.96 (m, 2H), 2.87-2.81 (m, 1H), 2.67-2.62 (m, 1H), 
2.09 (s, 3H), 0.76 (d, 3H, J = 7.0). 
13C NMR (125.77 MHz, CDCh): 
0 208.5, 167.0, 139.8, 138.1 , 128.5, 128.4, 127.7, 127.1 , 125.8, 99.0, 71.4, 69.4, 
63.6, 59.5, 59.1 , 54.8, 47.0, 42.7, 33.8, 30.5, 12.8. 
IR (neat): 
3380, 2933, 1710, 1654, 1046, 731 cm-1• 
MS (APCI): 
455.1 (M+1 , 100). 
(2S,5S,6R)-2-( (R)-1-(Benzylamino )propyl)-2-hydroxy-4,5-dimethyl-6-
phenylmorpholin-3-one (25) 
To a solution of 24 (450 mg, 1.72 mmol) in THF (20 mL) at 0 oc was added 
benzylamine (0.200 mL, 1.72 mmol) at room temperature. The mixture was the heated to 
260 
reflux for 6 h and then cooled to room temperature. The solvent was removed under 
reduced pressure and the residue was purified by flash chromatography on silica gel 
(ethyl acetate) to provide 430 mg (68%) of25 as a pale yellow gum. 
1H NMR (500 MHz, CDCh): 
8 7.40-7.24 (m, IOH), 5.61 (br d, 1H, J = 2.5), 4.11 (d, IH, J = 12.5), 3.82 (d, 1H, 
J = 12.5), 3.50 (dq, lH, J = 6.5, 2.5), 2.82 (s, 3H), 2.84-2.82 (m, lH), 1.91-1.85 
(m, 1H), 1.75-1.69 (m, 1H), 1.84 (t, 3H, J = 7.0), 1.04 (d, 3H, J = 6.5). 
13C NMR (125. 77 MHz, CDC b): 
8 169.0, 140.3, 137.7, 128.6, 128.5, 128.4, 128.3, 127.7, 127.1 , 125.8, 125.4, 97.7, 
72.5, 65.6, 58.9, 53.0, 33.3, 23.8, 12.7, 12.6. 
IR (neat); 
3338, 2973, 1636, 1046, 736 cm-1• 
MS (APCI): 
369.2(M+1 , 100). 
HRMS (EI): 
m/z 368.2104 (368.2100 calc. for C22H2sN203, M+). 
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(2S,5S,6R)-2-( (R)-1-(N-Benzyl-3-methylbut-2-en-1-amine )propyl)-2-hydroxy-4,5-
dimethyl-6-phenylmorpholin-3-one (22) 
To a solution of25 (260 mg, 0.700 mmol) and DIPEA (0.200 mL, 1.16 mmol) in 
acetonitrile (2 mL) was added allyl bromide (0.090 mL, 0.770 mmol) and the mixture was 
stirred vigorously at room temperature for 48 h. The solvent was removed under reduced 
pressure and the residue was purified by flash chromatography on silica gel (2/1, ethyl 
acetate/hexane) to provide 0.169 g (55%) of21 as pale yellow gum. 
1H NMR (500 MHz CDCh): 
8 7.37-7.21 (m, 10H), 5.61 (br d, 1H), 5.2 (m, lH), 4.73 (br s, 1H), 3.53-3.32 (m, 
3H), 3.01 (s, 3H), 2.00-1.91 (m, 1H), 1.78-1.66 (m, 4H), 1.55 (s, 3H), 1.12 (t, J = 
7.5, 3H), 0.77 (d, J = 6.6, 3H). 
13C NMR (125. 77 MHz, CDCb): 
8 168.6, 138.3, 128.5, 128.4, 127.5, 127.1 , 125.7, 122.1 , 97.6, 72.2, 68.4, 58.9, 
33.7, 26.0, 20.5, 18.3, 13.7, 12.6. 
MS (APCI): 
437.4 (M+1, 100). 
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HRMS (CI): 
mlz 437.2807 (437.2804 calc. for C22H2sN203, [M+Ht). 
(SS,6R,2S)-4,5-Dimethyl-6-phenyl-3-(methoxy)-2-(1-(tosylamino)methyl)morpholin-
3-one (27) 
To a solution of 24 (1.25g, 5.40 mmol) in dichlromethane (30 mL) at room 
temperature was added p-toluenesulfonamide (2.8 g, 16.2 mmol), iodosobenzene (3.54 
g, 16.2 mmol), methanol (3 mL) and activated 4 A molecular sieves (1 g). The mixture 
was cooled to 0 °C and Cu(CH3CN)4PF6 (0.6 g, 1.6 mmol) was added and the mixture 
was stirred for 2 h at 0 °C. The mixture was then filtered through celite and the filtrate 
was concentrated. The resulting residue was purified by flash chromatography on silica 
gel (111 , ethyl acetate/hexane) to provide 1.42 g (61 %) of 27 as pale yellow gum and as a 
~3:2 mixture of diastereomers (1H NMR). The diastereomers were separated by flash 
chromatography on silica gel (4/1, ethyl acetate/hexane) to give 0.850 g (37%) of the 
major diastereomer and 0.560 g (24%) of the minor diastereomer. 
1H NMR (500 MHz, CDCb): 
Major diastereomer; o 7.71 (d, 2H, J = 7.5), 7.39-7.26 (m, 7H), 5.78 (br d, J = 8, 
1H), 5.25 (d, J = 3.0), 3.96 (m, 1H), 3.46 (dq, 1H, J = 3.0, 8.0), 3.36 (s, 3H), 3.02 
(s, 3H), 2.37 (s, 3H), 1.16 (d, 3H, J = 6.5), 1.01 (d, 3H, J = 8.0). 
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Minor diastereomer; 8 7.80 (d, 2H, J= 8.5), 7.40-7.30 (m, 7H), 5.37 (br d, 1H, J = 
3.5), 4.75 (br d, 1H, J = 9.0), 3.91 (m, 1H), 3.45 (dq, J = 3.5, 6.0), 3.15 (s, 3H), 
2.97 (s, 3H), 2.42 (s, 3H3), 1.24 (d, 3H, J= 6.5), 1.01 (d, 3H, J= 6.0). 
IR (neat): 
1684, 1652, 1164, 839 cm-1• 
MS (APCI): 
431.1 (M-1, 100). 
HRMS (CI): 
(5S,6R)-4,5-Dimethyl-6-phenyl-2-( (S)-1-( tosylamino )methyl)morpholin-3-one (32): 
To a solution of 27 (0.200 g, 0.460 mmol) in dichloromethane ( 4 mL) at -78 °C 
was added triethylsilane (0.740 mL), 0.460 mmol) followed by BF3•etherate (0.550 mL), 
4.6 mmol). The mixture was stirred at -78 oc for 15 min and then warmed to ambient 
temperature and stirred for 22 h. Cold water was added and the mixture was extracted 
with dichloromethane (3 x 5 mL). The combined organic layers were dried and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica gel (113 ethyl acetate/hexane) to provide 0.178 g (54%) of32 as a colourless oil. 
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1H NMR (500 MHz, CDC~)) : 
8 7.81 (d, 2H, J = 10, ArH), 7.34 (m, 3H, ArH), 5.24 (d, 1H, J = 9.7, TsNH), 4.84 
(br d, J = 2.6, PhCH), 4.16 (s, 1H, CHO), 4.16 - 4.12 (m, 2H, TsNCH), 3.45 (dq, 
1H, J = 6.5, 2.6 CHCH3), 2.98 (s, 3H, ArCH3), 2.42 (s, 3H, NCH3), 1.20 (d, 1H, J 
= 6.6, TsNCHCH3), 0.93 (d, 3H, J = 6.5, CHCH3). 
13C NMR (125. 77 MHz, CDCh): 
8 166.4, 143.5, 138.2, 137.3, 129.9, 128.7, 128.3, 127.4, 125.6, 80.0, 76.9, 58.9, 
51.3, 33.5, 21.8, 17.1 , 13.3. 
IR (neat); 
3380, 1684, 1653, 1158 cm-1• 
MS (APCI): 
403 .1 (M+ 1, 100). 
HRMS (EI): 
(5S,6R,2S)-4,5-Dim etby 1-6-pbeny 1-3-( m etboxy )-2-(1-(3-methyi-N-tosy lbu t-2-en-1-
amine)metbyl)morpholin-3-one (28) 
To a solution ofthe amide 27 (400 mg, 0.900 mmol) in THF (15 mL) at 0 °C was 
added KH (66 mg (obtained by washing a 30 wt% dispersion in mineral oil with hexane), 
-------- - ------------------------------------
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1.10 mmol). The mixture was stirred at 0 °C for 15 min and 3,3-dimethylallyl bromide 
(0.133 mL), 1.00 mmol) was added dropwise. The mixture was then warmed up to 50 oc 
and stirred at that temperature for 9 h. The reaction mixture was then cooled to 0 °C and 
cold water was added. The suspension was extracted with ethyl acetate (3 x 15 mL) and 
the combined organic layers were dried and concentrated under reduced pressure. The 
residue was purified by flash chromatography on silica gel (2/3, ethyl acetate/hexane) to 
provide 318 mg ( 69 %) of 28 as a colourless gum. 
1H NMR (500 MHz, CDCh): 
Major diastereomer: () 7.71 (d, 2H, J = 8.3), 7.43-7.36 (m, 7H, ArH), 5.39 (br d, 
1H, J = 3.2), 5.04-5.01 (brm, 1H), 4.78 (q, 1H, J = 7.2), 4.06 (dd, 1H, J = 16.7, 
6.7), 3.85 (dd, 1H, J = 6.7, 15.5), 3.49 (dq, 1H, J = 6.6, 3.2), 3.36 (s, 3H), 2.99 (s, 
3H), 2.41 (s, lH), 1.55 (s, 6H), 1.23 (d, 3H, J = 7.2), 1.05 (d, 3H, J = 6.6). 
Visible peaks of minor diastereomer: () 7.52 (d, 2H, J = 8.3), 5.77 (brd, 1H, J = 
3.2), 4.71 (q, 1H, J = 7.2), 3.93 (dd, lH, J = 6.7, 18.3), 3.55 (dq, 1H, J = 3.2, 6.6), 
3.38 (s, 3H), 3.04 (s, 3H), 2.36 (s, 3H), 1.62 (s, 6H), 1.26 (d, 3H, J = 7.2), 1.04 (d, 
3H, J = 6.6). 
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Chapter 6 
Studies on Chiral Amino Alcohol Alternatives to Ephedrine 
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Introduction 
Along with the exploitation of the utility of the ephedrine-derived morpholine-
dione as a chiral starting material in asymmetric synthesis, efforts were also directed 
toward identifying other chiral amino alcohols that may be utilized in place of ephedrine. 
The search for these amino alcohols focused on two aspects of the ephedrine-based 
methodology: 
1) Replacing ephedrine with a more accessible alternative: Both enantiomers of 
ephedrine can be obtained from commercial sources for synthetic purposes. However, 
ephedrine is also a controlled substance and hence the use of an alternative amino alcohol 
is desirable. 
2) Removal of the ephedrine portion: In the studies described in this thesis, the removal 
of the ephedrine portion has been achieved by reductive cleavage (dissolving metal 
reduction). This results in destruction of the ephedrine. Clearly, a recoverable ammo 
alcohol would enhance the utility of the chiralmorpholinone based methodology. 
Objective 
The objective of this study was to survey easily-accessible aminoalcohols for the 
synthesis of morpholine-diones which could serve as alternatives to the ephedrine-based 
morpholine-dione. This goal also included a plan to identify an amino alcohol, which 
could be recovered at the end of the synthesis and thus would serve as a chiral auxiliary 
rather than a chiral starting material. Importantly, such a study could also provide some 
understanding of the origin of stereoselectivity in the ephedrine-based template. 
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Results and discussion 
Section 1: Investigations on potentially recoverable chiral amino alcohols. 
The initial objective was to identify a chiral amino alcohol that could be recovered 
easily at the desired stage of the synthesis. It was hoped that synthesis of intermediates 
such as 3 from the diones 2 could be achieved with stereoselectivities similar to those 
derived using the ephedrine-derived morpholine-dione (Scheme 1 ). The dione 2 would, in 
turn, be obtained from the amino alcohol 1 by using a procedure similar to the ephedrine-
based morpholine-dione. 
Scheme 1 
R 
)__ iPh 'N~ f'··'Ph 
H OH 
·------- ..-
·---..- ___ .._ 
It is known that diphenylmethyl ethers are readily cleaved under acidic 
conditions. 1 It was reasoned that in the presence of aqueous acid, diphenylmethyl ether 
cleavage in 3 may be followed by a N~o acyl transfer reaction. Subsequent hydrolysis 
of the resulting ester would give the a.-hydroxy acid 4 and amino alcohol 1 (Figure 1). 
Also, heterolytic C-0 bond cleavage under anhydrous conditions could result in the 
formation of a benzylic carbocation which may react further (Figure 1) to provide the 
required a.-hydroxy acid and the aminoalcohol auxiliary. 
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_______., 1 ;Ph 
H20 'N' !'··'Ph 
H OH 
1 
Figure 1. Proposed removal of the chiral auxiliary in 3. 
With these objectives in mind, the diphenylalaninol 7 was prepared from (S)-
alanine (5, Scheme 2).2 Reaction of (S)-alanine 5 with methanolic-HCl gave the 
corresponding methyl ester which, in turn, was reacted with phenylmagnesium bromide 
to give the tertiary alcohol 6 (70%).3 Formylation of the secondary amine in 6 followed 
by reduction ofthe resulting amide gave the required amino alcohol 7 (86%, two steps). 
Scheme 2 
'f----!<0 Ph 0 0 1) MeOH, HCI 
>-Z·•Ph 1) )1-_0J-_H , CH2CI2, rt Jy,Ph 
'N 'Ph H2N OH 2) PhMgBr, THF H2N OH 2) LiAIH4, THF 0 oc H OH 
5 
o oc 86% (two steps) 6 7 
70% (two steps) 
The reaction of the amino alcohol 7 with oxalyl chloride afforded the dione 8 
(46%, Scheme 3). Treatment of 6 with propylmagnesium bromide yielded 9 as a 4/1 
mixture of diastereomers (86%). The hemiacetal in 9 was allylated (BF3•Et20 
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allyltrimethylsilane, -40 °C) to provide the dialkylated glycolamide derivative 10 (78%) 
as a single diastereomer. Energy minimization (Spartan software, MM2 calculations) 
studies on the oxocarbenium ion intermediate derived from 9 suggested a conformation 
that was very similar to the oxocarbenium ion derived from the corresponding ephedrine-
based hemiacetal. Hence, the stereochemistry of the newly formed stereocenter in 10 was 
tentatively assigned as 'R'. 
Scheme 3 
' ... Ph 
'NT-''Ph 
H OH 
7 
OHO 
Cl Cl 
Et3N, DMAP 
CH2CI2 , 
o ·c to rt 
Single diastereomer 4:1 mixture of diastereomers 
With the dialkyl morpholinone 10 in hand, diphenyl ether cleavage under a variety 
of acid hydrolysis conditions was examined. However, all attempts to effect the desired 
transformation were unsuccessful (Scheme 4, Table 1). 
Scheme 4 
Conditions~ 
, ... 
11 
Table 1: Attempted removal of the chiral auxiliary in 10. 
Entry Reagent and conditions Time 
1 H2S04 (cat), H20, reflux 24 h 
2 CF3COOH, DCM, 55 oc 2h 
3 HBr (33%wt in acetic acid), rt 18 h 
4 H2S04 (cat), HO(CH2)20H, 160 oc 4d 
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+ 
Result 
Decomposition 
No reaction 
Decomposition 
Decomposition 
Diphenylprolinol, was also examined as an alternative to the diphenyl alaninol 
auxiliary (7). Diphenyl((S)-pyrrolidin-2-yl)methanol (15) is commercially available. 
However, it was also easily made from (S)-proline (12) by following a procedure reported 
by Kanth and Periasamy (Scheme 5).4 Protection ofthe amine in 12 as an ethylcarbamate 
gave 13 (96%). Conversion of the carboxylic acid in 13 to a methyl ester followed by its 
reaction with phenylmagnesium bromide gave the alcohol 14 (74%). Finally, alkaline 
hydrolysis of the carbamate in 14 afforded the required amino alcohol15 (92%). 
Scheme 5 
~0 
H OH 
12 96% 
90% 
15 
~0 
A OH 
0 0 
13 ~ 
1) SOCI2, MeOHl 
2) PhMgBr, THF 
70% (two steps) 
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Treatment of diphenyl((S)-pyrrolidin-2-yl)methanol (15) with ethyloxalyl chloride 
gave dione 16 (78%, Scheme 6). Treatment of 16 with propylmagnesium bromide 
provided hemiacetal 17 (86%) as a 3/1 mixture of diastereomers ctH NMR). The 
hemiacetal in 17 failed to undergo allylation when BF3•Et20 was used as a Lewis acid. 
Fortunately, however, allylation of the hemiacetal in 17 could be achieved with TiCl4 and 
allyltrimethylsilane at -40 oc to provide 18 as a 1.7/1 mixture of diastereomers el-I 
NMR). 
Scheme 6 
1\ fh 
"N\···•Ph 
H OH 
15 
1.7:1 mixture of diastereomers 
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3: 1 mixture of diastereomers 
However, as was also seen for compound 10, the dialkyl morpholinone derivative 18 was 
remarkably resistant to acid hydrolysis and could not be converted to the required a-
hydroxy acid. 
Thus, use of the aminoalcohol 7 was partially successful in that it provided 
excellent stereocontrol. However, the yield of the allylation reaction was low and the 
chiral auxiliary could not be removed under the attempted conditions. Aminoalcohol 15 
provided poor stereoselectivity and the auxiliary could not be removed. It should be noted 
that the search for conditions to recover the chiral auxiliary from 10 and 18 remains 
incomplete and will be pursued further in our group. 
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Section 2: Studies with non-recoverable amino alcohols. 
The utility of chiral morpholine-diones similar to the ephedrine-based morpholine-
dione in asymmetric allylation reactions was then explored. Recovery of the amino 
alcohol was not an objective in this particular study. The study commenced with the 
synthesis of the amino alcohol 21 which was prepared from (S)-phenylglycine (19) by 
following a reported procedure (Scheme 7). 5 Thus, formylation of the amine in 19 gave 
the amide 20 (80%). Simultaneous reduction of the amide and the carboxylic acid group 
in 20 gave the required amino alcohol 21 in quantitative yield. 
Scheme 7 
0 0 0 Ph PhHO 
_)lO)lH 
Ph H)lN~O LiAIH4, THF 'N~ H2N OH 
CH2CI2, rt H OH ooc H OH 
19 20 quant. 21 80% 
The morpholine-dione 22 was prepared (32%) from arninoalcohol 21 and 
ethyloxalyl chloride. Treatment of 22 with ethylmagnesium bromide generated the 
hemiacetal 23 (77%, Scheme 8). The diastereoselectivity of the process was moderate 
(311) and the stereochemistry of the major diastereomer was not determined. The 
hemiacetal in 23 was readily allylated (TiC4, allyltrimethylsilane, -40 °C) to provide the 
dialkylated glycolamide derivative 24 (78%) as a 111 mixture of diastereomers ctH NMR, 
Scheme 8). This observation emphasizes the importance of the stereocenter adjacent to 
the oxygen in the ephedrine-derived morpholinone system. The lack of 1,3 stereocontrol 
may be responsible for the completely unselective allylation of23. 
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Scheme 8 
Ph 
OHO Ph 'N~ Et3N, DMAP HN~ Cl OEt 
H OH o)yo 
21 CH2CI2, 0 •c to rt 
32% 0 22 
CH,CH2Mg8' 1 
ether 
77% 
o ·c tort 
Ph Ph 
'N~ ~SiMe3 TiCI 'N~ ' 4 0~ CH2CI2. -78 ·c to 4o•c 0~0 78% OH 
24 ~ 23 
1:1 mixture of diastereomers 3:1 mixture of diastereomers 
Next, the amino alcohol 27 was made from (S)-mandelic acid (25) according to 
the procedure reported by Davies and co-workers (Scheme 9). 6 Reaction of (S)-mandelic 
acid with acetone under acid catalysis generated the dioxolanone derivative 26 (80%). 
Treatment of 26 with methylamine in ethanol, gave N-methylmandelamide, which in turn, 
could be reduced with lithium aluminium hydride to yield the amino alcohol27 (93%). 
Scheme 9 
0 
Ohh A ohph 1) MeNH2, EtOH, rt 'Nl,,,Ph 
HO OH H2S04 (cat.) oxo 2) LiAIH4 , THF 
H OH 
ooc 
25 80% 26 93% 27 
The dione 28 was synthesized from ammo alcohol 27 by using conditions 
identical to those employed for the dione 22 (39%, Scheme 1 0). Treatment of 28 with the 
ethylmagnesium iodide cleanly generated the hemiacetal 29 in 77% yield. The 
294 
diastereoselectivity of the process was moderate (5/1) and the stereochemistry at the 
hemiacetal stereocenter was not determined. The hemiacetal in 29 was readily allylated 
(TiC14, allyltrimethylsilane, -40 °C) to provide the dialkylated morpholinone 30 (68%) as 
a 2/1 mixture of diastereomers eH NMR, Scheme 10). Energy minimization (Spartan 
software) studies on the oxocarbenium ion intermediate derived from 29 suggested a 
conformation that was very similar to the ephedrine-based oxocarbeniurn ion. 
Consequently, the newly formed stereocenter was tentatively assigned the 
'S' configuration. 
Scheme 10 
OHO 
Cl OEt 
"-N/'y'Ph 
'N1·''Ph Et~N, DMAP .. 0~0 H OH CH2CI2, 
27 0 octo rt 0 28 
39% 
CH3CH2MgBr 
ether 
77% 
0 octo rt 
~SiMe3 
'N1·''Ph TiCI4 'N/'y'Ph 
0~ CH2CI2, 0~0 
30 ( "' 
-78 octo 40°C '<::>H 
74% 29 
2:1 mixture of diastereomers single diastereomer 
Interestingly, this allylation reaction proceeded with slightly better stereocontrol 
as compared to that of hemiacetal 23. This observation suggests that 1,3 stereocontrol 
definitely plays a role in the reactions of23 and 29. However, the ephedrine-based system 
.----------------------------------~-------------
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is far superior to either of the two systems described above. Clearly, 1,3 stereocontrol is 
not the only deciding factor. 
The dialkyl morpholinones 24 and 30 could be readily cleaved under dissolving 
metal reduction conditions to afford the hydroxyamides 31 and 32 respectively (Scheme 
11). These results are in tune with expectations and supported the proposed mechanism 
for the removal of the ephedrine portion in the ephedrine-based template (Chapter 2). The 
configuration of the newly formed stereocenter in the major diastereomer in 30 was 
confirmed as 'S' on the basis of the specific rotation of the amide 32 ([a]23o = -6.5 (c 1.7, 
H20)), which indicated an excess of the 'S' enantiomer ([a]23n = +16 (c 1.7, HzO) for 
(R)-24\ 
Scheme 11 
Ph 
'NH 'N~ Na, NH3 0?70H 0?70 THF, -78 oc ~ ~ 90% 
24 31 
'N1·''Ph 'NH Na, NH3 ~H 0~ 0 THF, -78 oc 
90% ~ 
30 32 
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Conclusions 
The search for alternatives to ephedrine has provided some insights into the 
morpholinone structural elements that were necessary for good diastereoselection. It 
appears that both stereocenters in ephedrine may be important for stereoselectivity. 
Diphenylalaninol may be a potential alternative to ephedrine and further investigations on 
this system are currently underway in our laboratories. 
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Experimental 
General 
General experimental techniques that have been described in the experimental section 
of Chapter 2 were followed. 
(S)-4,5-Dimethyl-6,6-diphenylmorpholine-2,3-dione (8): 
To a cold (0 °C), stirred solution of (S)-2-(methylamino )-1 , 1-diphenylpropan-1-ol 
(1.00 g, 4.1 mmol) in dichloromethane (20 mL) was added DMAP (0.03 g, 0.03 mmol). 
Triethylamine (0.23 mL, 16.6 mmol) was added followed by dropwise addition of oxalyl 
chloride (1.05 mL, 12.4 mmol). The mixture was stirred at 0 °C for 1 h and then at 
ambient temperature for 4 h. Cold water was added and the mixture was extracted with 
dichloromethane (3 x 30 mL). The combined organic layers were washed with HCl (2M, 
2 x 20 mL), dried (Na2S04) and concentrated under reduced pressure to give a pale 
yellow oil. Purification of the crude product by flash chromatography on silica gel (7 /3 
ethyl acetate/hexane) gave 0.521 g (46%) of8 as a pale green solid. 
1H NMR (500 MHz, CDCh): 
o 7.44-7.27 (m, lOH), 4.47 (q, 1H, J= 7.5, lH), 3.15 (s, 3H), 1.22 (d, 3H, J = 7.5). 
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13C NMR (125.77 MHz, CDCh): 
8 156.6, 153.5, 141.6, 139.7, 129.5, 129.1 , 128.8, 128.3, 125.7, 124.8, 87.2, 59.1 , 
34.1, 15.2. 
IR (neat): 
2297, 1763, 1681 , 1495, 769 cm-1• 
MS (APCI): 
296.1 (M+ 1, 1 00). 
HRMS (CI): 
rn/z 296.1280 (296.1287 calc. for C1sH1sN03, [M+Ht). 
(SS)-2-Hydroxy-4,5-dimethyl-6,6-diphenyl-2-propylmorpholin-3-one (9) 
'- 1 ~Ph 
ofx't'Ph 
) OH 
To a suspension of 8 (0.495 g, 1.70 mmol) in anhydrous ether (10 mL) at 0 oc 
was added propylmagnesium bromide (prepared from 131 mg of Mg and 0.460 mL of 1-
bromopropane in ether (10 mL)) and the mixture was warmed up to ambient temperature. 
The reaction mixture was stirred 3 hat ambient temperature and saturated aqueous N~Cl 
solution was added. The mixture was stirred to dissolve any precipitated solids and was 
extracted with ethyl acetate (3 x 15 mL). The combined organic layers were dried 
(Na2S04) and concentrated. Purification of the crude product by flash chromatography on 
silica gel (3/1 ethyl acetate/hexane) gave 0.490 g (86%) of 9 as a pale green oil (5/1 
299 
mixture of diastereomers ). 
1H NMR (500 MHz, CDC~]): Major diastereomer. 
o 7.36-7.19 (m, 10H), 4.28 (q, 1H, J = 6.5), 3.17 (s, 3H), 2.50 (s, 1H), 1.93-1.87 
(m, 2H), 1.72-1.67 (m, 1H), 1.66-1.61 (m, 1H), 1.01 (d, 3H, J = 6.5), 1.00 (t, 3H, J 
= 7.5). 
Visible peaks of the minor diastereomer. 
o 7.36-7.19 (m, 10H), 4.22 (q, 1H, J= 6.6), 3.15 (s, 3H), 2.85 (s, 1H), 1.93-1.87 
(m, 2H), 1. 72-1.67 (m, 1 H), 1.66-1.61 (m, 1 H), 1.14 ( d, 3H, J = 6.5), 0.08 (t, 3H, J 
= 7.4) 
13C NMR (125.77 MHz, CDC~)): Major diastereomer. 
0 169.6, 144.2, 142.8, 128.7, 128.4, 128.2, 127.3, 125.5, 97.0, 80.1 , 58.1 , 43.8, 
34.3, 16.5, 15.0, 14.5. 
Visible peaks of the minor diastereomer. 
0 168.4, 144.0, 143.1, 128.4, 128.3, 128.0, 127.7, 125.8, 97.5, 81.8, 58.9, 39.2, 
34.2, 15.4, 14.9, 14.0. 
MS (APCI): 
322.1 (M-H20, 1 00). 
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(2R ,SS)-2-Ally 1-4,5-d imethyl-6,6-dipheny 1-2-p ropy lmo rpholin -3-one (1 0) 
To a solution of 9 (0.214 g, 0.628 mmol) in dichloromethane (6 mL) at - 78 °C 
was added BF3•Et20 (0.470 mL, 3.8 mmol) and allyltrimethylsilane (0.604 mL, 23.8 
mmol). The mixture was gradually warmed to room temperature and allowed to stir at 
this temperature for 1 h . Water was added and the mixture was warmed to ambient 
temperature. The biphase was separated and the aqueous layer was extracted with CH2Ch 
(3 x 10 mL). The combined extracts were dried (Na2S04) and concentrated. The residue 
was purified by flash chromatography on silica (211 ethyl acetate/hexane) to give 0.050 g 
(22%) of 10 as a colourless gum. 
1H NMR (500 MHz, CDCh): 
o 7.30-7.22 (m, 10H), 5.90-5 .85 (m, 1H), 5.01 (br d, 1H), 4.98 (brd, 2H), 4.25 (q, 
1H, J = 6.5), 3.21 (s, 3H), 2.08 (dd, 1H, J = 15 .0, 8.0), 1.85 (dt, 1H, J = 13.0, 4.0), 
1.75 (m, 1H, J = 13 .0, 3.7), 1.72-1.68 (m, 1H), 1.48 (dd, 1H, J = 15 .0, 5.0), 1.39-
1.34 (m, 1H), 0.96 (d, 3H, J = 6.5), 0.92 (t, 3H, J = 7.0). 
13C NMR (125 .77 MHz, CDCh): 
0 171.9, 145.5, 144.0, 134.4, 128.5, 128.4, 127.2, 117.4, 81.0, 79.4, 59.2, 42.2, 
41.1 , 33.9, 18.8, 15.9, 14.5 . 
IR (neat): 
2957, 1648, 1445, 760 cm-1• 
MS (APCI): 
364.2 (M+1, 100). 
HRMS (CI): 
m/z 364.2295 (364.2277 calc. for C24H3oN02, [M+Ht). 
(S)-Tetrahydro-1,1-diphenyl-1H-pyrrolo[2,1-c] [1,4]oxazine-3,4-dione (16) 
n APh 
"~---r'Ph 
o)yo 
0 
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To a cold (0 °C), stirred solution of diphenyl((S)-pyrrolidin-2-yl)methanol (0.250 
g, 1.0 mrnol) in dichloromethane (1 mL) was added DMAP (0.006 g, 0.05 mmol). 
Triethylamine (0.280 mL, 0.200 mrnol) was added followed by dropwise addition of 
ethyloxalyl chloride (6.7 mL, 0.06 mmol). The mixture was stirred at 0 °C for 1 h and 
then at an1bient temperature for 26 h. Cold water was added and the mixture was 
extracted with dichloromethane (3 x 5 mL). The combined organic layers were washed 
with HCI (2M, 3 x 5 mL), dried (Na2S04) and concentrated under reduced pressure to 
give a pale yellow oil. Purification of the crude product by flash chromatography on silica 
gel (7/3 ethyl acetate/hexane) gave 0.250 g (78%) of 16 as a pale yellow oil. 
302 
1H NMR (500 MHz, CDCh): 
cS 7.42-7.33 (m, 8H), 7.15-7.11 (m, 2H), 4.76 (t, 1H, J = 8, 1H), 3.78-3.74 (ddd, J 
= 12.4, 8.7, 2.9 1H), 3.61-3.55 (m, 1H), 2.35-2.2 (m, 2H), 1.97-1.84 (m, 2H). 
13C NMR (125.77 MHz, CDC~)): 
cS 158.0, 152.6, 140.7, 137.6, 129.2, 129.1 , 128.8, 128.7, 128.6, 127.3, 89.8, 63.3, 
46.1 , 29.5, 23.1. 
IR (neat): 
1755, 1689, 1442, 1186, 955 cm-1. 
MS (APCI): 
308.1 (M+1 , 100). 
HRMS (EI): 
mlz 307.1213 (307.1208 calc. for C,9H1 7N03, M+). 
(8S)-Tetrahydro-3-hydroxy-1,1-diphenyl-3-propyl-1 H-pyrrolo [2,1-c] [1,4] oxazin-
4(3H)-one (17) 
n .Ph 
0~'Ph 
) OH 
To a suspension of 16 (0.320 g, 1.04 mmol) in anhydrous THF (10 mL) at 0°C 
was added propylmagnesiumbromide (prepared from 80 mg of Mg and 0.300 mL of 
bromopropane in ether (10 mL)) and the mixture was warmed up to an1bient temperature. 
The reaction mixture was stirred 3 h and saturated aqueous NH4Cl solution was added. 
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The mixture was stirred to dissolve any precipitated solids and was extracted with ethyl 
acetate (3 x 15 mL). The combined organic layers were dried (Na2S04) and concentrated. 
Purification of the crude product by flash chromatography on silica gel (311 ethyl 
acetate/hexane) gave 0.350 g (96%) of 17 as a colourless gum (3/1 mixture of 
diastereomers). 
1H NMR (500 MHz, CDCh): Mixture of diastereomers (A and B) 
8 7.51-7.20 (m, 8H), 6.95-6.93 (m, 2H), 5.08 (t, 1H, J = 7), 3.48-3.40 (m, 2H), 
2.21-2.28 (m, 1H), 2.33-2.28 (m, 1H), 2.10-2.03 (m, lH), 1.93-1.90 (m, lH), 1.76-
1.56 (m, 4H), 1.04 (t, 3H, J = 7), 0.97 (t, 3H, J = 7.4). 
13C NMR (125.77 MHz, CDCh): Diastereomer A 
8 166.8, 146.5, 142.9, 129.8, 128.5, 128.2, 127.8, 127.0, 98.2, 83.1 , 60.1 , 45.0, 
39.9, 31.2, 23 .0, 16.6, 14.5, 14.3. 
Visible peaks of the diastereomer B. 
8 169.0, 144.8, 140.5, 129.8, 128.5, 128.3, 127.9, 127.7, 97.9, 81.3, 66.4, 46.5, 
43.2, 29.7, 22.9, 16.9. 
MS (APCI): 
334.1 (M-H20 , 1 00). 
(3R,8S)-3-Allyl-tetrahydro-1 ,1-diphenyl-3-propyi-1H-pyrrolo [2,1-c] [1 ,4] oxazin-
4(3H)-one (18) 
n .. Ph 
'~f.' Ph 0~~ 
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To a solution of 17 (0.160 g, 0.460 nunol) in dichloromethane (2 mL) at - 78 °C 
was added TiC14 (0.310 mL, 2.7 mmol) and allyltrimethylsilane (0.43 mL, 2.7 nunol). 
The mixture was gradually warmed to - 40 °C and allowed to stir at this temperature for 
5.5 h. Saturated NH4Cl was added and the mixture was warmed to ambient temperature. 
Water was added, the biphase was separated and the aqueous layer was extracted with 
CH2Ch (3 x 10 mL). The combined extracts were dried (Na2S04) and concentrated. The 
residue was purified by flash chromatography on silica (1/1 ethyl acetate/hexane) to give 
0.120 g (70%) of18 as a colourless gum (1.7/1 mixture ofdiastereomers). 
1H NMR (500 MHz, CDCh): Major diastereomer 
o 7.42-7.10 (m, 10H), 5.98-5.90 (m, 1H), 5.21 (br d, 1H), 5.10 (br d, 1H), 4.03-
3.97 (m, 1H), 3.84-3 .74 (m, 2H), 2.68 (dd, 1H, J = 7.0, 13.8), 2.42 (dd, 1H, J = 
7.0, 14.3), 2.19-2.05 (m, 2H), 1.94-1.78 (m, 4H), 1.35-1.19 (m, 2H), 0.50 (t, 3H, J 
= 7.0). 
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1H NMR (500 MHz, CDCh): Visible peaks of the minor diastereomer 
8 7.42-7.10 (m, 10H), 5.74-5.65 (m, 1H), 4.94-4.80 (m, 2H), 4.03-3.97 (m, 1H), 
3.84-3.74 (m, 2H), 2.40-2.34 (m, 2H), 1.94-1.78 (m, 4H), 1.54-1.49 (m, 1H2), 
1.35-1.19 (m, 2H), 0.94 (t, 3H, J= 6.5), 0.39-0.33 (m, 1H). 
13C NMR (125. 77 MHz, CDCh): Major diastereomer 
8 170.9, 145.8, 141.3, 134.0, 130.1 , 128.2, 128.0, 127.1 , 118.7, 82.5, 80.3 , 66.0, 
46.1 , 43.4, 38.4, 29.7, 22.6, 15.9, 14.1. 
13C NMR (125.77 MHz, CDCh): Visible peaks ofthe minor diastereomer. 
145.7, 141.1 , 134.3, 13 .3, 128.3, 128.0, 127.6, 127.1 , 117.6, 82.0, 80.4, 66.2, 46.2, 
41.8, 40.9, 29.8, 22.7, 17.6, 14.5 . 
IR (neat): 
2960, 1647, 1445, 700 cm-1• 
MS (APCI): 
376.1 (M+1 , 100). 
HRMS (CI): m/z 376.2287 (376.2277 calc. for C2sH3oN02, [M+Ht). 
(S)-4-Methyl-5-phenylmorpholine-2,3-dione (22) 
To a cold (0 °C), stirred solution of (S)-2-(methylamino)-2-phenylethanol (0.700 
mg, 2.00 mmol) in dichloromethane (15 mL) was added DMAP (0.031 g, 0.26 mrnol). 
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Triethylamine (2.20 mL, 15.6 mmol) was added followed by dropwise addition of 
ethyloxalyl chloride (0.710 mL, 15.6 mmol). The mixture was stirred at 0 °C for 1 hand 
then at ambient temperature for 48 h. Cold water was added and the mixture was 
extracted with dichloromethane (3 x 15 mL). The combined organic layers were washed 
with HCl (2M, 3 x 15 mL), dried (Na2S04) and concentrated under reduced pressure to 
give a pale yellow oil. Purification of the crude product by flash chromatography on silica 
gel (7/3 ethyl acetate/hexane) gave 0.300 g (32%) of22 as a white solid. 
1H NMR (500 MHz, CDCh): 
8 7.47-7.43 (m, 3H), 7.29-7.24 (m, 2H), 4.85 (dd, 1H, J= 3.6, 11.7) -4.78 (t, 1H, 
J = 3.6), 4.51 (dd, J = 3.6, 11.7, 1H), 3.05 (s, 3H). 
13C NMR (125.77 MHz, CDCh): 
8 156.9, 154.3, 134.1 , 129.7, 129.5, 126.8, 70.26, 61.1 , 33.9. 
IR (neat): 
1752, 1674, 1161 cm-1 
MS (APCI): 
206.1 (M+ 1, 1 00). 
HRMS (CI): 
m/z 205.0742 (205.0739 calc. for C1IHIIN03, M+). 
----------------------------------
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(5S)-2-Ethyl-2-hydroxy-4-methyl-5-phenylmorpholin-3-one (23) 
To a suspension of22 (0.180 g, 0.900 mmol) in anhydrous ether (10 mL) at 0°C 
was added ethylmagnesiumbromide (prepared from 65 mg of Mg and 0.220 mL of 
bromoethane in ether (10 mL)) and the mixture was warmed up to ambient temperature. 
The reaction mixture was stirred 3 h at ambient temperature and the precipitated solids 
were dissolved with saturated aqueous NH.tCl solution. The resulting mixture was 
extracted with ethyl acetate (3 x 5 mL), the combined organic layers were dried (NazS04) 
and concentrated. Purification of the crude product by flash chromatography on silica gel 
(2/1 ethyl acetate/hexane) gave 0.160 g (77%) of 23 as a colourless oil (3/1 mixture of 
diastereomers by 1H NMR). 
1H NMR (500 MHz, CDCh): Major diastreomer 
8 7.42-7.25 (m, 5H), 4.67 (dd, 1H, J = 6.0, 11.0), 4.22 (dd, 1H, J = 11.0, 12.0), 
3.87 (dd, 1H, J = 6.0, 12.0), 2.73 (s, 3H), 2.20-2.11 (m, 1H), 1.92-1.86 (m, 1H), 
0.97 (t, 3H, J = 7.5) . 
Visible peaks of the minor diastreomer 
8 7.42-7.25 (m, 5H), 4.72 (dd, 1H, J= 9.0, 12.0), 3.78 (d, 1H, J = 12.0), 2.93 (s, 
3H), 1.99-1.93 (m, lH), 1.03 (t, 3H, J = 8.0). 
IR (neat): 
1638, 1238, 1191 cm-1• 
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MS (APCI): 
218.1 (M-H20, 100). 
HRMS (CI): 
mlz 236.1292 (236.1287 calc. for C13HisN03, [M+Ht) 
(5S)-2-Allyl-2-ethyl-4-methyl-5-phenylmorpholin-3-one (24) 
Ph 
"N~ 
0~ 
To a solution of23 (0.140 g, 6.00 mmol) in dichloromethane (2 mL) at - 78 ac 
was added TiC14 (0.400 mL, 3.6 mmol) and allyltrimethylsilane (0.6 mL, 3.6 mmol). The 
mixture was gradually warmed to - 40 ac and allowed to stir at this temperature for 3 h. 
Saturated NH4Cl was added and the mixture was warmed to ambient temperature. Water 
was added, the biphase was separated and the aqueous layer was extracted with CHzClz (3 
x 10 mL). The combined extracts were dried (Na2S04) and concentrated. The residue was 
purified by flash chromatography on silica (2/1 ethyl acetate/hexane) to give 0.120 g 
(78%) of24 as a colourless gum (1 /1 mixture of diastereomers). 
1H NMR (500 MHz, CDCh): Mixture of diastereomers (A and B). 
8 7.54-7.23 (m, 10H), 5.91-5.82 (m, 2H), 5.15-5.10 (m, 4H), 4.53-4.48 (m, 1H), 
4.53 (dd, 1H, J = 4.5, 7.2),4.5 (m, 1H), 4.07 (dAB, J = 4.5, 12.4), 3.83 (dAB, J = 
6.8, 12.4), 3.09 (s, 3H), 3.17 (s, 3H), 2.72 (dd, 1H, J = 6.9, 14.2), 2.59-2.50 (m, 
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1H), 2.10-1.96 (m, 1H), 1.89-1.84 (m, 1H), 1.80-1.74 (m, IH), 1.00 (t, J = 7.5, 
1H), 0.94 (t, J = 7.4, 1H), 
13C NMR (125.77 MHz, CDC~)): Diastereomer A. 
8 172.7, 137.3, 133.4, 129.1, 128.6, 127.5, 118.5, 82.1 , 65.4, 63.4, 40.6, 32.8, 
30.2, 7.9. 
13C NMR (125.77 MHz, CDCh): Visible peaks of diastereomer B. 
8 172.7, 137.8, 128.6, 127.3, 118.4, 81.9, 65.2, 63.3, 40.5, 30.0, 29.1 , 8.2. 
IR (neat): 
2973, 1646, 1122 cm-1. 
MS (APCI): 
260.1 (M+1, 100). 
HRMS (EI): 
m/z 259.1570 (259.1572 calc. for C16H21N02, M+). 
(S)-4-Methyl-6-phenylmorpholine-2,3-dione (28) 
To a cold (0 °C), stirred solution of (S)-2-(methylamino)-1-phenylethanol (0.300 
mg, 2 .00 mmol) in dichloromethane (3 mL) was added DMAP (0.013 g, 0.120 mmol). 
Triethylamine (0.850 mL, 6.00 mmol) was added followed by dropwise addition of 
ethyloxalyl chloride (0.250 mL, 2.4 mmol). The mixture was stirred at 0 °C for 1 h and 
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then at ambient temperature for 72 h. Cold water was added and the mixture was 
extracted with dichloromethane (3 x 5 mL). The combined organic layers were washed 
with HCl (2 M, 3 x 5 mL), dried (Na2S04) and concentrated under reduced pressure to 
yield a pale yellow oil. Purification of the crude product by flash chromatography on 
silica gel (7/3 ethyl acetate/hexane) gave 0.160 g (39%) of28 as a white solid. 
1H NMR (500 MHz, CDC~)): 
8 7.46-7.41 (m, 4H), 5.73 (dd, 1H, J = 10.0, 3.0 1H), 3.98 (dd J = 13.0, 10.0, 1H), 
3.61 (dd, J = 13.0, 3.0, 1H), 3.15 (s, 3H). 
13C NMR (125.77 MHz, CDC~)): 
8 156.7, 153.9, 134.4, 129.8, 129.7, 129.2, 126.3 (ArCH), 77.8, 53.5, 35.2. 
IR (neat): 
2936,1752,1690,1231, 1192cm-1 
MS (APCI): 
206.1 (M+1 , 100). 
HRMS (CI): 
mlz 206.0817 (206.0817 calc. for CttHttN03, [M+Ht). 
(6S)-2-Ethyl-2-hydroxy-4-methyl-6-phenylmorpholin-3-one (29) 
To a suspension of28 (0.150 g, 0.700 mmol) in anhydrous ether (10 mL) at 0 oc 
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was added ethylmagnesiurn bromide (prepared from 65 mg of Mg and 0.220 mL of 
bromoethane in ether (10 mL)) and the mixture was warmed up to ambient temperature. 
The reaction mixture was stirred 3 h at ambient temperature and the precipitated solids 
were dissolved with saturated aqueous N~Cl solution. The resulting mixture was 
extracted with ethyl acetate (3 x 5 mL), the combined organic layers were dried (Na2S04) 
and concentrated. Purification of the crude product by flash chromatography on silica gel 
(2/1 ethyl acetate/hexane) gave 0.160 g (77%) of29 as a white solid. 
1H NMR (500 MHz, CDCh): 
8 7.42-7.32 (m, 3H), 5.36 (dd, 1H, J = 3.5, 11.0), 4.07 (brs, 1H), 3.58 (t, 1H, J = 
11.0), 3.30 (1H, dd, J = 3.5, 11.0), 3.02 (s, 3H), 2.18-2.12 (m, 1H), 1.93-1.87 (m, 
1H), 0.99 (t, 3H, J = 7.7 ) . 
13C NMR (125. 77 MHz, CDCh): 
8 168.4, 138.0, 128.7, 128.6, 126.4, 98.5, 69.2, 55.9, 34.8, 33.0, 8.0. 
IR (neat): 
3383,1638, 1231 , 1184cm-1• 
MS (APCI): 
218.1 (M-H20, 100). 
HRMS (EI): 
m/z 236.1290 (236.1287 calc. for C13HisN03, [M+Ht) 
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(6S)-2-Ailyl-2-etbyl-4-metbyl-6-pbenylmorpholin-3-one (30) 
To a solution of 29 (0.140 g, 6.00 mmol) in dichloromethane (2 mL) at - 78 °C 
was added TiC14 (0.400 mL, 3.6 mmol) and allyltrimethylsilane (0.6 mL, 3.6 mmol). The 
mixture was gradually warmed to - 40 oc and allowed to stir at this temperature for 3.5 h. 
Saturated aqueous NH4Cl was added and the mixture was warmed to ambient 
temperature. Water was added, the biphase was separated and the aqueous layer was 
extracted with CH2Ch (3 x 10 rnL). The combined extracts were dried (Na2S04) and 
concentrated. The residue was purified by flash chromatography on silica (2/1 ethyl 
acetate/hexane) to give 0.114 g (74%) of 30 as a colourless gum (2/1 mixture of 
diastereomers ). 
1H NMR (500 MHz, CDCIJ): Major diastereomer 
8 7.42-7.32 (m, 3H), 5.93-5.86 (m, 1H), 5.14-5.10 (m, 3H), 3.61-3.60 (m, 1H), 
3.28 (dd, 1H, J = 2.2, 12.2), 3.03 (s, 3H), 2.86 (dd, 1H, J = 6.1 , 14.6), 2.54-2.51 
(m, 1H) 4.54 (dd, J = 4.1 , 7, 1H), 3.04 (s, 3H), 1.96-1.89 (m, 1H), 1.79-1.73 (m, 
1H), 0.97 (t, 3H, J = 7.2). 
1H NMR (500 MHz, CDCh): Visible peaks of minor diastereomer 
4.94 (m, 2H), 3.54-3.51 (m, 1H), 3.23 (dd, 1H, J = 3.1 , 12.2), 3.03 (s, 3H), 2.10 
(m, 1H), 0.97 (t, 3H, J = 7.2). 
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13C NMR (125.77 MHz, CDCh): Major diastereomer 
8 171.3, 138.7, 133.5, 128.8, 128.7, 126.4, 126.3, 118.4, 82.8, 70.3, 55.9, 41.4, 
34.9, 32.1 , 8.4. 
13C NMR (125.77 MHz, CDCh): Visible peaks of minor diastereomer 
8 171.1 , 138.6, 133.7, 128.7, 128.5, 118.5, 82.8, 70.5, 55.9, 42.3, 34.8, 29.1 , 8.0. 
IR (neat): 
2935, 1646, 1231 cm-1. 
MS (APCI): 
260.1 (M+ 1, 1 00). 
HRMS (EI): 
m/z 259.1575 (259.1572 calc. for C16H21N02, M+H). 
(S)-2-Ethyl-2-hydroxy-N-methylpent-4-enamide (32) 
\ 
NH 
0~ 
To anhydrous liquid ammonia (distilled over sodium) was added Na (0.044 g, 
1.93 mmol) at - 78 oc and the mixture was stirred for 15 min. To the resulting blue 
solution was added a solution of 30 (0.050 g, 0.2 mmol) in anhydrous THF (2.5 mL) and 
the mixture was stirred for 1.5 min. A mixture of 2/1 methanol/water (1.5mL) was added 
and the reaction mixture was brought to ambient temperature and stirred for 30 min to 
remove ammonia. The resulting solution was concentrated under reduced pressure and the 
.--------------------------------~--- ------ -
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residue was purified by flash column chromatography on silica gel (3/2 ethyl 
acetate/hexane) to yield 32 26 mg (90%) as a white solid. 
1H NMR (500 MHz, CDCh): 
8 6.70 (br s, 1H), 5.80-5.72 (m, 1H), 5.21-4.16 (m, 2H), 2.83 (d, 3H, J = 5.4), 
2.71 (dd, 1H, J = 6.5, 13.5), 2.71 (dd, 1H, J = 9.3 , 13.5), 1.92-1.85 (m, 1H), 1.64-
1.56 (m, 1H), 0.89 (t, 3H, J = 7.5) . 
13C NMR (125.77 MHz, CDCh): 
8 175.2 ' 133.0, 120.4, 78.0, 33.9, 32.3, 26.1 ' 8.0. 
IR (neat): 
3349, 2935, 1646 cm-1. 
MS (APCI): 
158.1 (M+1, 100). 
HRMS (CI): 
m/z 157.1102 (157.1103 calc. for CsH1sN02, M+). 
[a]230 = -6.5 (c 1.7, H20). 
A similar reaction of compound 24 provided compound 31 (90%). 
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Future plans 
This thesis describes the applications of an ephedrine-derived morpholine-dione 
as a chiral starting material in the enantioselective synthesis of a-hydroxy acids and 
medium-sized oxacycles. Based on the observations from the present studies, future 
investigations on morpholine-dione systems could examine, 1) expanding the scope of 
the morpholine-dione based synthetic methods and 2) the development of an alternative 
to 1 R,2S ephedrine. 
1) Expanding the scope of the morpholine-dione based synthetic methods: 
So far, only allyltrimethylsilane and allyltributyltin have been used as 
nucleophiles in the reactions of ephedrine-based oxocarbenium ions. The use of other 
carbon nucleophiles will be a useful addition to the existing method. Also, the ring 
opening of ephedrine-derived spiroepoxides with nitrogen nucleophiles can potentially 
lead to the synthesis the a-hydroxy-~-amino acids. Similarly, epoxide opening with 
carbon nucleophiles can lead to a-hydroxy-~,~-dialkylated acids, whereas the use of 
cyanide as a nucleophile may provide access to a-hydroxy-~-alkyl-y-amino acids. A 
synthesis of stereoselectively functionalized tetrahydrofurans, analogous to the 
pyrrolidine synthesis studies, can also be examined. 
2) The development of an alternative to 1R,2S ephedrine: 
Understanding the origin of stereoselectivity m the ephedrine-derived 
morpholine-dione system may help in the development of a recoverable amino alcohol 
replacement for ephedrine. Diphenylalaninol has shown some promise and further 
investigations on related amino alcohols, such as di-p-methoxyphenylalaninol, would be 
interesting. 
Appendix 6: 
X-ray crystallographic data for compound 40 
(Chapter 3) 
X-ray crystallographic data for epoxide 40. 
Sample: VA-11-95 
X-ray Structure Report 
for 
Dr. Sunil V. Pans are 
Prepared by 
Julie L. Collins 
August 4, 2006 
Introduction 
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Collection, solution and refinement all proceeded normally. Hydrogen atoms were included in 
calculated or difference map positions with isotropic parameters set twenty percent greater than 
those of their bonding partners. 
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Experimental 
Data Collection 
A colorless prism crystal of C14H 17N03 having approximate dimensions of 0.20 x 0.15 x 
0.10 mm was mounted on a glass fiber. All measurements were made on a Rigaku Saturn CCD 
area detector with graphite monochromated Mo-Ka radiation. 
Indexing was performed from 165 images that were exposed for 50 seconds. The crystal-
to-detector distance was 35.01 mm. 
Cell constants and an orientation matrix for data collection corresponded to a primitive 
orthorhombic cell with dimensions: 
a = 8.6454(12) A 
b = 10.7876(17) A 
c = 13.704(2) A 
v = 1278.1(3) A3 
For Z = 4 and F.W. = 247.29, the calculated density is 1.285 g/cm3. The systematic absences of: 
hOO: h ± 2n 
OkO: k± 2n 
001: 1 ± 2n 
uniquely determine the space group to be: 
The data were collected at a temperature of -120 ± 1 °C to a maximum 28 value of 61.70. 
A total of 285 oscillation images were collected. A sweep of data was done using ro scans from -
50.0 to 70.00 in 1.00 step, at X= O.oo and ~ = o.oo. The exposure rate was 50.0 [sec./0]. The 
detector swing angle was 10.080. A second sweep was performed using ro scans from -80.0 to 
85.00 in 1.00 step, at x=45.00 and ~ = 90.00. The exposure rate was 50.0 [sec./O]. The detector 
swing angle was 10.080. The crystal-to-detector distance was 35.01 mm. Readout was performed 
in the 0.13 7 mm pixel mode. 
-~--------------------------------------
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Data Reduction 
Ofthe 11571 reflections that were collected, 2916 were unique (Rint = 0.032); equivalent 
reflections were merged. Data were collected and processed using CrystalClear (Rigaku). Net 
intensities and sigmas were derived as follows: 
F2 = [L:(Pi- mBave)] · Lp-l 
where Pi is the value in counts of the ith pixel 
Bave = L:(Bj)/n 
m is the number of pixels in the integration area 
Bave is the background average 
Lp is the Lorentz and polarization factor 
where n is the number of pixels in the background area 
Bj is the value of the jth pixel in counts 
cr2(F2hki) = [(L:Pi) + m((L:(Bave- Bj)2)/(n-1))] · Lp · errmul + ( erradd · F2)2 
where erradd = 0.00 
errmul = 1.00 
The linear absorption coefficient, )-1., for Mo-Ka. radiation is 0.902 cm-1 . The data were 
corrected for Lorentz and polarization effects. A numerical absorption correction was applied 
which resulted in transmission factors ranging from 0.9688 to 0.9791. A correction for secondary 
extinction2 was applied (coefficient = 0.013370). 
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Structure Solution and Refinement 
The structure was solved by direct methods3 and expanded using Fourier techniques4. 
The non-hydrogen atoms were refined anisotropically. Hydrogen atoms were refined using the 
riding model. The final cycle of full-matrix least-squares refinementS on F2 was based on 2916 
observed reflections and 165 variable parameters and converged (largest parameter shift was 
0.00 times its esd) with unweighted and weighted agreement factors of: 
R1 = L liFo! - !Fell I L IFol = 0.0446 
The standard deviation of an observation of unit weight6 was 1.07. Unit weights were 
used. The maximum and minimum peaks on the final difference Fourier map corresponded to 
0.14 and -0.17 e-;A3, respectively. The absolute structure was deduced based on Flack parameter 
-0.1(12), refined using Friedel pair 1234.7 
Neutral atom scattering factors were taken from Cromer and Waber8. Anomalous 
dispersion effects were included in Fcalc9; the values for ilf and ilf' were those of Creagh and 
McAuley 10. The values for the mass attenuation coefficients are those of Creagh and HubbeUll . 
All calculations were performed using the Crysta1Structure12,13 crystallographic software 
package except for refinement, which was performed using SHELXL-9714. 
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EXPERIMENTAL DETAILS 
A. Crystal Data 
Empirical Formula C,4HI7N03 
Formula Weight 247.29 
Crystal Color, Habit colorless, prism 
Crystal Dimensions 0.20 X 0.15 X 0.10 mm 
Crystal System orthorhombic 
Lattice Type Primitive 
Indexing Images 165 images @ 50.0 seconds 
Detector Position 35.01 mm 
Pixel Size 0.137 mm 
Lattice Parameters a= 8.6454(12) A 
b = 10.7876(17)A 
c = 13.704(2) A 
v = 1278.1(3) A3 
Space Group P212(21 (#19) 
Z value 4 
Deale 1.285 g/cm3 
Fooo 528.00 
!J.(MoKa) 0.902 cm-1 
B. Intensity Measurements 
Detector 
Goniometer 
Radiation 
Detector Aperture 
Data Images 
ro oscillation Range (x=O.O, ~=0.0) 
Exposure Rate 
Detector Swing Angle 
ro oscillation Range (x=45.0, 0 =90.0) 
Exposure Rate 
Detector Swing Angle 
Detector Position 
Pixel Size 
29m ax 
No. of Reflections Measured 
Corrections 
Rigaku Saturn 
Rigaku AFC8 
MoKa (A. = 0.71070 A) 
graphite monochromated 
70 nun x 70mm 
285 exposures 
-50.0 - 70.00 
50.0 sec.fO 
10.080 
-80.0 - 85.00 
50.0 sec.fO 
10.080 
35.01 nun 
0.137 mm 
61.70 
Total: 11571 
Unique: 2916 (Rint = 0.032) 
Lorentz-polarization 
Absorption 
(trans. factors: 0.9688 - 0.9791) 
Secondary Extinction 
(coefficient: 1.3 3 700e-002) 
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C. Structure Solution and Refinement 
Structure Solution 
Refinement 
Function Minimized 
Least Squares Weights 
28max cutoff 
Anomalous Dispersion 
No. Observations (All reflections) 
No. Variables 
Reflection/Parameter Ratio 
Residuals: R1 (1>2.00cr(l)) 
Residuals: R (All reflections) 
Residuals: wR2 (All reflections) 
Goodness of Fit Indicator 
Flack Parameter (Friedel pairs = 1234) 
Max Shift/Error in Final Cycle 
Maximum peak in Final Diff. Map 
Minimum peak in Final Diff. Map 
Direct Methods (SIR92) 
Full-matrix least-squares on F2 
w = 1/ [ cr2(Fo2) + (0.0521 · P)2 
+ 0.2055 . p] 
where P = (Max(Fo2,0) + 2Fc2)/3 
55 .0° 
All non-hydrogen atoms 
2916 
165 
17.67 
0.0446 
0.0496 
0.1103 
1.072 
-0.1(12) 
0.000 
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Table 1. Atomic coordinates and BisoiBeq 
atom X y z Beq 
0(1) -0.04806(16) 0.29510(12) 0.49274(9) 3.49(2) 
0(2) 0.07376(18) 0.11116(12) 0.36193(11) 3.92(3) 
0(3) 0.05358(13) 0.44230(11) 0.38061(9) 2.72(2) 
N(1) 0.2450(2) 0.25828(12) 0.31235(11) 3.01(2) 
C(1) -0.2701(2) 0.4001(2) 0.40667(14) 3.52(3) 
C(2) -0.1546(2) 0.29754(19) 0.40991 (13) 3.27(3) 
C(3) 0.0103(2) 0.32095(17) 0.39673(12) 2.83(3) 
C(4) 0.1139(2) 0.22086(17) 0.35573(12) 3.05(3) 
C(5) 0.3466(2) 0.1652(2) 0 .26909( 18) 4.43(4) 
C(6) 0.2967(2) 0.38778(16) 0.30894(12) 2.76(3) 
C(7) 0.2701(2) 0.44345(18) 0.20792(12) 3.25(3) 
C(8) 0.21860(19) 0.45775(16) 0.39176(12) 2.52(2) 
C(9) 0.2533(2) 0.59407(16) 0.39483(12) 2.62(2) 
C(lO) 0.3767(2) 0.63576(19) 0.45148(13) 3.30(3) 
C(11) 0.4095(2) 0.7618(2) 0.45561(14) 4.03(4) 
C(12) 0.3203(2) 0.84583(18) 0.40505(14) 3.90(4) 
C(13) 0.1979(2) 0.80583(17) 0.34906(14) 3.47(3) 
C(14) 0.1649(2) 0.67922(17) 0.34322(13) 3.07(3) 
Beq = 8/3 1t2(U II (aa*)2 + U22(bb*)2 + U33(cc*)2 + 2U 12(aa*bb*)cos y + 2U IJ(aa*cc*)cos p + 2U2J(bb*cc*)cos a) 
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Table 2. Atomic coordinates and B iso involving hydrogens/Beg 
atom X y z Beq 
H(1) -0.3644 0.3744 0.4409 4.22 
H(2) -0.2950 0.4194 0.3386 4.22 
H(3) -0.2269 0.4738 0.4384 4.22 
H(4) -0.1923 0.2149 0.3869 3.92 
H(5) 0.4214 0.1369 0.3180 5.32 
H(6) 0.4018 0.2015 0.2136 5.32 
H(7) 0.2847 0.0946 0.2467 5.32 
H(8) 0.4106 0.3886 0.3216 3.31 
H(9) 0.2965 0.3821 0.1579 3.89 
H(10) 0.3355 0.5169 0.1999 3.89 
H(11) 0.1612 0.4671 0.2011 3.89 
H(12) 0.2509 0.4198 0.4551 3.03 
H(13) 0.4380 0.5784 0.4871 3.96 
H(14) 0.4942 0.7902 0.4937 4.84 
H(15) 0.3434 0.9318 0.4088 4.68 
H(16) 0.1362 0.8640 0.3146 4.16 
H(17) 0.0815 0.6513 0.3038 3.68 
Beq = 8/3 n2(u 11 (aa*)2 + U22(bb*)2 + U33(cc*)2 + 2U 12(aa*bb*)cos y + 2U 13(aa*cc*)cos P + 2U2J(bb*cc*)cos a) 
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Table 3. Anisotropic displacement parameters 
atom u11 u22 U33 u\2 u\3 u23 
0(1) 0.0486(7) 0.0498(8) 0.0343(6) -0.0034(6) -0.0026(5) 0.0104(5) 
0(2) 0.0585(8) 0.0290(6) 0.0614(9) -0.0015(6) -0.0151 (7) 0.0022(5) 
0(3) 0.0311(5) 0.0292(6) 0.0429(6) -0.0003(5) 0.0002(5) 0.0028(4) 
N(l) 0.0460(8) 0.0292(7) 0.0394(7) 0.0064(6) -0.0009(7) -0.0040(5) 
C(1) 0.0387(9) 0.0528(11) 0.0422(9) -0.0026(9) 0.0030(8) 0.0097(9) 
C(2) 0.0412(9) 0.0427(10) 0.0401(9) -0.0069(8) -0.0047(8) 0.0092(8) 
C(3) 0.0406(9) 0.0336(9) 0.0335(8) -0.0039(7) -0.0050(7) 0.0045(7) 
C(4) 0.0461(10) 0.0314(8) 0.0381(9) 0.0003(8) -0.0139(7) -0.0003(7) 
C(5) 0.0677(14) 0.0388(10) 0.0620(13) 0.0141(10) 0.0064(11) -0.0114(10) 
C(6) 0.0337(8) 0.0317(8) 0.0395(9) 0.0018(7) -0.0020(7) -0.0040(7) 
C(7) 0.0475(10) 0.0396(9) 0.0363(9) 0.0019(8) 0.0027(8) -0.0010(7) 
C(8) 0.0317(8) 0.0311 (8) 0.0331(8) 0.0007(6) -0.0047(7) 0.0004(6) 
C(9) 0.0366(8) 0.0331(8) 0.0299(8) -0.0017(7) 0.0031(7) -0.0022(6) 
C(10) 0.0453(10) 0.0438(10) 0.0362(9) -0.0053(8) -0.0050(8) 0.0001(7) 
C(11) 0.0635(13) 0.0504(12) 0.0391(10) -0.0198(10) -0.0071(9) -0.0053(8) 
C(12) 0.0753(14) 0.0324(9) 0.0404(10) -0.0123(9) 0.0089(10) -0.0035(7) 
C(13) 0.0559(11) 0.0327(9) 0.0431(9) 0.0019(8) 0.0063(8) 0.0025(8) 
C(14) 0.0417(9) 0.0337(9) 0.0412(9) 0.0018(7) -0.0002(8) 0.0008(7) 
The general temperature factor expression: exp(-2n2(a*2U11h2 + b*2U22k2 + c*2U33I2 + 
2a*b*U hk + 2a*c*U hl + 2b*c*U kl)) 12 13 23 
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Table 4. Bond lengths (A) 
atom atom distance atom atom distance 
0(1) C(2) 1.462(2) 0(1) C(3) 1.436(2) 
0(2) C(4) 1.236(2) 0(3) C(3) 1.379(2) 
0(3) C(8) 1.444(2) N(l) C(4) 1.342(2) 
N(l) C(5) 1.460(2) N(l) C(6) 1.467(2) 
C(1) C(2) 1.491(2) C(2) C(3) 1.459(2) 
C(3) C(4) 1.511(2) C(6) C(7) 1.526(2) 
C(6) C(8) 1.521(2) C(8) C(9) 1.501(2) 
C(9) C(lO) 1.394(2) C(9) C(14) 1.389(2) 
C(10) C(11) 1.390(2) C(11) C(12) 1.377(3) 
C(12) C(13) 1.377(3) C(13) C(14) 1.398(2) 
--------------------------- - ~------
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Table 5. Bond lengths involving hydrogens (A) 
atom atom distance atom atom distance 
C(l) H(l) 0.980 C(l) H(2) 0.980 
C(l) H(3) 0.980 C(2) H(4) 1.000 
C(5) H(5) 0.980 C(5) H(6) 0.980 
C(5) H(7) 0.980 C(6) H(8) 1.000 
C(7) H(9) 0.980 C(7) H(lO) 0.980 
C(7) H(ll) 0.980 C(8) H(12) 1.000 
C(l O) H(13) 0.950 C(ll) H(14) 0.950 
C(12) H(l5) 0.950 C(13) H(16) 0.950 
C(14) H(17) 0.950 
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Table 6. Bond angles (O) 
atom atom atom angle atom atom atom angle 
C(2) 0(1) C(3) 60.43(11) C(3) 0(3) C(8) 111.15(12) 
C(4) N(1) C(5) 118.74(15) C(4) N(l) C(6) 123.88(15) 
C(5) N(1) C(6) 117.34(16) 0(1) C(2) C(1) 117.29(16) 
0(1) C(2) C(3) 58.91(11) C(l) C(2) C(3) 121.49(17) 
0(1) C(3) 0(3) 115.23(14) 0(1) C(3) C(2) 60.66(11 ) 
0(1) C(3) C(4) 114.20(14) 0(3) C(3) C(2) 116.71(15) 
0(3) C(3) C(4) 117.23(15) C(2) C(3) C(4) 120.10(16) 
0(2) C(4) N(l) 123.73(17) 0(2) C(4) C(3) 119.49(17) 
N(l) C(4) C(3) 116.77(15) N(1) C(6) C(7) 110.96(14) 
N(l) C(6) C(8) 108.28(14) C(7) C(6) C(8) 114.50(14) 
0(3) C(8) C(6) 107.58(13) 0(3) C(8) C(9) 108.27(13) 
C(6) C(8) C(9) 114.72(14) C(8) C(9) C(10) 118.99(15) 
C(8) C(9) C(14) 121.56(15) C(10) C(9) C(14) 119.45(16) 
C(9) C(lO) C(11) 119.64(18) C(10) C(11) C(12) 120.6(2) 
C(11) C(12) C(13) 120.31(18) C(12) C(13) C(14) 119.70(18) 
C(9) C(14) C(13) 120.30(17) 
----------------------~----
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Table 7. Bond angles involving hydrogens (O) 
atom atom atom angle atom atom atom angle 
C(2) C(1) H(l) 109.5 C(2) C(l) H(2) 109.5 
C(2) C(1) H(3) 109.5 H(1) C(1) H(2) 109.5 
H(l) C(l) H(3) 109.5 H(2) C(l) H(3) 109.5 
0(1) C(2) H(4) 115.7 C(1) C(2) H(4) 115.7 
C(3) C(2) H(4) 115.7 N(1) C(5) H(5) 109.5 
N(1) C(5) H(6) 109.5 N(1) C(5) H(7) 109.5 
H(5) C(5) H(6) 109.5 H(5) C(5) H(7) 109.5 
H(6) C(5) H(7) 109.5 N(1) C(6) H(8) 107.6 
C(7) C(6) H(8) 107.6 C(8) C(6) H(8) 107.6 
C(6) C(7) H(9) 109.5 C(6) C(7) H(lO) 109.5 
C(6) C(7) H(11) 109.5 H(9) C(7) H(10) 109.5 
H(9) C(7) H(ll) 109.5 H(lO) C(7) H(11) 109.5 
0(3) C(8) H(12) 108.7 C(6) C(8) H(12) 108.7 
C(9) C(8) H(12) 108.7 C(9) C(10) H(13) 120.2 
C(11) C(lO) H(13) 120.2 C(10) C(11) H(14) 119.7 
C(12) C(11) H(14) 119.7 C(11) C(12) H(15) 119.8 
C(13) C(12) H(15) 119.8 C(12) C(13) H(16) 120.1 
C(14) C(13) H(16) 120.2 C(9) C(14) H(17) 119.9 
C(13) C(14) H(17) 119.8 
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Table 8. Torsion Angles(O) 
atom1 atom2 atom3 atom4 angle atom1 atom2 atom3 atom4 angle 
C(2) 0(1) C(3) 0(3) 107.77(17) C(2) 0(1) C(3) C(4) -112.22(18) 
C(3) 0(1) C(2) C(1) -112.05(19) C(3) 0(3) C(8) C(6) 67.52(16) 
C(3) 0(3) C(8) C(9) -167.97(13) C(8) 0(3) C(3) 0(1) 98.07(16) 
C(8) 0(3) C(3) C(2) 166.40(15) C(8) 0(3) C(3) C(4) -40.70(19) 
C(5) N(1) C(4) 0(2) 0.5(2) C(5) N(1) C(4) C(3) -178.21(17) 
C(4) N(l) C(6) C(7) -1 04.45(19) C(4) N(l) C(6) C(8) 22.0(2) 
C(6) N(l) C(4) 0(2) -176.96(17) C(6) N(l) C(4) C(3) 4.4(2) 
C(5) N(1) C(6) C(7) 78.1(2) C(5) N(1) C(6) C(8) -155.46(16) 
0(1) C(2) C(3) 0(3) -105.34(16) 0(1) C(2) C(3) C(4) 102.57(17) 
C(1) C(2) C(3) 0(1) 104.98(19) C(1) C(2) C(3) 0(3) -0.4(2) 
C(l) C(2) C(3) C(4) -152.44(17) 0(1) C(3) C(4) 0(2) 46.3(2) 
0(1) C(3) C(4) N(1) -135.00(16) 0(3) C(3) C(4) 0(2) -174.57(16) 
0(3) C(3) C(4) N(1) 4.2(2) C(2) C(3) C(4) 0(2) -22.6(2) 
C(2) C(3) C(4) N(1) 156.12(17) N(1) C(6) C(8) 0(3) -56.34(17) 
N(1) C(6) C(8) C(9) -176.86(14) C(7) C(6) C(8) 0(3) 68.04(18) 
C(7) C(6) C(8) C(9) -52.5(2) 0(3) C(8) C(9) C(10) 147.44(16) 
0(3) C(8) C(9) C(14) -32.1(2) C(6) C(8) C(9) C(lO) -92.42(19) 
C(6) C(8) C(9) C(14) 88.0(2) C(8) C(9) C(lO) C(11) -179.52(17) 
C(8) C(9) C(14) C(13) 178.67(17) C(10) C(9) C(14) C(13) -0.9(2) 
C(14) C(9) C(lO) C(11) 0.0(2) C(9) C(lO) C(11) C(12) 0.7(3) 
C(lO) C(11) C(l2) C(13) -0.5(3) C(11) C(12) C(13) C(14) -0.4(3) 
C(12) C(13) C(l4) C(9) 1.0(3) 
The sign is positive ifwhen looking from atom 2 to atom 3 a clock-wise motion of atom I would 
superimpose it on atom 4. 
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Table 9. Distances beyond the asymmetric unit out to 3.60 A 
atom atom distance atom atom distance 
0(1) N(l)l) 3.266(2) 0(1) C(1i) 3.479(2) 
0(1) C(4) 1) 3.590(2) 0(1) C(5) 1) 3.416(2) 
0(2) C(1)2) 3.449(2) 0(2) C(13t) 3.469(2) 
0(2) C(14t 3.564(2) N(1) 0(1) ) 3.266(2) 
C(1) 0(1) ) 3.479(2) C(l) 0(2) 1) 3.449(2) 
C(2) C(13t) 3.570(2) C(4) O(li) 3.590(2) 
C(5) 0(1) ) 3.416(2) C(ll) C(14t) 3.589(2) 
C(13) 0(2)6) 3.469(2) C(13) C(2)) 3.570(2) 
C(14) 0(2)7) 3.564(2) C(14) C(11)8) 3.589(2) 
Symmetry Operators: 
(1) X+1/2-1,-Y+l/2,-Z+1 (2) X+I/2,-Y+l/2,-Z+l 
(3) X,Y-1 ,Z (4) -X,Y+1 /2-1,-Z+1/2 
(5) X+1/2,-Y+l/2+1,-Z+1 (6) X,Y+1,Z 
(7) -X,Y+ 1/2,-Z+ 1/2 (8) X+1/2-1,-Y+ 112+ 1,-Z+ 1 
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Table 10. Distances beyond the asymmetric unit out to 3.60 A involving hydrogens 
atom atom distance atom atom distance 
0(1) H(l)t) 2.587 0(1) H(4)1> 3.492 
0(1) H(5)2) 2.708 0(1) H(8)2) 3.244 
0(1) H(12i> 2.984 0(1) H(15)3> 3.374 
0(2) H(1)1) 2.758 0(2) H(3)1) 3.361 
0(2) H(11)4> 2.699 0(2) H(13)2) 3.137 
0(2) H(15)5> 3.097 0(2) H(16)5) 2.797 
0(2) H(17)4> 2.673 0(3) H(14)3) 3.400 
0(3) H(16t) 3.249 N(1) H(17)4) 3.440 
C(1) H(7)) 2.972 C(1) H(8)7) 2.999 
C(1) H(13)7> 3.359 C(l) H(15)3) 3.263 
C(1) H(16)4) 3.268 C(2) H(12)2) 3.096 
C(2) H(16)4) 3.163 C(2) H(17)4) 3.386 
C(3) H(1)1) 3.251 C(3) H(16t 3.194 
C(3) H(17)4) 3.395 C(4) H(1) > 2.976 
C(4) H(16t) 3.536 C(4) H(17)4> 2.863 
C(5) H(2)) 3.067 C(5) H(10t) 3.208 
C(5) H(15t) 3.163 C(6) H(1) ) 3.447 
C(6) H(2) ) 3.570 C(7) H(4)6> 3.274 
C(7) H(5)to) 3.405 C(7) H(13)tt) 3.529 
C(9) H(6)to) 3.527 C(9) H(14)3> 2.985 
C(10) H(6)to) 3.047 C(lO) H(9)t2) 3.207 
C(10) H(14t) 3.484 C(11) H(3)t3) 3.412 
C(11) H(6) o) 2.909 C(11) H(9)t o) 3.250 
C(12) H(2)6) 3.439 C(12) H(3)t 3) 2.926 
C(12) H(5)t4) 3.471 C(12) H(6)t o) 3.292 
C(12) H(7)t4) 3.465 C(12) H(9)t o) 3 .445 
C(12) H(14t> 3.468 C(13) H(2)6) 2.970 
C(l3) H(4) > 3.380 C(13) H(7)t4) 3.498 
C(13) H(13t> 3.414 C(13) H(14i) 2.970 
C(14) H(4) ) 3.186 C(14) H(14t) 2.698 
H(1) 0(1i) 2.587 H(l) 0(2) ) 2.758 
H(l) C(3)2> 3.251 H(l) C(4)2> 2.976 
H(l) C(6/> 3.447 H(1) H(5)7) 3.583 
H(1) H(7)6) 3.567 H(1) H(8)7> 2.546 
H(l) H(12)7> 3.367 H(1) H(13t> 2.856 
H(l) H(15)3> 3.440 H(2) C(5) > 3.067 
H(2) C(6)7) 3.570 H(2) C(12)4> 3.439 
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Table 10. Distances beyond the asymmetric unit out to 3.60 A involving hydrogens (continued) 
atom atom distance atom atom distance 
H(2) C(13)4> 2.970 H(2) H(5)6> 3.362 
H(2) H(6)6> 3.260 H(2) H(7)6> 2.224 
H(2) H(8)7> 2.577 H(2) H(13/> 3.523 
H(2) H(15t> 3.419 H(2) H(16)4> 2.578 
H(3) 0(2) ) 3.361 H(3) C(11)3l 3.412 
H(3) C(12)3) 2.926 H(3) H(6)6> 3.558 
H(3) H(7)6> 2.895 H(3) H(13)7> 3.180 
H(3) H(14)3) 3.317 H(3) H(15l) 2.407 
H(4) 0(1i> 3.492 H(4) C(7) > 3.274 
H(4) C(13)4> 3.380 H(4) C(14t> 3.186 
H(4) H(5)7> 3.571 H(4) H(1 0)4> 2.740 
H(4) H(11)4) 2.945 H(4) H(12i> 2.653 
H(4) H(16)4> 3.232 H(4) H(17t> 2.867 
H(5) 0(1)1) 2.708 H(5) C(7)8> 3.405 
H(5) C(12)5) 3.471 H(5) H(1)9l 3.583 
H(5) H(2)4> 3.362 H(5) H(4)9> 3.571 
H(5) H(8)8> 3.598 H(5) H(1 0)8> 2.480 
H(5) H(15)5) 2.627 H(6) C(9)8l 3.527 
H(6) C(10)8> 3.047 H(6) C(ll )8> 2.909 
H(6) C(12)8> 3.292 H(6) H(2)4> 3.260 
H(6) H(3)4) 3.558 H(6) H(10)8> 3.244 
H(6) H(13t> 3.353 H(6) H(14)8l 3.129 
H(7) C(1) l 2.972 H(7) C(12)5> 3.465 
H(7) C(13)5l 3.498 H(7) H(1)4) 3.567 
H(7) H(2)4> 2.224 H(7) H(3)4> 2.895 
H(7) H(8)8) 3.572 H(7) H(10)8l 3.467 
H(7) H(15)5> 2.878 H(7) H(16t> 2.950 
H(7) H(17)4l 3.297 H(8) 0(1) ) 3.244 
H(8) C(1)9> 2.999 H(8) H(1)9) 2.546 
H(8) H(2)9> 2.577 H(8) H(5)1 0) 3.598 
H(8) H(7)t o) 3.572 H(9) C(lO)tt ) 3.207 
H(9) C(11)8> 3.250 H(9) C(12)8l 3.445 
H(9) H(12) 11 > 3.530 H(9) H(13) tt ) 3.126 
H(9) H(14)8> 2.927 H(9) H(15t> 3.289 
H(lO) C(5)t o) 3.208 H(10) H(4) > 2.740 
H(lO) H(5)1 0) 2.480 H(lO) H(6)t o) 3.244 
H(10) H(7)t o) 3.467 H(10) H(12)11 l 3.503 
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Table 10. Distances beyond the asymmetric unit out to 3.60 A involving hydrogens (continued) 
atom atom distance atom atom distance 
H(10) H(15t> 3.282 H(11) 0(2)6) 2.699 
H(ll) H(4) l 2.945 H(11) H(13(,11) 3.095 
H(11) H(16)4> 2.809 H(12) 0(1) ) 2.984 
H(12) C(2)1> 3.096 H(12) H(1)9> 3.367 
H(12) H(4)1> 2.653 H(12) H(9)12) 3.530 
H(12) H(10)12> 3.503 H(13) 0(2)1) 3.137 
H(13) C(1)9) 3.359 H(13) C(7)12) 3.529 
H(l3) C(13J 13> 3.414 H(13) H(1)9> 2.856 
H(l3) H(2) > 3.523 H(13) H(3)9> 3.180 
H(13) H(6)10) 3.353 H(13) H(9)12) 3.126 
H(13) H(11?:12) 3.095 H(13) H(16) 13> 3.273 
H(l4) 0(3) 3) 3.400 H(l4) C(9)13) 2.985 
H(14) C(10)13> 3.484 H(14) C(12)13) 3.468 
H(14) C(13)13> 2.970 H(14) C(14~ 13> 2.698 
H(14) H(3)13) 3.317 H(14) H(6) o) 3.129 
H(14) H(9)1 0) 2.927 H(14) H(16ll3) 3.344 
H(l4) H(l71,13> 2.945 H(15) 0(1) 3) 3.374 
H(15) 0(2) 4) 3.097 H(15) C(1)13) 3.263 
H(l5) C(5)14) 3.163 H(15) H(l)l3) 3.440 
H(15) H(2)6> 3.419 H(15) H(3)13) 2.407 
H(15) H(5)1 4) 2.627 H(15) H(7)14) 2.878 
H(15) H(9)1 0l 3.289 H(15) H(102:10> 3.282 
H(16) 0(2)14) 2.797 H(16) 0(3) ) 3.249 
H(16) C(l ) 6) 3.268 H(16) C(2)6> 3.163 
H(l6) C(3)6> 3.194 H(16) C(4)6> 3.536 
H(16) H(2)6> 2.578 H(l6) H(4)6> 3.232 
H(16) H(7)14) 2.950 H(16) H(ll)6> 2.809 
H(16) H(13t> 3.273 H(16) H(l4tl 3.344 
H(17) 0(2) ) 2.673 H(l7) N(1) > 3.440 
H(l7) C(2)6> 3.386 H(l7) C(3)6> 3.395 
H(17) C(4)6> 2.863 H(l7) H(4)6l 2.867 
H(l7) H(7)6> 3.297 H(17) H(14)3) 2.945 
Symmetry Operators: 
(1) X+1/2,-Y+l/2,-Z+1 (2) X+ 1/2-1,-Y+ 1/2,-Z+ 1 
(3) X+l /2-1 ,-Y+l/2+1,-Z+ 1 (4) -X,Y+1/2-1 ,-Z+l/2 
(5) X,Y-l ,Z (6) -X,Y+l /2,-Z+1/2 
(7) X-1 ,Y,Z (8) -X+1,Y+1/2-1 ,-Z+l/2 
(9) X+1,Y,Z (10) -X+1,Y+ l/2,-Z+1/2 
(11) -X+1/2,-Y+1,Z+1/2-1 
(13) X+1/2,-Y+1/2+1,-Z+1 
(12) -X+l/2,-Y+l,Z+l/2 
(14) X,Y+l ,Z 
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